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ABSTRACT	  
	  
	  	   Retinopathy	   of	   Prematurity	   (ROP)	   is	   a	  major	   cause	   of	   vision	   loss	   in	   the	   pediatric	  
population.	  A	  growing	  body	  of	  evidence	  suggests	  that	  a	  heritable	  component	  contributes	  to	  
risk	  of	  disease	  development.	  Identification	  of	  genes	  that	  modify	  disease	  susceptibility	  may	  
provide	  a	  means	  to	  determine	  which	  children	  are	  at	  higher	  risk	  of	  developing	  ROP,	  as	  well	  
as	   identify	  potential	  pharmacological	   targets	   to	  prevent	  progression	  of	  disease	   to	  vision-­‐
threatening	  stages.	  Using	  the	  murine	  model	  of	  ROP,	  oxygen-­‐induced	  retinopathy	  (OIR),	  we	  
developed	   a	   mapping	   cross	   that	   identified	   2	   quantitative	   trait	   loci	   associated	   with	  
resistance	   to	   OIR.	   This	   work	   also	   found	   an	   association	   between	   albinism	   and	   reduced	  
retinal	  avascular	  area.	  As	  albinism	  in	  our	  study	  was	  caused	  by	  loss	  of	  function	  of	  Tyrosinase	  
(Tyr),	   we	   confirmed	   that	   function	   of	   this	   gene	   is	   associated	   with	   increased	   risk	   of	   OIR	  
susceptibility	   using	   the	   Tyr-­‐null	   murine	   strain.	   Tyr	   function	   was	   also	   found	   to	   inhibit	  
endothelial	  progenitor	  cell	  (EPC)	  proliferation,	  mobilization,	  and	  recruitment	  to	  the	  retina.	  
Subsequent	   studies	   exploring	   the	   mechanism	   of	   these	   findings	   demonstrated	   that	   Tyr	  
function	   contributes	   to	   peripheral	   production	   of	   dopamine,	   and	   that	   dopamine	   inhibits	  
retinal	  revascularization	  and	  EPC	  recruitment	  to	  the	  retina	  by	  signaling	  through	  the	  D1-­‐like	  
family	  of	   receptors.	  A	   time	  course	  study	  examining	   the	  number	  of	  EPCs	   in	  bone	  marrow,	  
blood,	   and	   retina	   using	   both	   Tyr-­‐null	   and	   wild-­‐type	   mice	   identified	   patterns	   of	  
proliferation,	   mobilization,	   and	   recruitment	   associated	   with	   more	   and	   less	   successful	  
response	   to	   OIR.	   This	   study	   additionally	   suggested	   that	   retinal	   revascularization	   and	  
associated	   EPC	   response	   in	   this	  model	   begins	   prior	   to	   the	   customary	   time	   point	   of	   P12,	  
which	  has	  important	  implication	  for	  future	  studies	  seeking	  to	  modify	  EPC	  contribution	  to	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this	  disease.	  A	  microarray	  analysis	  comparing	  transcriptional	  regulation	  between	  strains	  of	  
mice	  known	  to	  be	  susceptible	  and	  resistant	  to	  OIR	  identified	  additional	  pathways	  that	  also	  
contribute	   to	   disease	   susceptibility,	   and	   identified	   several	   areas	   of	   interest	   for	   future	  
experiments.	   Together,	   these	   studies	   describe	   a	   novel	   role	   of	   dopaminergic	   signaling	   in	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RETINA	  
The	  human	  retina,	  although	  less	  than	  10	  cm2	  in	  area	  (Kolb,	  2005),	  is	  an	  exceedingly	  
complex	  and	  active	  tissue.	  Located	  along	  the	  posterior	  of	  the	  eye,	  the	  retina	  is	  comprised	  of	  
55	  distinct	  types	  of	  cells,	   including	  5	  types	  of	  neurons	  and	  2	  types	  of	  glia	  (Ye,	  Wang	  et	  al.,	  
2009),	   organized	   into	   10	   distinct	   layers	   (Figure	   1.1).	   Within	   these	   layers	   lie	   parallel	  
microcircuits	  made	  of	  millions	  of	  neurons	  that	  work	  together	  to	  receive	  visual	  input	  as	  light	  
energy	  and	  convert	   it	   into	  an	  electrical	   signal.	  This	   signal	   is	   subsequently	   transmitted	  via	  
the	   optic	   nerve	   to	   the	   visual	   cortex	   in	   the	   occipital	   lobe	   of	   the	   brain	   for	   processing	   and	  
perception	  (Dorrell,	  Friedlander	  et	  al.,	  2007).	  	  
Light	   transduction	   is	   a	   metabolically	   demanding	   process,	   and	   the	   adult	   retina	  
consumes	  more	  oxygen	  per	  unit	  weight	  of	  any	  other	  tissue	  in	  the	  human	  body.	  A	  sufficient	  
blood	   supply	   is	   therefore	   critical	   to	   its	   function	   (Chan-­‐Ling	  and	  Stone,	  1993;	   Saint-­‐Geniez	  
and	  D'Amore,	   2004;	   Sapieha,	   2012).	   To	  meet	   the	   demands	   of	   this	   high	   level	   of	  metabolic	  
activity,	   two	   distinct	   vascular	   beds	   serve	   the	   retina:	   the	   choriocapillaris	   and	   the	   retinal	  
vasculature.	   The	   choroidal	   vasculature	   is	   derived	   from	   the	   ophthalmic	   artery.	   Located	  
posterior	   to	   the	   retinal	   pigment	   epithelium	   (RPE),	   it	   supplies	   the	   outer	   retinal	   layers,	  
including	   the	   outer	   plexiform	   and	   nuclear	   layers,	   the	   photoreceptors,	   and	   the	   RPE.	   The	  
choriocapillaris	   additionally	   supplies	   the	  macula,	   the	   area	   of	   the	   retina	   that	   provides	   fine	  
visual	  discrimination	  (Dorrell,	  Friedlander	  et	  al.,	  2007;	  Anand-­‐Apte	  and	  Hollyfield,	  2010).	  	  
The	  retinal	  vasculature	  originates	  from	  the	  central	  retinal	  artery.	  Upon	  entering	  the	  
eye,	   it	   branches	   into	   4	   intraretinal	   arteries.	   In	   higher	   order	   mammals,	   these	   intraretinal	  
arteries	  form	  3	  layers	  of	  vessels	  –	  the	  superficial,	  intermediate,	  and	  deep	  plexuses	  –	  which	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Figure	  1.1.	  Anatomy	  and	  organization	  of	  the	  human	  retina.	  	  
The	  human	   retina	   is	   located	   along	   the	   posterior	  wall	   of	   the	   eye.	   It	   consists	   of	   10	   distinct	  
layers	  of	  cells,	  with	  3	  vascular	  plexi.	   Images	  adapted	  from	  Webvision:	  The	  Organization	  of	  
the	   Retina	   and	   Visual	   System,	   Webvision,	   http://webvision.med.utah.edu, Creative	  
Commons	  Attribution-­‐Noncommercial	  license.	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  are	   interconnected	   by	   capillaries	   (Gariano	   and	   Gardner,	   2005).	   Blood	   returns	   via	   a	  
corresponding	   venous	   system	   that	   exits	   the	   eye	   as	   the	   central	   retinal	   vein.	   The	   retinal	  
vasculature	   is	   responsible	   for	   supplying	   the	   innermost	   layers	   of	   the	   retina,	   including	   the	  
ganglion	   cell	   layer,	   inner	   and	   the	   nuclear	   and	   plexiform	   layers	   (Dorrell	   and	   Friedlander,	  
2006).	  
Appropriate	  organization	  of	  the	  retinal	  vasculature	  is	  also	  critical	  for	  retinal	  function.	  
Each	  vascular	  plexus	  has	  specific	  and	  conserved	  locations	  within	  the	  structure	  of	  the	  retina.	  
The	  superficial	  plexus	  forms	  within	  the	  ganglion	  cell	   layer,	  and	  the	  deep	  and	  intermediate	  
plexuses	  form	  at	  the	  outer	  and	  inner	  edges	  of	  the	  inner	  nuclear	  layers,	  respectively	  (Figure	  
1.1).	  If	  the	  vasculature	  does	  not	  form,	  the	  retina	  may	  degenerate	  due	  to	  hypoxic	  stress.	  If	  it	  
forms	  but	  is	  improperly	  organized,	  or	  if	  vessels	  are	  located	  within	  regions	  of	  the	  retina	  that	  
normally	   remain	   avascular,	   such	   as	   the	   photoreceptor	   layer	   or	   the	   macula,	   then	   visual	  
function	  may	   be	   disrupted	   (Dorrell,	   Friedlander	   et	   al.,	   2007).	   Examples	   of	   these	   diseases	  
include	   neovascular	   (‘wet”)	   age-­‐related	   macular	   degeneration	   and	   proliferative	   diabetic	  
retinopathy	  (Gariano	  and	  Gardner,	  2005).	  
	  
RETINAL	  VASCULAR	  DEVELOPMENT	  
Unlike	  other	  species,	  human	  retinal	  vascular	  development	  occurs	  almost	  completely	  
in	   utero,	   an	   environment	   that	   has	   relatively	   low	   oxygen	   tension	   (PaO2	   =	   30	   mm	   Hg)	  
(Polverini,	   Cotran	   et	   al.,	   1977;	   Fleck	   and	   McIntosh,	   2008)	   compared	   to	   the	   extrauterine	  
environment	  (PaO2	  =	  60-­‐100	  mm	  Hg)	  (Chen	  and	  Smith,	  2007).	  This	  process	  begins	  during	  
the	  second	  trimester	  and	  continues	  until	  almost	  full	  gestational	  term,	  approximately	  36	  –	  40	  
weeks	  postmenstrual	  age	  (PMA)	  (Chan-­‐Ling	  and	  Stone,	  1993).	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FETAL	  BLOOD	  SUPPLY	  
The	   developing	   eye	   is	   supplied	   by	   the	   hyaloid	   and	   choroidal	   vasculature	   systems.	  
These	   structures	   begin	   to	   form	   approximately	   5	   weeks	   after	   conception.	   The	   choroidal	  
vasculature	   arises	   from	   the	   neural	   tube	   vasculature	   and	   initially	   forms	   a	   large	   plexus	   of	  
primitive	   vessels	   that	   extend	   around	   the	   developing	   optic	   cup.	   Over	   time,	   this	   plexus	  
increases	  in	  density	  and	  size.	  The	  growth	  of	  the	  choroidal	  vasculature	  is	  largely	  dependent	  
on	   growth	   factors	   produced	   by	   the	   RPE	   (Saint-­‐Geniez	   and	   D'Amore,	   2004).	   The	   choroid	  
begins	  branching	  during	   the	  eleventh	  week	  post-­‐conception	  and	  matures	  during	   the	   third	  
and	  fourth	  months	  of	  gestation	  (Anand-­‐Apte	  and	  Hollyfield,	  2010).	  
The	  hyaloid	  artery	  originates	  from	  the	  primitive	  dorsal	  ophthalmic	  artery	  and	  passes	  
through	   the	   embryonic	   fissure	   into	   the	   optic	   cup.	   It	   next	   extends	   through	   the	   primitive	  
vitreous	   and	   reaches	   the	   developing	   lens	   where	   it	   branches	   to	   form	   a	   dense	   capillary	  
network	  around	  the	  lens	  surface.	  This	  network	  anastomoses	  with	  the	  annular	  vessel	  at	  the	  
anterior	  of	  the	  optic	  cup	  to	  connect	  with	  the	  choroidal	  vasculature,	  which	  also	  serves	  as	  a	  
venous	  drain	   for	   the	  hyaloid	   artery.	  The	  hyaloid	   system	   is	   complete	  by	   approximately	  11	  
weeks	   after	   conception,	   and	   supplies	   the	   anterior	   and	   intraoptic	   structures	   of	   the	  
developing	   eye	   (Saint-­‐Geniez	   and	   D'Amore,	   2004).	   The	   hyaloid	   vasculature	   begins	   to	  
undergo	  macrophage-­‐mediated	   apoptosis	   as	   the	   retinal	   vasculature	   develops	   in	   the	   later	  
half	  of	  gestation	  and	  completely	  regresses	  by	  birth	  (Fruttiger,	  2007).	  
	  
VASCULOGENESIS	  
Vasculogenesis,	  or	   the	   formation	  of	  blood	  vessels	  de	  novo,	   is	   thought	   to	   initiate	   the	  
development	  of	  the	  retinal	  vasculature	  in	  humans	  and	  other	  primates	  (Dorrell,	  Friedlander	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et	   al.,	   2007).	  At	  approximately	  14	   to	  15	  weeks	  PMA	  (Chan-­‐Ling	  and	  Stone,	  1993;	  Hughes,	  
Yang	  et	  al.,	  2000;	  Fleck	  and	  McIntosh,	  2008),	  vascular	  precursor	  cells	  (VPCs)	  appear	  at	  the	  
optic	   nerve	   head	   (Chan-­‐Ling).	   These	   progenitor	   cells	   are	   concentrated	   in	   4	   lobes	   that	  
correspond	  to	  future	  artery-­‐vein	  pairs.	  VPCs	  then	  migrate	  anteriorly	  along	  the	  retina	  tissue;	  
cells	  remaining	  behind	  unite	  to	  form	  cords,	  which	  become	  patent,	  primitive	  vascular	  tubes	  
by	  approximately	  15	  weeks	  PMA	  (Chan-­‐Ling;	  Hughes,	  Yang	  et	  al.,	  2000;	  Fleck	  and	  McIntosh,	  
2008).	  Vasculogenesis	  forms	  the	  primitive	  vasculature	  of	  a	  portion	  of	  the	  superficial	  retinal	  
plexus,	  the	  first	  layer	  of	  the	  retinal	  vasculature	  to	  form	  (Chan-­‐Ling	  and	  Stone,	  1993;	  Dorrell,	  
Friedlander	   et	   al.,	   2007).	   This	   process	   is	   independent	   of	   oxygen-­‐regulated	   factors	   and	   is	  
generally	   complete	   by	   21	   weeks	   PMA	   (Chan-­‐Ling;	   Hughes,	   Yang	   et	   al.,	   2000;	   Fleck	   and	  
McIntosh,	  2008).	  	  
	  
ANGIOGENESIS	  
Angiogenesis	  describes	  the	  formation	  of	  new	  blood	  vessels	  from	  existing	  vasculature.	  
This	   process	   is	   driven	   by	   perceived,	   or	   “physiologic”,	   tissue	   hypoxia	   (Saint-­‐Geniez	   and	  
D'Amore,	   2004).	   In	   oxygen-­‐sufficient	   conditions,	   prolyl	   hydroxylase	   domain	   proteins	  
hydroxylate	   specific	   proline	   residues	   in	   hypoxia-­‐inducible	   factor-­‐1α	   (HIF-­‐1α)	   target	  
proteins.	  Hydroxylated	  HIF-­‐1α	  proteins	  are	  recognized	  by	  von	  Hippel-­‐Lindau	  E3	  ubiquitin	  
ligase	   complex	   and	   subsequently	   degraded.	   In	   hypoxic	   conditions,	   however,	   insufficient	  
supply	  of	  oxygen	  prevents	  hydroxylation	  of	  HIF-­‐1α.	  The	  more	  stable,	  unhydroxylated	  HIF-­‐
1α	  binds	   to	   the	  HIF-­‐1β	  subunit.	  The	  resulting	  heterodimer	   forms	  an	  active	   transcriptional	  
complex	   that	   initiates	   expression	   of	   hundreds	   of	   genes	   that	   promote	   angiogenesis.	   Most	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important	   among	   these	   HIF-­‐1	   target	   genes	   is	   vascular	   endothelial	   growth	   factor	   (VEGF)	  
(Fraisl,	  Mazzone	  et	  al.,	  2009).	  
	   Retinal	   vasculature	  develops	   in	   close	  association	  with	   supporting	  astrocytes	   (Fleck	  
and	  McIntosh,	  2008).	  Prior	  to	  initiation	  of	  vessel	  growth,	  astrocytes	  migrate	  into	  the	  retina	  
and	   grow	   peripherally	   to	   create	   a	  mesh-­‐like	   template.	   In	   response	   to	   perceived	   hypoxia,	  
these	  cells	  produce	  VEGF	  and	  other	  pro-­‐angiogenic	  HIF-­‐1	  gene	  targets,	  as	  described	  (Chan-­‐
Ling;	  Gariano	  and	  Gardner,	  2005).	  Stimulated	  by	  these	  factors,	  nascent	  vessels	  sprout	  from	  
existing	   structures	   formed	  by	  vasculogenesis.	  Each	  vascular	   sprout	   is	   led	  by	  a	   specialized	  
“tip	   cell”,	   a	   type	   of	   endothelial	   cell	   (EC)	   that	   forms	   filopodia	   at	   the	   leading	   edge	   of	   the	  
developing	  vascular	  front,	  which	  responds	  to	  the	  gradient	  of	  VEGF	  to	  guide	  the	  developing	  
vessel.	  To	  ensure	  that	  only	  one	  EC	  becomes	  a	  tip	  cell	  in	  each	  sprout,	  Notch	  signaling	  tightly	  
regulates	   this	   response	   by	   lateral	   inhibition.	   Tip	   cells	   express	   higher	   levels	   of	   Delta-­‐like	  
ligand	  4	   (Dll4),	  which	  acts	  on	  neighboring	  stalk	  cells’	  Notch	  receptors.	  Upon	  binding	  Dll4,	  
Notch	   is	   cleaved	   to	   release	   the	   notch	   intracellular	   domain,	   which	   is	   transported	   to	   the	  
nucleus	   to	  decrease	   expression	  of	  VEGF	   receptor	  2	   (VEGFR2).	  Reduced	  VEGF	   signaling	   in	  
stalk	  cells	  results	  in	  their	  proliferation	  rather	  than	  migration,	  so	  that	  they	  form	  the	  length	  of	  
the	  nascent	  vessel.	  This	  signaling	  pathway	  effectively	  represses	  the	  formation	  of	  multiple	  tip	  
cells	  (Hellstrom,	  Phng	  et	  al.,	  2007;	  Jakobsson,	  Franco	  et	  al.,	  2010).	  	  
In	   addition	   to	  proliferation	  of	   existing	  ECs,	   bone	  marrow	   (BM)-­‐derived	  endothelial	  
progenitor	   cells	   (EPCs)	   are	   also	   incorporated	   into	  developing	  vessels.	  Mobilization	  of	   this	  
cell	   population	   from	   the	   BM	   is	   stimulated	   by	   systemic	   expression	   of	   colony	   stimulating	  
factors,	   VEGF,	   and	   erythropoietin	   (EPO).	   Cells	   subsequently	   migrate	   to	   the	   site	   of	  
angiogenesis	  by	  unclear	  mechanisms.	   It	   is	  believed	   that	   this	  critical	  step	  relies	  on	  cell-­‐cell	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interactions	  between	  EPCs	  and	  existing	  ECs	  via	  integrin	  expression	  (Urbich	  and	  Dimmeler,	  
2004).	   HIF-­‐1α	   activity	   stimulates	   increased	   production	   of	   stromal	   cell-­‐derived	   factor-­‐1	  
(SDF-­‐1),	   or	   chemokine	   (C-­‐X-­‐C)	   motif	   ligand	   12	   (CXCL12),	   which	   been	   shown	   to	   be	  
chemotactic	   for	   EPCs	   via	   interactions	   with	   their	   chemokine	   (C-­‐X-­‐C)	   motif	   receptor	   4	  
(CXCR4)	   receptor	   (Semenza,	   2009).	   Once	   EPCs	   arrive	   to	   the	   site	   of	   angiogenesis,	   they	  
incorporate	   into	   developing	   vessel	   walls	   and	   differentiate	   into	   mature	   ECs	   (Urbich	   and	  
Dimmeler,	  2004).	  
Wnt	  signaling	  plays	  a	  crucial	  role	  in	  retinal	  angiogenesis,	  the	  importance	  of	  which	  is	  
highlighted	   in	   cases	   of	   pathology.	   Wnt	   molecules	   are	   secreted	   glycoproteins	   that	   act	   on	  
specific	   families	   of	   cell	   surface	   receptors	   and	   their	   co-­‐receptors,	   ultimately	   producing	   an	  
intracellular	  signal	  to	  inhibit	  the	  degradation	  of	  cytosolic	  β-­‐catenin.	  β-­‐catenin	  subsequently	  
translocates	   to	   the	   nucleus	   where	   it	   forms	   a	   complex	   with	   transcription	   factors	   and	  
activates	  transcription	  of	  target	  genes.	  In	  the	  retina	  specifically,	  Muller	  glial	  cells	  produce	  a	  
non-­‐canonical	  Wnt	  ligand,	  Norrin.	  Norrin	  binds	  with	  the	  frizzled	  4	  receptor	  (FZD4)	  and	  low-­‐
density	   lipoprotein	   receptor-­‐related	   protein	   5	   (LRP5)	   or	   6	   co-­‐receptor	   on	   both	   neuronal	  
and	  vascular	  cells.	  Tetraspanin-­‐12	  (TSPAN12)	   is	  expressed	  only	  on	  ECs,	  where	   it	  binds	   to	  
FZD4	  to	  enhance	  signaling,	  possibly	  by	  inducing	  receptor	  clustering	  at	  the	  cell	  surface.	  Loss	  
of	  this	  signaling	  pathway	  through	  mutations	  in	  any	  of	  the	  described	  genes	  results	  in	  delayed	  
and	   disorganized	   vascular	   growth	   with	   characteristic	   retinal	   defects:	   loss	   of	   the	  
intermediate	  and	  deep	  plexuses,	   tortuous	  and	  dilated	  primary	  arteries	  and	  veins,	  delayed	  
regression	  of	  the	  hyaloid	  vasculature,	  and	  frequently	  intraocular	  hemorrhage	  (Ye,	  Wang	  et	  
al.,	  2009).	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Angiogenesis	  begins	  between	  17	  and	  18	  weeks	  PMA	   in	   the	  human	   retina	   (Hughes,	  
Yang	   et	   al.,	   2000;	   Fleck	   and	  McIntosh,	   2008)	   and	   completes	   the	   formation	   of	   the	   nascent	  
retinal	   vascular	   system	   (Fleck	   and	   McIntosh,	   2008).	   Sprouting	   occurs	   first	   in	   avascular	  
spaces	  between	  the	  radial	  vessels	  nearest	  the	  optic	  nerve.	  Over	  time,	  vessels	  form	  centrally	  
to	  peripherally,	  following	  the	  centrifugal	  gradient	  of	  VEGF	  produced	  by	  astrocytes.	  (Gariano	  
and	  Gardner,	   2005).	   By	   approximately	   25	  weeks	   PMS,	   branches	   from	   the	   still-­‐developing	  
superficial	   plexus	   dive	   posteriorly	   to	   begin	   the	   forming	   the	   deep	  plexus	   (Chan-­‐Ling).	   The	  
intermediate	  plexus	  forms	  last,	  and	  is	  formed	  by	  sprouting	  from	  both	  the	  superficial	  and	  the	  
deep	   plexuses	   (Dorrell,	   Friedlander	   et	   al.,	   2007).	   Angiogenesis	   is	   additionally	   responsible	  
for	  the	  formation	  of	  the	  dense	  peripheral	  capillary	  systems,	  and	  numerous	  arterial-­‐venous	  
arcades	  (Hughes,	  Yang	  et	  al.,	  2000;	  Fleck	  and	  McIntosh,	  2008).	  The	  most	  peripheral	  retina	  is	  
vascularized	  by	  approximately	  36	  to	  40	  weeks	  PMA	  (Polverini,	  Cotran	  et	  al.,	  1977).	  
As	   the	   vascular	   front	   moves	   peripherally,	   more	   central	   vessels	   begin	   to	   recruit	  
pericytes	  to	  initiate	  vessel	  maturation	  and	  stabilization	  (Dorrell	  and	  Friedlander,	  2006).	  ECs	  
lining	  nascent	  vessels	  secrete	  platelet-­‐derived	  growth	  factor,	  which	  acts	  as	  a	  potent	  mitogen	  
for	  mural	   cells	   (Dorrell,	   Friedlander	   et	   al.,	   2007).	  Wnt	   signaling	   has	   also	   been	   proven	   to	  
contribute	   to	   vascular	   stabilization	   by	   enhancing	   EC	   interactions	   with	   pericytes	   and	  
promoting	   pericyte	   proliferation	   (Ye,	  Wang	   et	   al.,	   2009).	   Pericytes	   then	  wrap	   around	   the	  
ECs	   and	   function	   to	   create	   a	   blood-­‐retinal	   barrier.	   During	   the	   final	   stages	   of	   vascular	  
development,	  pericytes	  stabilize	  the	  nascent	  vessels	  even	  as	  VEGF	  levels	  decline,	  as	  well	  as	  
to	  prevent	  vessel	  leakage	  (Dorrell,	  Friedlander	  et	  al.,	  2007).	  	  
The	   final	   steps	   of	   retinal	   vascular	   development	   involve	   pruning	   of	   superfluous	  
vessels	   formed	  during	   the	   process	   of	   angiogenesis.	   The	   nascent	   vessels	   are	   remodeled	   in	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response	   to	   relative	   tissue	   hyperoxia	   (Dorrell	   and	   Friedlander,	   2006),	  which	   leads	   to	   up-­‐
regulation	  of	  intercellular	  cell	  adhesion	  molecule	  1	  (ICAM-­‐1)	  on	  the	  luminal	  surface	  of	  ECs.	  
Circulating	   leukocytes	   bind	   ICAM-­‐1	   via	   interactions	   with	   their	   surface	   expression	   of	   the	  
CD18	  molecule,	   leading	  to	  extravasation	  and	  activation	  of	  these	  cells.	  Activated	  leukocytes	  
then	   initiate	   Fas-­‐ligand-­‐mediated	   apoptosis	   of	   unnecessary	   vessels.	   Unstable,	   mural	   cell-­‐
deficient	   vessels	   are	   leakier,	   thus	   favoring	   increased	   leukocyte	   recruitment	   and	  apoptosis	  
(Dorrell,	   Friedlander	   et	   al.,	   2007).	   This	   final	   step	   in	   retinal	   vascularization	   generates	   the	  
mature	  vasculature	  (Chan-­‐Ling	  and	  Stone,	  1993).	  
	  
RETINOPATHY	  OF	  PREMATURITY	  
SIGNIFICANCE	  
Retinopathy	   of	   Prematurity	   (ROP)	   is	   a	   leading	   cause	   of	   blindness	   in	   the	   pediatric	  
population	   (Hughes,	   Yang	   et	   al.,	   2000).	   A	   type	   of	   retinal	   vascular	   disease,	   ROP	   affects	  
approximately	   16,000	   (Hartnett,	   2010),	   or	   7.4%	  of	   (Lad,	  Nguyen	   et	   al.,	   2008),	   premature	  
infants	  in	  the	  US.	  Among	  other	  causes	  of	  childhood	  blindness,	  ROP	  is	  estimated	  to	  account	  
for	   6-­‐18%	   of	   cases	   in	   industrialized	   countries	   (Coats,	   2005).	   ROP	   is	   more	   prevalent	   in	  
countries	  with	   low	   infant	  mortality	   rates,	   in	   large	  part	   because	   those	  with	  high	  mortality	  
rates	   often	   lack	   sufficient	   resources	   to	   care	   for	   premature	   infants.	   In	   countries	   with	  
moderate	   and	   low	   infant	   mortality	   rates,	   ROP	   is	   a	   significant	   and	   increasing	   cause	   of	  
childhood	   blindness	   (Gilbert	   and	   Foster,	   2001;	   Wheatley,	   Dickinson	   et	   al.,	   2002;	   Coats,	  
2005).	   Some	   studies	   suggest	   that	   the	   increase	   in	   cases	   from	  middle	   income	   countries	   in	  
Latin	  America	  and	  Eastern	  Europe	  may	  lead	  to	  an	  epidemic	  of	  ROP	  (Gilbert,	  2008).	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Although	   ROP	   affects	   a	   relatively	   small	   number	   of	   people,	   it	   causes	  
disproportionately	   large	   burden	   of	   disease	   due	   to	   the	   extremely	   early	   onset	   of	   visual	  
impairment.	   Blind	   children	   have	  more	   frequent	   and	   lengthier	   hospital	   stays	   compared	   to	  
sighted	  children,	  and	  are	  significantly	  more	  likely	  to	  have	  comorbid	  diseases.	  Additionally,	  
blindness	   impacts	   normal	   motor,	   language,	   and	   social	   development	   (Crewe,	   Lam	   et	   al.,	  
2013).	  This	  often	  necessitates	  special	  education	  and	  training,	  despite	  which	  blind	  children	  
have	  reduced	  productivity	  potential.	   In	   the	  US,	   the	   federal	  and	  state	  government	  assumes	  
much	  of	   the	  economic	  burden,	  often	   in	  the	   form	  of	  disability	  pay	  and	  medical	  care	  (Coats,	  
2005).	  In	  developing	  countries,	  the	  costs	  incurred	  both	  from	  care	  of	  a	  premature	  infant	  and	  
the	  subsequent	  needs	  of	  a	  blind	  child	  may	  be	  catastrophic	  for	  the	  family	  (Gilbert	  and	  Muhit,	  
2012).	  	  
In	   addition	   to	   impact	   overall	   health	   and	   economic	   expenses,	   blindness	   has	   a	  
staggering	   emotional	   cost	   for	   both	   the	   child	   and	   the	   child’s	   family.	   ROP	   often	   becomes	  
severe	   enough	   to	   threaten	   vision	   at	   approximately	   the	   same	   time	   as	   infants	   become	  
medically	  stable,	  exacerbating	  the	  emotional	  impact	  on	  parents	  who	  have	  already	  suffered	  
much	  anxiety	  over	  the	  health	  of	  their	  premature	  infant	  (Ryan,	  2001).	  Furthermore,	  because	  
ROP	   is	   a	   preventable	   disease,	   its	   associated	   costs	   –	   financial,	   emotional,	   and	   social	   –	   are	  
incurred	   unnecessarily	   (Coats,	   2005).	   For	   these	   reasons,	   it	   was	   identified	   by	   the	   World	  
Health	  Organization	  (WHO)	  as	  a	  target	  cause	  of	  preventable	  blindness	  in	  their	  Vision2020:	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Originally	   termed	   “retrolental	   fibroplasia”	   (RLF),	  ROP	  was	   first	  described	   in	   a	   case	  
study	  report	   in	  1942.	  Terry	  observed	   the	  development	  of	  bilateral	   lesions	   in	  7	  premature	  
infants,	  all	  of	  which	  followed	  3	  characteristics:	  partial	  or	  complete	  persistence	  of	  the	  hyaloid	  
vasculature,	   the	   presence	   of	   embryonic	   connective	   tissue	   posterior	   to	   the	   lens,	   and	  
maintained	   fibrillar	   structure	   of	   the	   vitreous	   (Terry,	   1942).	   Several	   other	   cases	   were	  
subsequently	   reported	   that	   same	   year,	   and	   an	   epidemic	   number	   of	   cases	   soon	  developed	  
both	  in	  the	  US	  and	  world-­‐wide	  (Coats,	  2005).	  
Owens	   and	   Owens	   proved	   in	   1950	   that	   infants	   were	   born	   with	   a	   normal	   hyaloid	  
system	  and	  developed	  RLF	  post-­‐natally	  (Owens	  and	  Owens,	  1950).	  At	   that	   time	  there	  was	  
no	   indication	   as	   to	   the	   cause	   of	   this	   disease,	   and	   initial	   hypotheses	   included	   deficient	  
development	   of	   aqueous	   humor	   and	   improper	   development	   of	   the	   ciliary	   body	   (Terry,	  
1944).	   X-­‐ray	   treatment	  was	   the	   first	   therapeutic	   attempt	   to	   improve	   the	   vision	   of	   infants	  
with	  RLF,	  with	  very	  disappointing	  results	  (Terry,	  1944).	  	  
The	  role	  of	  oxygen	  therapy	  in	  the	  development	  of	  ROP	  was	  not	  identified	  until	  almost	  
a	  decade	  after	  Terry’s	  initial	  observations.	  In	  1951,	  Campbell	  reported	  an	  increased	  rate	  of	  
ROP	   in	   infants	  with	   higher	   levels	   of	   administered	   oxygen	   (Campbell,	   1951;	   Coats,	   2005).	  
Shortly	   after	   her	   published	   results,	   Patz	   conducted	   a	   randomized,	   prospective	   trial	   of	  
oxygen	   therapy	   confirming	   Campbell’s	   findings	   (Patz,	   Hoeck	   et	   al.,	   1952;	   Coats,	   2005).	  
Oxygen	  administration	  had	  become	  commonplace	  in	  neonatal	  care	  in	  the	  1930s	  and	  1940s,	  
with	   unchecked	   use	   (Coats,	   2005).	   After	   identifying	   oxygen	   as	   a	  major	   risk	   factor	   in	   the	  
development	  of	  ROP,	   its	  use	  was	  dramatically	   curtailed.	  While	   rates	  of	  blindness	  dropped	  
from	   7.9	   cases	   to	   1.2	   per	   100,000	   from	   1950	   to	   1965,	   it	   unfortunately	   also	   lead	   to	   an	  
increase	  in	  neonatal	  morbidity	  and	  mortality	  (Coats,	  2005).	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The	   field	  of	  neonatal	   care	   improved	  over	   the	   following	  decades	  such	   that	  very	   low	  
birth	  weight	  premature	  infants,	  those	  weighing	  less	  than	  1,000	  g,	  were	  surviving	  in	  record	  
numbers	   by	   the	   1970s	   and	   1980s.	   This	   lead	   to	   a	   concurrent	   resurgence	   of	   ROP	   and	   an	  
interest	   in	   better	   understanding	   the	   disease	   (Coats,	   2005).	   Thus,	   the	   International	  
Classification	   of	  Retinopathy	   of	   Prematurity	   (ICROP)	  developed	   a	   staging	   system	   to	  more	  
objectively	  describe	  disease	  development	  and	  compare	  outcomes	  (Lang	  and	  Bishop,	  1993;	  
Lutty,	  Chan-­‐Ling	  et	  al.,	  2006),	  and	  the	  first	  major	  clinical	  trial	  was	  begun	  in	  the	  mid	  1980s	  
(Hartnett	  and	  Penn,	  2012).	  	  
Recently,	  ROP	  has	  become	  a	  more	  prevalent	  cause	  of	  childhood	  blindness	  in	  middle-­‐
income	  countries.	  Nations	  such	  as	  Sri	  Lanka,	  Lithuania,	  Thailand,	  and	  the	  Philippines	  have	  
reported	   their	   first	   documented	   cases	   of	   ROP	   within	   the	   last	   decade.	   As	   their	   neonatal	  
intensive	   care	   improves,	   allowing	   the	   survival	   of	   increasingly	   premature	   infants,	   ROP	   is	  
expected	  to	  become	  a	  more	  common	  cause	  of	  childhood	  blindness	  (Broderick,	  Hoek	  et	  al.,	  
2002;	  Davies,	   Eubanks	   et	   al.,	   2003).	  Accordingly,	   several	   international	   organizations	  have	  
dedicated	   resources	   to	  ROP	  prevention	   and	   treatment,	   including	   the	  WHO	  and	   the	  Global	  
Initiative	  for	  the	  Elimination	  of	  Avoidable	  Blindness	  (Broderick,	  Hoek	  et	  al.,	  2002).	  	  
	  
PATHOGENESIS	  
As	   vascular	   development	   in	   the	   human	   retina	   is	   not	   complete	   until	   almost	   full	  
gestational	  term	  (Figure	  1.2A),	  premature	  children	  are	  likely	  to	  be	  born	  with	  incompletely	  
vascularized	  peripheral	  tissue	  (Figure	  1.2B).	  The	  relative	  hyperoxia	  of	  room	  air	  (PaO2	  =	  60-­‐	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Figure	  1.2	  Pathogenesis	  of	  ROP.	  	  
(A)	  An	  illustration	  of	  the	  retinal	  vasculature	  of	  a	  full-­‐term	  child	  at	  birth.	  Blood	  vessel	  have	  
grown	  to	  supply	  the	  peripheral	  tissue.	  (B)	  Illustration	  of	  the	  vasculature	  of	  a	  pre-­‐term	  child	  
at	   birth.	   The	   blood	   vessels	   have	   not	   yet	   reached	   the	   peripheral	   retina,	   and	   the	   relative	  
hyperoxia	  of	  the	  extrauterine	  environment	  inhibits	  further	  vascularization,	  the	  first	  phase	  of	  
ROP.	   (C)	   As	   the	   retina	   becomes	  more	  metabolically	   active,	   the	   avascular	   tissue	   becomes	  
increasingly	  hypoxic.	  Astrocytes	   in	   these	  areas	  express	  VEGF	  and	  other	  angiogenic	   factors	  
as	   a	   result	   of	   increased	   HIF-­‐1	   signaling.	   This	   leads	   to	   neovascularization	   at	   the	   juncture	  
between	  vascular	  and	  avascular	  retina	  (D).	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100	  mm	  Hg,	  assuming	  intact	  lung	  function)	  relative	  to	  uterine	  conditions	  (PaO2	  =	  30	  mm	  Hg)	  
(Chen	   and	   Smith,	   2007)	   leads	   to	   vasoattenuation	   and	   regression	   of	   existing	   vessels	  
(Polverini,	  Cotran	  et	  al.,	  1977;	  Chen	  and	  Smith,	  2007).	  This	  creates	   the	   first	  phase	  of	  ROP	  
(Figure	  1.2C).	  This	  stage	  generally	  occurs	  from	  birth	  to	  30-­‐32	  weeks	  PMA	  (Chen	  and	  Smith,	  
2007).	  
The	  second,	  or	  proliferative,	   stage	  of	  ROP	  begins	  around	  32-­‐34	  weeks	  PMA.	  As	   the	  
infant	  matures,	  the	  retinal	  tissue	  becomes	  more	  metabolically	  active.	  Increased	  demands	  for	  
oxygen	  combined	  with	  prior	  attenuation	  of	  blood	  vessels	  results	  in	  hypoxia	  of	  the	  avascular	  
periphery.	   The	   ischemic	   tissue	   responds	   by	   expressing	   HIF-­‐1	   target	   genes	   such	   as	   VEGF,	  
which	   can	   result	   in	   neovascularization	   (NV)	   at	   the	   junction	   between	   the	   vascular	   and	  
avascular	  retina	  (Figure	  1.2D).	  Over	  time,	  neovessels	  can	  leak	  or	  produce	  a	  fibrous	  scar	  that	  
can	  retract	  and	  cause	  retinal	  detachment,	   the	  most	  dangerous	  complication	  of	  ROP	  (Penn,	  
Tolman	  et	  al.,	  1993;	  Chen	  and	  Smith,	  2007).	  	  
The	  development	  of	  ROP	  is	  divided	  into	  5	  clinical	  stages	  based	  on	  severity	  of	  retinal	  
findings	  during	  dilated	  indirect	  ophthalmic	  exam,	  as	  defined	  by	  ICROP	  (Ryan,	  2001;	  Lutty,	  
Chan-­‐Ling	  et	  al.,	  2006;	  Hartnett	  and	  Penn,	  2012).	  Retinae	  in	  the	  first	  stage	  of	  ROP	  have	  a	  line	  
demarcating	   vascular	   and	   avascular	   peripheral	   zones;	   this	   is	   the	   first	   clinical	   sign	   of	  ROP	  
development	  and	  is	  pathognomonic	  for	  the	  disease.	  In	  Stage	  2,	  this	   line	  has	  grown	  in	  both	  
height	  and	  width	  to	  form	  an	  appreciable	  ridge.	  Neovascularization	  of	  the	  ridge	  characterizes	  
Stage	  3	  ROP,	  which	  may	  be	  continuous	  with	  the	  ridge	  or	  grow	  perpendicularly	  to	  enter	  the	  
intravitreal	  space.	  If	   the	  disease	  progresses	  to	  partial	  retinal	  detachment,	   it	   is	  classified	  as	  
Stage	   4;	   the	   fifth	   and	  most	   severe	   stage	   is	   defined	   by	   total	   retinal	   detachment.	   The	   term	  
“Plus	  Disease”	   is	   often	  used	   in	   conjunction	  with	   the	   staging	   system	   to	  denote	   that	   retinal	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vessels	  appear	  dilated	  and	  tortuous,	  an	  indication	  of	  vascular	  incompetence	  and	  a	  worsened	  
prognosis	  (Ryan,	  2001;	  Hartnett	  and	  Penn,	  2012).	   	  Additionally,	  a	  diagnosis	  of	  “threshold”	  
ROP	  indicates	  a	  50%	  likelihood	  of	  developing	  a	  retinal	  detachment	  (Coats,	  2005)	  
Clinically,	   ROP	   is	   also	   described	   in	   terms	   of	   the	   area	   of	   retina	   containing	  
neovascularization.	  To	  standardize	  this,	  the	  retina	  is	  divided	  into	  zones.	  Zone	  I	  includes	  an	  
area	   with	   a	   radius	   extending	   from	   the	   optic	   disk	   that	   is	   twice	   the	   distance	   between	   the	  
center	  of	  the	  disk	  and	  the	  center	  of	  the	  macula.	  Disease	  in	  this	  zone	  is	  the	  most	  difficult	  to	  
treat,	   and	   has	   the	   highest	   risk	   of	   recurrence.	   Zone	   II	   encircles	   Zone	   I,	   and	   extends	   to	   the	  
nasal	   extent	   of	   the	   retina.	   The	   radius	   of	   Zone	   II	   is	   three	   times	   the	   distance	   between	   the	  
center	   of	   the	   disk	   and	   the	   center	   of	   the	   macula.	   The	   third	   and	   final	   zone	   includes	   the	  
remainder	  of	  the	  retina,	  and	  is	  largely	  made	  of	  peripheral	  tissue	  (Ryan,	  2001).	  	  
ROP	   is	   a	   self-­‐limiting	   disease,	   which	   eventually	   becomes	   inactive	   and	   can	   even	  
spontaneously	   regress.	   Even	   in	   cases	   of	   spontaneous	   regression,	   however,	   children	   with	  
ROP	   do	   not	   return	   to	   normal	   ophthalmological	   status.	   Long-­‐term	   complications	   include	  
reduced	   visual	   acuity,	   decreased	   contrast	   sensitivity,	   refractive	   errors,	   and	   strabismus.	  
Some	   premature	   infants	   additionally	   suffer	   from	   improperly	   differentiated	   macula	  
(Hellstrom,	  Ley	  et	  al.,	  2010).	  Over	   time,	   the	  retina	  may	  also	  undergo	  pigmentary	  changes,	  
thin,	   or	   degenerate	   (Ryan,	   2001).	   These	   children	   also	   carry	   a	   life-­‐long	   increased	   risk	   of	  
glaucoma,	  cataract	  formation,	  retinal	  breaks,	  and	  retinal	  detachment,	  all	  of	  which	  threaten	  
vision	  (Ryan,	  2001;	  Lutty,	  Chan-­‐Ling	  et	  al.,	  2006;	  Hellstrom,	  Ley	  et	  al.,	  2010).	  Permanent	  and	  
vision-­‐impairing	   sequelae	   are	   determined	   by	   the	   maximum	   severity	   of	   disease.	  
Approximately	  half	  of	   infants	  with	  diagnosed	  ROP	  will	   regresses	   in	  early	   stages,	   and	   thus	  
have	  fewer	  long-­‐term	  complications,	  while	  the	  remaining	  half	  will	  progress	  to	  severe	  stages	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(Coats,	  2005).	  It	  is	  currently	  unclear	  why	  ROP	  progresses	  to	  a	  severe	  stage	  in	  these	  children	  
despite	  timely	  intervention	  (Shastry,	  2010).	  	  
	  
CLINICAL	  MANAGEMENT	  	  
	   In	  the	  US,	  it	  is	  recommended	  that	  infants	  born	  at	  less	  than	  30	  weeks	  PMA	  or	  weigh	  
less	  than	  1500	  g	  at	  birth	  receive	  a	  dilated,	  indirect	  ophthalmic	  exam	  at	  a	  chronological	  age	  
of	  4-­‐6	  weeks	  or	  at	  post-­‐gestational	   age	  of	  31	  weeks.	  Additional	   screening	  exams	  are	   then	  
scheduled	  as	  recommended	  by	  the	  ophthalmologist	  on	  the	  basis	  of	  retinal	  findings	  (Hartnett	  
and	  Penn,	  2012).	  	  
	   Current	   management	   of	   ROP	   focuses	   on	   treating	   neovascularization.	   Diode	   laser	  
photocoagulation	  is	  the	  mainstay	  of	  current	  approaches,	  which	  is	  used	  to	  cauterize	  involved	  
areas	   of	   the	   retina	   (Sapieha,	   Joyal	   et	   al.,	   2010).	   Complications	   of	   this	   procedure	   include	  
corneal	   edema,	   intraocular	   hemorrhage	   and	   cataract	   formation,	   all	   of	   which	   may	  
compromise	   vision	   (Chen,	   Stahl	   et	   al.,	   2011).	   While	   this	   prevents	   further	   NV,	   and	   thus	  
reduces	  risk	  of	  retinal	  detachment,	  it	  permanently	  destroys	  the	  peripheral	  retina	  and,	  with	  
it,	  a	  portion	  of	  the	  child’s	  visual	  field	  (Hellstrom,	  Ley	  et	  al.,	  2010).	  	  
	  
MAJOR	  CLINICAL	  TRIALS	  	  
The	   first	  multicenter	   trial	   investigating	   a	   cryotherapy	   as	   a	   potential	   treatment	   for	  
ROP	  began	  in	  1986.	  Cryotherapy	  for	  Retinopathy	  of	  Prematurity	  (CRYO-­‐ROP)	  showed	  that	  
ablation	  of	  the	  unvascularized	  peripheral	  retina	  resulted	  in	  improved	  vision	  in	  infants	  with	  
severe	  ROP.	  This	  study	  additionally	  investigated	  the	  incidence	  and	  natural	  course	  of	  disease	  
and	   set	   minimum	   standards	   for	   defining	   disease	   stages,	   which	   have	   been	   used	   in	  
subsequent	   studies.	   Preliminary	   results	   showed	   improved	   clinical	   outcome,	   measured	   as	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visual	  acuity,	  with	  use	  of	  cryotherapy.	  This	  treatment	  subsequently	  became	  the	  mainstay	  of	  
treatment	  for	  ROP	  (Diez-­‐Roux,	  Argilla	  et	  al.,	  1999;	  Lutty,	  Chan-­‐Ling	  et	  al.,	  2006;	  Hartnett	  and	  
Penn,	  2012).	  	  
With	   the	   development	   of	   laser	   photocoagulation,	   the	   Early	   Treatment	   for	  
Retinopathy	  of	  Prematurity	  (ETROP)	  was	  sponsored	  by	  the	  NIH	  and	  begun	  in	  1999.	  Results	  
from	  ETROP	  supported	   the	  use	  of	   laser	   therapy	   to	  ablate	  peripheral	  avascular	   retina,	  and	  
supported	   intervention	   at	   earlier	   stages	   in	   ROP	   pathogenesis.	   Laser	   photocoagulation	  
remains	  the	  mainstay	  of	  treatment	  today.	  
	   Recently,	  results	  from	  the	  primary	  completion	  date	  of	  Bevacizumab	  Eliminates	  the	  
Angiogenic	  Threat	  of	  Retinopathy	  of	  Prematurity	  (BEAT-­‐ROP,	  Clinical	  trial	  number	  
NCT00622726)	  were	  published	  (Mintz-­‐Hittner,	  Kennedy	  et	  al.,	  2011).	  	  Bevacizumab	  (trade	  
name	  Avastin,	  Genentech/Roche)	  is	  a	  humanized	  monoclonal	  antibody	  targeted	  to	  inhibit	  
VEGF	  function.	  Anti-­‐VEGF	  therapies	  have	  been	  used	  successfully	  to	  treat	  a	  variety	  of	  
diseases,	  including	  neoplasia	  and	  other	  types	  of	  vascular	  retinopathies	  (Dorrell,	  Uusitalo-­‐
Jarvinen	  et	  al.,	  2007).	  BEAT-­‐ROP	  compared	  use	  of	  bevacizumab	  as	  monotherapy	  to	  laser	  
photocoagulation.	  Initial	  results	  show	  that	  bevacizumab	  treatment	  significantly	  benefited	  
infants	  with	  Stage	  3	  or	  greater	  ROP	  in	  Zone	  I,	  nearest	  the	  fovea,	  but	  had	  no	  benefit	  for	  
infants	  with	  ROP	  in	  Zone	  II.	  Disadvantages	  of	  this	  treatment	  identified	  in	  BEAT-­‐ROP	  are	  
primarily	  related	  its	  intravitreal	  delivery,	  which	  can	  cause	  ophthalmic	  inflammation	  or	  
other	  complications,	  and	  must	  be	  repeated	  for	  continued	  efficacy.	  However,	  this	  trial	  was	  
too	  small	  to	  assess	  local	  and	  systemic	  toxicity	  that	  may	  be	  caused	  by	  bevacizumab	  in	  this	  
patient	  population,	  and	  additional	  studies	  are	  also	  needed	  to	  determine	  the	  optimal	  dose	  
(Mintz-­‐Hittner,	  Kennedy	  et	  al.,	  2011).	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Two	  additional	  clinical	  trials	  have	  investigated	  the	  regulation	  of	  oxygen	  therapy	  as	  a	  
means	   to	   prevent	   ROP	   development.	   Supplemental	   Therapeutic	  Oxygen	   for	   Pre-­‐threshold	  
Retinopathy	  of	  Prematurity	  (STOP-­‐ROP)	  enrolled	  infants	  with	  prethreshold	  ROP	  in	  at	  least	  
one	  eye.	  Initial	  data	  published	  in	  1999	  found	  no	  differences	  in	  rate	  of	  ROP	  development	  in	  
infants	  with	  96-­‐99%	  oxygen	   saturation	   (SaO2)	   versus	   those	  with	  89-­‐94%.	  A	  decade	   later,	  
the	  Surfactant,	  Positive	  Pressure,	   and	  Pulse	  Oximetry	  Randomized	  Trial	   (SUPPORT)	   study	  
compared	   rates	  of	  ROP	  development	  between	  premature	   infants	  born	  24	   -­‐26	  weeks	  PMA	  
with	  85-­‐89%	  SaO2	   and	   those	  with	  91-­‐95%.	  Lower	  oxygen	   saturation	  was	   associated	  with	  
decreased	  rates	  of	  ROP	  development	  but	  increased	  mortality	  (Hartnett	  and	  Penn,	  2012).	  	  
	  
	  
RISK	  FACTORS	  FOR	  RETINOPATHY	  OF	  PREMATURITY	  
ROP	  is	  a	  multifactorial	  disease	  with	  several	  well-­‐characterized	  risk	  factors.	  The	  first	  
risk	   factor	  associated	  with	  development	  of	  ROP	  was	  use	  of	   supplemental	  oxygen	   therapy.	  
The	   first	  epidemic	  of	  ROP	  was	  primarily	  due	   to	  widespread	  and	  unchecked	  use	  of	  oxygen	  
therapy	  in	  care	  for	  premature	  infants.	  Oxygen	  therapy	  increases	  retinal	  oxygen	  tension	  and	  
thus	   contributes	   to	   inhibition	  of	   vascular	  development,	   and	  may	  even	   contribute	   to	   vaso-­‐
obliteration	  of	  the	  newly	  formed	  vasculature.	  When	  Campbell	  noted	  the	  correlation	  in	  1951	  
and	  scientific	  evidence	  confirmed	  her	  observation	  (Wheatley,	  Dickinson	  et	  al.,	  2002),	  more	  
conservative	   use	   of	   oxygen	   was	   implemented.	   This	   simple	   change	   in	   clinical	   practice	  
resulted	  in	  substantially	  reduced	  incidence	  of	  ROP	  (Hatfield,	  1972).	  	  
Multiple	  studies	  have	  confirmed	  that	  short	  gestational	  age	  closely	  correlates	  with	  an	  
infant’s	   risk	   of	   developing	   ROP	   (Wheatley,	   Dickinson	   et	   al.,	   2002;	   Kim,	   Sohn	   et	   al.,	   2004;	  
Good,	   Hardy	   et	   al.,	   2005;	   Bizzarro,	   Hussain	   et	   al.,	   2006).	   Because	   the	   retinal	   vasculature	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does	  not	  reach	  the	  most	  peripheral	  tissue	  until	  almost	  full	  term,	  the	  gestational	  age	  at	  which	  
a	   premature	   infant	   is	   born	   directly	   correlates	   with	   the	   area	   of	   avascular	   tissue	   in	   the	  
peripheral	   retina	   (Chen	   and	   Smith,	   2007).	   Advances	   in	  medicine	   in	   the	   1970s	   and	   1980s	  
lead	  to	  increased	  survival	  rates	  of	  very	  premature	  children,	  which	  resulted	  in	  a	  resurgence	  
of	  ROP	  despite	  cautious	  use	  of	  oxygen	  therapy	  (Valentine,	  Jackson	  et	  al.,	  1989;	  Gibson,	  Sheps	  
et	  al.,	  1990;	  Wheatley,	  Dickinson	  et	  al.,	  2002;	  Coats,	  2005;	  Fleck	  and	  McIntosh,	  2008).	  	  
Reduced	   gestational	   weight	   is	   an	   independent	   risk	   factor	   for	   ROP	   (Wheatley,	  
Dickinson	  et	  al.,	  2002;	  Kim,	  Sohn	  et	  al.,	  2004;	  Good,	  Hardy	  et	  al.,	  2005;	  Bizzarro,	  Hussain	  et	  
al.,	  2006).	  As	  many	  as	  68%	  of	   infants	  born	  weighing	   less	   than	  1250	  g	  develop	  ROP;	  when	  
born	  at	  less	  than	  750	  g,	  ROP	  affects	  up	  to	  93%	  (Bizzarro,	  Hussain	  et	  al.,	  2006).	  Poor	  weight	  
gain	   in	   the	   first	  week	   of	   life	   has	   also	   been	   highly	   associated	  with	   risk	   of	   developing	  ROP	  
(Hellstrom,	  Ley	  et	  al.,	  2010).	  Weight	  is	  likely	  related	  to	  levels	  of	  insulin-­‐like	  growth	  factor	  1	  
(IGF-­‐1),	  an	  important	  somatic	  growth	  factor	  produced	  both	  by	  the	  fetus	  and	  by	  the	  placenta.	  	  
Prematurely	  born	   infants	  have	   reduced	   serum	   levels	   of	   IGF-­‐1	  due	   to	   the	   loss	   of	   placental	  
and	   amniotic	   sources.	   In	   vitro	   studies	   have	   shown	   that	   sufficient	   levels	   of	   IGF-­‐1	   are	  
necessary	   for	   VEGF	   activation	   of	   survival	   pathways	   in	   ECs.	   Reduced	   IGF-­‐1	   levels	   may	  
therefore	  contribute	  to	  vasoattenuation	  early	  in	  ROP	  (Hellstrom,	  Perruzzi	  et	  al.,	  2001).	  	  
More	   recently,	   risk	   of	   ROP	   development	   has	   been	   associated	   with	   reduced	   serum	  
levels	  of	   insulin-­‐like	  growth	  factor	  binding	  protein	  3	  (IGFBP3)	  (Lofqvist,	  Chen	  et	  al.,	  2007;	  
Fleck	   and	   McIntosh,	   2008).	   Produced	   in	   the	   liver,	   this	   molecule	   has	   several	   functions	  
including	   regulating	   the	   pro-­‐mitogenic	   and	   anti-­‐apoptotic	   functions	   of	   IGFs,	   as	   well	   as	  
additional	  roles	  in	  angiogenic	  regulation	  that	  are	  still	  unclear.	  Lofqvist	  et	  al.	  (2007)	  showed	  
that	  IGFBP3	  modulates	  vascular	  survival	  in	  the	  murine	  model	  of	  ROP	  using	  both	  knockout	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models	  and	  pharmacological	  rescue	  (Lofqvist,	  Chen	  et	  al.,	  2007).	  Clinical	  studies	  comparing	  
serum	  levels	  of	  IGFBP3	  between	  infants	  who	  developed	  proliferative	  ROP	  and	  those	  with	  no	  
ROP	  showed	  a	  statistically	  significant	  difference	  between	  the	  2	  groups	  (Lofqvist,	  Chen	  et	  al.,	  
2007).	  	  
A	  variety	  of	  other	   risk	   factors	  have	  been	   identified	  but	   are	   less	  well	   characterized.	  
Many	  pulmonary	  issues	  increase	  the	  risk	  of	  developing	  ROP	  independently	  of	  birth	  weight	  
and	   gestational	   age,	   including	   apnea,	   prolonged	   use	   of	   ventilators,	   use	   of	   surfactant	  
treatment	   (Kim,	   Sohn	   et	   al.,	   2004),	   bronchopulmonary	  dysplasia,	   and	   respiratory	  distress	  
syndrome	   (Lad,	  Nguyen	  et	   al.,	   2008).	  Additionally,	   several	   conditions	  affecting	   the	  overall	  
health	   of	   the	   child	   have	   also	   been	   found	   to	   increase	   risk.	   These	   conditions	   include	  
intraventricular	  hemorrhage,	  cerebral	  palsy,	   the	  number	  of	  blood	  transfusions	  required	   in	  
the	   neonatal	   period,	   requirement	   of	   parenteral	   nutrition,	   hypo-­‐	   and	   hypercarbia,	   early	  
intubation,	  hypotension,	  patent	  ductus	  arteriosus,	  necrotizing	  enterocolitis,	  poor	  postnatal	  
weight	   gain,	   and	   sepsis	   caused	   by	   Candida	   yeast.	   However,	   no	   relationships	   were	   found	  
between	   ROP	   development	   and	   factors	   such	   as	   maternal	   smoking,	   maternal	   alcohol	  
consumption,	  or	  exposure	  of	  retina	  to	  light	  (Wheatley,	  Dickinson	  et	  al.,	  2002).	  	  
	  
HEREDITARY	  RISK	  FACTORS	  
A	  growing	  body	  of	   evidence	   suggests	   that	  a	  genetic	   component	  may	  also	  modulate	  
risk	   of	   ROP	   development.	   A	   retrospective	   twin	   study	   published	   in	   2006	   found	   a	   genetic	  
predisposition	  to	  ROP,	  suggesting	  that	  as	  much	  as	  70%	  of	   the	  variance	   in	  susceptibility	  to	  
ROP	  is	  due	  to	  a	  heritable	  component	  (Bizzarro,	  Hussain	  et	  al.,	  2006).	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Additionally,	   epidemiological	   studies	   published	   in	   the	   last	   decade	   have	   identified	  
differences	   in	   ROP	   risk	   between	   various	   ethnic	   groups.	   CYROP-­‐ROP	   found	   that	   African	  
American	  infants	  are	  at	  lower	  risk	  than	  Caucasian	  (Tadesse,	  Dhanireddy	  et	  al.,	  2002),	  while	  
Latino	  Americans	   are	   at	   higher	   risk	   than	   either	   group	   (Lad,	  Nguyen	   et	   al.,	   2008).	  A	   small	  
study	  out	  of	  Alaska	   found	   that	  native	  Alaskan	  and	  Asian	   infants	  had	  higher	  ROP	  risk	   than	  
either	   Caucasian	   or	  African	  American	   infants	   (Lang,	   Blackledge	   et	   al.,	   2005).	  More	   recent	  
results	  indicate	  that,	  among	  US	  infants,	  nonblack	  race	  and	  of	  male	  gender	  were	  predictors	  of	  
severe	  ROP,	  independent	  of	  any	  underlying	  conditions	  that	  might	  explain	  the	  difference	  in	  
disease	   severity	   (Yang,	  Donovan	   et	   al.,	   2006).	   Internationally,	   rates	   of	  ROP	   cases	   are	   also	  
disparate	  between	  countries	  in	  North	  and	  South	  America	  (Munoz	  and	  West,	  2002).	  	  
Several	  studies	  have	  examined	  the	  role	  of	  single	  nucleotide	  polymorphisms	  (SNPs)	  in	  
genes	  with	  known	  roles	  in	  angiogenesis	  (Holmstrom,	  van	  Wijngaarden	  et	  al.,	  2007).	  A	  
clinical	  investigation	  comparing	  infants	  with	  and	  without	  ROP	  found	  that	  homozygosity	  of	  
VEGF–634	  G	  allele	  in	  the	  5’	  untranslated	  region	  served	  as	  an	  independent	  risk	  factor	  for	  the	  
development	  of	  ROP	  (Cooke,	  Drury	  et	  al.,	  2004).	  Another	  group	  demonstrated	  the	  that	  the	  
VEGF–634	  C	  allelotype	  was	  significantly	  more	  common	  in	  infants	  with	  ROP	  (Vannay,	  Dunai	  
et	  al.,	  2005).	  Others	  have	  suggested	  that	  the	  polymorphisms	  in	  VEGF	  may	  be	  in	  linkage	  
disequilibrium	  with	  polymorphisms	  in	  the	  5’	  flanking	  sequence	  (Holmstrom,	  van	  
Wijngaarden	  et	  al.,	  2007).	  The	  most	  recently	  published	  analysis	  suggested	  no	  association	  
between	  ROP	  development	  and	  VEGF-­‐634	  C,	  VEGF-­‐460C,	  VEGFR-­‐2,	  hepatocyte	  growth	  
factor	  (HGF),	  or	  HGF	  receptor	  polymorphisms	  (Kaya,	  Cokakli	  et	  al.,	  2013).	  To	  date	  our	  
understanding	  of	  the	  role	  of	  VEGF	  polymorphisms	  on	  disease	  development	  is	  incomplete.	  
Other	  SNP	  analyses	  found	  no	  association	  between	  ROP	  outcome	  and	  polymorphisms	  of	  IGF-­‐
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1	  (Balogh,	  Derzbach	  et	  al.,	  2006)	  or	  endothelial	  nitric	  oxide	  synthase	  (Rusai,	  Vannay	  et	  al.,	  
2008).	  	  
	  
Related	  Ophthalmic	  Diseases	  
Several	  inherited	  vascular	  retinopathies	  share	  phenotypes	  with	  the	  second	  phase	  of	  
ROP.	   Familial	   Exudative	   Vitreoretinopathy	   (FEVR)	   (MIM	   #133780)	   and	   Norrie	   disease	  
(MIM#	  310600)	   are	   congenital	   diseases	   characterized	  by	   abnormal	   vascularization	   of	   the	  
peripheral	   retina,	   retinal	   folds,	   retinal	   detachment,	   and	   the	   formation	   of	   a	   retrolental	  
fibrovascular	  membrane	  (Nikopoulos,	  Venselaar	  et	  al.,	  2010).	  Both	  diseases	  are	  caused	  by	  
mutations	   in	   genes	   that	   play	   a	   role	   in	   non-­‐canonical	   Wnt	   signaling	   pathways,	   which	  
functions	   in	   retinal	   vascular	   development	   as	   previously	   described	   (Fruttiger,	   2007;	   Ye,	  
Wang	   et	   al.,	   2009).	   Because	   the	   peripheral	   retina	   is	   incompletely	   vascularized	   in	   these	  
diseases,	  the	  resulting	  tissue	  ischemia	  leads	  to	  NV,	  similar	  to	  Phase	  2	  ROP.	  These	  neovessels	  
are	  prone	  to	  leakage	  and	  rupture,	  causing	  exudates	  and	  bleeding,	  which	  can	  lead	  to	  further	  
complications	  such	  as	  scarring,	  retinal	  detachment	  and	  blindness	  (Robitaille,	  MacDonald	  et	  
al.,	  2002).	  	  
FEVR	   is	   a	   genetically	   heterogeneous	   disease	   that	   follows	   several	   modes	   of	  
transmission.	  Although	  autosomal	  dominance	  is	  most	  common,	  autosomal	  recessive	  and	  X-­‐
linked	   recessive	   patterns	   also	   exist.	   Mutations	   in	   FZD4	   (located	   on	   11q14.2),	   LDP5	  
(11q13.2)	   and	   Norrin	   disease	   protein	   (NDP,	   the	   protein	   produce	   of	   Norrin,	   Xp11.3)	  
(Robitaille,	   MacDonald	   et	   al.,	   2002;	   Nikopoulos,	   Venselaar	   et	   al.,	   2010),	   and	   TSPAN12	  
(7q31.31)	  (Nikopoulos,	  Gilissen	  et	  al.,	  2010)	  have	  all	  been	  identified	  as	  causative	  of	  FEVR.	  
Due	  to	  the	  genetic	  heterogeneity,	  cases	  of	  FEVR	  range	  from	  mild,	  with	  only	  a	  small	  avascular	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peripheral	   retinal	   zone,	   to	   severe,	   with	   retinal	   holes,	   tears,	   NV,	   exudation,	   vitreal	  
hemorrhage,	  retinal	  folding,	  retinal	  detachment,	  and	  even	  blindness	  (Nikopoulos,	  Venselaar	  
et	  al.,	  2010).	  
Norrie	   disease	   is	   an	   X-­‐linked	   disease	   specifically	   caused	   by	   mutations	   in	   NDP.	  
Affected	   infants	   present	   with	   congenital	   blindness,	   and	   nearly	   a	   third	   also	   suffer	   from	  
mental	   retardation	   and	   deafness.	   Hearing	   loss	   in	   the	   second	   decade	   is	   common.	   An	  
intraocular	   pseudoglioma	   is	   often	   found	   and	   can	   lead	   to	   microphthalmia.	   Other	   ocular	  
findings	  include	  cataract	  development,	  alterations	  in	  the	  composition	  of	  the	  vitreous	  body,	  
vitreoretinal	  hemorrhage,	  formation	  of	  a	  retrolental	  fibrovascular	  tissue,	  retinal	  folding	  and	  
detachment,	  and	  subretinal	  exudations	  (Nikopoulos,	  Venselaar	  et	  al.,	  2010).	  
A	   small	   percentage	   of	   infants	   with	   severe	   cases	   of	   ROP	   have	   been	   found	   to	   have	  
mutations	   in	  NDP	  (Shastry,	  Pendergast	  et	  al.,	  1997;	  Hiraoka,	  Berinstein	  et	  al.,	  2001;	  Talks,	  
Ebenezer	   et	   al.,	   2001;	   Haider,	   Devarajan	   et	   al.,	   2002;	   Hutcheson,	   Paluru	   et	   al.,	   2005;	  
Dickinson,	  Sale	  et	  al.,	  2006;	  Hiraoka,	  Takahashi	  et	  al.,	  2010),	  FZD4	  (MacDonald,	  Goldberg	  et	  
al.,	  2005;	  Ells,	  Guernsey	  et	  al.,	  2010),	  and	  LRP5	  (Hiraoka,	  Takahashi	  et	  al.,	  2010).	  To	  date,	  no	  
mutations	   in	  TSPAN12	  have	  been	   reported	   in	  ROP	  patients,	   although	   it	   is	   likely	   that	   they	  
exist.	   None	   of	   these	   mutations,	   however,	   accounts	   for	   a	   substantial	   proportion	   of	   ROP	  
(Shastry,	  2010),	  and	  other	  genes	  are	  likely	  to	  play	  a	  role	  in	  ROP	  development.	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ANIMAL	  MODELS	  OF	  ROP	  
Mouse	  
Many	   investigational	   studies	   into	   ROP	   use	   a	   mouse	   model.	   Vascularization	   of	   the	  
murine	  retina	  progresses	  in	  a	  manner	  similar	  to	  humans	  (Fruttiger,	  2007).	  However,	  these	  
steps	  occur	  post-­‐natally,	  rather	  than	  in	  utero.	  The	  retinal	  vasculature	  of	  a	  newborn	  mouse	  is	  
analogous	   to	   that	   of	   an	   infant	   born	   at	   25	   weeks	   PMA	   (Yanni,	   McCollum	   et	   al.,	   2008).	   At	  
postnatal	   day	   2	   (P2),	   budding	   superficial	   vessels	   near	   the	   optic	   disc	   occupy	   only	   a	   single	  
plane.	  These	  vessels	  extend	  anteriorly	  and	  reach	  the	  most	  peripheral	  tissue	  between	  P7	  and	  
P12.	  The	  deep	  plexus	  forms	  from	  the	  superficial	  between	  P8	  and	  P12	  (Davies,	  Eubanks	  et	  al.,	  
2003;	   Gariano	   and	   Gardner,	   2005;	   Ritter,	   Banin	   et	   al.,	   2006;	   Zhao,	   Ma	   et	   al.,	   2009).	   The	  
intermediate	   plexus	   forms	   between	   P14	   and	   P21	   (Ritter,	   Banin	   et	   al.,	   2006).	   The	   retinal	  
vasculature	  then	  undergoes	  remodeling	  and	  mature	  vasculature	  is	  created	  by	  the	  end	  of	  the	  
first	  month	  of	  life	  (Ritter,	  Banin	  et	  al.,	  2006).	  	  
The	   murine	   model	   of	   ROP,	   termed	   oxygen-­‐induced	   retinopathy	   (OIR)	   was	   first	  
established	   by	   Smith	   in	   1994	   (Smith,	  Wesolowski	   et	   al.,	   1994).	   In	   this	   protocol,	   neonatal	  
mice	  are	  exposed	  to	  75%	  oxygen	  for	  96	  hours	  beginning	  on	  P7.	  The	  hyperoxia	  induces	  vaso-­‐
attenuation	   and	   obliteration	   of	   the	   central	   vascular	   bed	   (Polverini,	   Cotran	   et	   al.,	   1977;	  
Smith,	   Wesolowski	   et	   al.,	   1994;	   Chen	   and	   Smith,	   2007)	   and	   prevents	   development	   of	  
intermediate	  and	  deep	  retinal	  vessels	   (Davies,	  Eubanks	  et	  al.,	  2003).	  Mice	  are	  returned	   to	  
room	   air	   (~21%	   oxygen)	   on	   P12.	   The	   avascular	   central	   retina	   subsequently	   becomes	  
ischemic,	  which	  leads	  to	  vasoproliferation	  and	  NV.	  The	  development	  of	  NV	  peaks	  at	  P17,	  and	  
generally	   regresses	   by	   6	  months	   of	   age	   (Smith,	  Wesolowski	   et	   al.,	   1994;	   Chen	   and	   Smith,	  
2007).	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The	   murine	   OIR	   model	   reliably	   reproduces	   Phase	   1	   of	   ROP	   in	   infants	   exposed	   to	  
supplemental	   oxygen	   therapy	   and	   Phase	   2	   of	   ROP	   in	   all	   infants	   (Polverini,	   Cotran	   et	   al.,	  
1977;	   Lutty,	   Chan-­‐Ling	   et	   al.,	   2006).	   This	   model	   is	   advantageous	   as	   mice	   are	   relatively	  
inexpensive	   to	   purchase	   and	   maintain,	   and	   they	   reliably	   produce	   large	   litters.	   Mice	   are	  
especially	  useful	  for	  genetic	  studies	  as	  a	  variety	  of	  inbred	  strains	  and	  knock	  out	  models	  are	  
commercially	   available	   and	   have	   been	   extensively	   characterized	   (Lutty,	   Chan-­‐Ling	   et	   al.,	  
2006).	  	  
There	  are,	  however,	  disadvantages	  to	  the	  use	  of	  the	  murine	  model.	  The	  pathology	  of	  
murine	   OIR	   is	   the	   reverse	   of	   that	   observed	   in	   humans;	   in	   mice,	   the	   central	   vasculature	  
undergoes	   obliteration	  whereas	   the	   peripheral	   retina	   is	   affected	   in	   the	   human	   condition.	  
Additionally,	  OIR	  does	  not	  cause	  some	  of	  the	  complications	  seen	  in	  ROP.	  Namely,	  the	  murine	  
condition	  does	  not	   lead	   to	   retinal	  detachment,	   the	   complication	  most	  dangerous	   to	  vision	  
due	  to	  the	  disproportionately	  large	  lens	  of	  the	  murine	  eye	  (Polverini,	  Cotran	  et	  al.,	  1977).	  
Although	   the	   murine	   OIR	   model	   is	   reliable	   in	   its	   reproduction	   of	   ROP,	   there	   are	  
known	  differences	  in	  response	  between	  inbred	  strains	  of	  mice.	  The	  albino	  BALB/c	  strain	  of	  
mice	  has	  been	  shown	  to	  be	  more	  resistant	  to	  NV	  than	  the	  C57BL	  strain.	  This	  was	  associated	  
with	   improved	   survival	   of	   astrocytes	   and	   microglia	   immediately	   following	   return	   to	  
normoxia	  in	  the	  BALB/c	  strain	  compared	  to	  C57BL	  (Dorrell,	  Aguilar	  et	  al.,	  2010).	  Exposure	  
to	  hyperoxia	  has	  also	  been	  shown	  to	  induce	  more	  photoreceptor	  death	  in	  C57BL	  mice	  than	  
in	  BALB/c	  (Walsh,	  Bravo-­‐Nuevo	  et	  al.,	  2004).	  Studies	  of	  other	  angiogenic	  stimuli	  have	  also	  
documented	  variability	   in	  responses	  between	  inbred	  strains	  of	  mice	  (Rohan,	  Fernandez	  et	  
al.,	   2000;	   Zhu,	   Iurlaro	   et	   al.,	   2003;	   Chan,	   Pham	   et	   al.,	   2005;	   Liu,	   Smith	   et	   al.,	   2010),	  
suggesting	  a	  genetic	  component	  to	  angiogenesis	  generally	  and	  OIR	  specifically.	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Alternative	  Animal	  Models	  
Other	  models	  of	  ROP	  have	  been	  developed	  in	  rats,	  rabbits,	  cats,	  and	  dogs,	  all	  of	  which	  
undergo	  retinal	  vascular	  development	  in	  the	  post-­‐natal	  period	  (Lutty,	  Chan-­‐Ling	  et	  al.,	  2006;	  
Yanni,	  McCollum	  et	  al.,	  2008).	  	  The	  most	  commonly	  used	  rat	  model	  was	  developed	  in	  1993	  
by	  Penn	  (Penn,	  Tolman	  et	  al.,	  1993).	  In	  this	  protocol,	  newborn	  rats	  are	  exposed	  to	  oxygen	  
levels	  cycled	  between	  10%	  and	  50%	  oxygen	  every	  24	  hours	  for	  14	  days.	  The	  fluctuations	  in	  
oxygen	   levels	  are	   thought	   to	   reflect	   the	   fluctuating	   lung	   function	  and	  resulting	  changes	   in	  
PaO2	   of	   a	   preterm	   infant.	   Rats	   subsequently	   develop	   central	   vaso-­‐obliteration,	   similar	   to	  
that	   seen	   in	   human	   ROP	   (Penn,	   Tolman	   et	   al.,	   1993).	   The	  major	   disadvantage	   of	   the	   rat	  
model	  compared	  to	  the	  murine	  is	  the	  increased	  costs	  associated	  with	  purchase	  and	  keep	  of	  
the	  larger	  rodent	  species.	  Additionally,	  there	  are	  known	  differences	  in	  susceptibility	  within	  
the	  same	  strain	  between	  vendors	  which	  may	  alter	  experimental	  results	  (Yanni,	  McCollum	  et	  
al.,	  2008).	  	  
Large	   animal	  models	   –	   including	   the	   canine	   and	   feline	  models	   –	  were	   used	   in	   the	  
earliest	   studies	   of	   ROP.	   Both	   models	   involve	   exposing	   neonatal	   animals	   to	   hyperoxic	  
conditions	  (100%	  oxygen	  in	  the	  canine	  model,	  80%	  in	  the	  feline)	  for	  the	  first	  4	  days	  of	  life	  to	  
induce	   vaso-­‐obliteration.	   Return	   to	   normoxia	   leads	   to	   hypoxia	   in	   avascular	   areas	   and,	  
subsequently,	   NV.	   Experiments	   using	   the	   cat	   model	   were	   the	   first	   to	   demonstrate	   that	  
“physiological”	   hypoxia	   drives	   angiogenesis.	   The	   major	   benefits	   of	   using	   large	   animal	  
models	  of	  ROP	  over	  rodent	  models	  are	  the	  robust	  NV	  and	  associated	  consequences	  seen	  in	  
the	   large	   animals.	   Additionally,	   the	   large	   intravitreal	   space	   in	   eyes	   of	   larger	   animals	  
facilitates	   studies	   of	   therapeutic	   agents	   (Lutty,	   Chan-­‐Ling	   et	   al.,	   2006).	   The	   major	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disadvantage	   of	   these	   models	   includes	   increased	   gestational	   periods	   and	   the	   significant	  
increase	  in	  cost	  compared	  to	  rodent	  models.	  	  
	   Recently,	   a	   model	   of	   ROP	   has	   been	   developed	   using	   adult	   zebrafish	   model.	   This	  
model	   is	   the	   only	   one	   to	   date	   that	   does	   not	   rely	   on	   a	   phase	   of	   hyperoxia-­‐induced	   vaso-­‐
obliteration.	  Rather,	  adult	  zebrafish	  are	  maintained	  in	  hypoxic	  water	  (10%	  air	  saturation	  via	  
nitrogen	  gas	  perfusion)	   for	  6	  to	  12	  days.	  This	   induces	  retinal	  NV	  in	  regions	  near	  the	  optic	  
disc,	   which	   can	   be	   quantified	   by	   counting	   the	   number	   of	   sprouts,	   new	   branches,	   and	  
vascularization.	  Advantages	  of	  this	  model	  include	  the	  relatively	  cheap	  cost	  of	  zebrafish	  and	  
ease	   of	   maintenance.	   Similar	   to	   the	   murine	   model,	   zebrafish	   are	   also	   relatively	   easy	   to	  
manipulate	  genetically;	  for	  example,	  the	  fli1:EGFP	  strain	  of	  zebrafish	  are	  most	  often	  used	  in	  
this	   model	   as	   they	   are	   optically	   translucent	   and	   have	   green	   fluorescent	   vasculature.	  
Disadvantages	  of	  this	  model	  include	  the	  limited	  number	  of	  antibodies	  available	  for	  zebrafish	  
proteins	   and	   the	   requirement	   of	   specialized	   equipment	   and	   space	   for	   aquariums	   (Cao,	  
Jensen	  et	  al.,	  2010).	  
	  
SIGNIFICANCE	  
	  	   ROP	   is	   a	   leading	   cause	  of	  blindness	   in	   the	  pediatric	  population.	  A	  growing	  body	  of	  
evidence	   suggests	   that	   there	   is	   a	   heritable	   component	   that	   contributes	   to	   disease	   risk.	  
Identification	  of	  genes	  that	  modify	  susceptibility	  may	  provide	  a	  means	  to	  determine	  which	  
children	   are	   at	   higher	   risk	   of	   developing	  ROP,	  which	  would	   allow	  more	   informed	   clinical	  
management	   of	   premature	   infants.	   Furthermore,	   this	   work	   may	   lead	   to	   discovery	   of	  
pharmacological	   targets	   that	   would	   promote	   physiological	   retinal	   vascular	   regeneration.	  
Identification	   of	   mechanisms	   underlying	   revascularization	   in	   ROP	   would	   additionally	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improve	   understanding	   of	   other	   diseases	   of	   pathological	   angiogenesis.	   These	   diseases	  
include	   tumor	   growth	   and	   metastasis,	   atherosclerosis,	   endometriosis,	   and	   other	  
proliferative	   retinopathies	   such	  as	  diabetic	   retinopathy,	   the	  most	   common	  cause	  of	   visual	  
loss	  in	  adult	  Americans.	  	  
	   The	   first	   study	   (“The	  Genetic	  Control	   of	  Avascular	  Area	   in	  Murine	  Oxygen	   Induced	  
Retinopathy”),	  uses	  forward	  genetic	  techniques	  to	  identify	  regions	  of	  the	  genome	  associated	  
with	  murine	  OIR	  outcome.	   	  This	  study	   identified	  2	  quantitative	   trait	   loci	   (QTL)	  associated	  
with	   susceptibility	   to	   OIR.	   We	   additionally	   found	   that	   albino	   mice	   generated	   in	   the	  
intercross	  were	  more	  resistant	  to	  retinopathy	  than	  their	  pigmented	  littermates.	  
	   As	   albinism	   in	   our	   mapping	   cross	   was	   caused	   by	   homozygous	   loss	   of	   function	   of	  
Tyrosinase	  (Tyr),	   this	   later	   finding	   led	   to	   the	   second	   study	   (“Dopaminergic	  Modulation	   of	  
Retinal	   Endothelial	   Progenitor	   Cell	   Recruitment	   and	   Revascularization”).	   This	   study	  
investigated	  the	  candidacy	  of	  Tyr	  as	  a	  quantitative	  trait	  gene	  using	  the	  Tyr-­‐null	  B6(Cg)-­‐Tyrc-­‐
2J/J	   (“c-­‐2J”)	   strain	   of	   mice.	   This	   study	   confirmed	   that	   Tyr	   expression	   is	   associated	   with	  
increased	  susceptibility	  to	  OIR,	  and	  identified	  that	  this	  effect	  is	  mediated	  through	  increased	  
peripheral	   production	   of	   dopamine	   (DA).	   DA,	   signaling	   through	   the	   D1-­‐like	   family	   of	  
receptors,	   inhibited	   EPC	   proliferation	   within	   the	   bone	   marrow,	   migration	   to	   circulation,	  
recruitment	   to	   the	   retina,	   and	   revascularization	   after	   hyperoxic	   damage.	   This	   study	   has	  
important	  clinical	  implications	  as	  DA	  is	  used	  therapeutically	  in	  neonatal	  care.	  	  
	   The	   third	   study	   (“Response	   of	   Endothelial	   Progenitor	   Cells	   to	   Murine	   Oxygen	  
Induced	  Retinopathy:	  A	  Time	  Course	  Study”)	  was	  conducted	  in	  order	  to	  better	  understand	  
the	  role	  of	  EPC	  recruitment	  to	  the	  retina	  during	  revascularization	   in	  the	  OIR	  model.	  Using	  
the	   c-­‐2J	   and	   the	   appropriate	   control	   strain,	   EPCs	  were	  quantified	   in	  bone	  marrow,	  blood,	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and	  retinal	  samples	  on	  P7,	  prior	  to	  exposure	  to	  the	  OIR	  model;	  P7.5,	  12	  hours	  after	  exposure	  
to	   hyperoxia;	   P8;	   P9;	   P9.5;	   P10;	   P11;	   P12;	   and	   P13.	   Avascular	   area	   and	   weight	   were	  
additionally	   measured	   at	   these	   same	   time	   points.	   This	   study	   identified	   patterns	   in	   EPC	  
numbers	   that	   correlate	  with	   improved	   or	  worsened	  OIR	   outcome.	  Additionally	   this	   study	  
suggests	   that	   traditional	   time	   points	   used	   to	   define	   stages	   in	   this	   model	   inaccurately	  
describe	  the	  response	  of	  the	  retinal	  vasculature	  and	  of	  EPCs.	  
	   Finally,	   we	   performed	   a	   microarray	   analysis	   (“Microarray-­‐based	   Identification	   of	  
Genes	   and	   Pathways	   Associated	   with	   Differential	   Retinal	   Responses	   to	   Hypoxia	   in	   the	  
Murine	  Oxygen	  Induced	  Retinopathy	  Model”).	  Using	  samples	  from	  susceptible	  and	  resistant	  
murine	   strains,	   both	   from	   normoxic	   control	   mice	   and	   from	   mice	   exposed	   to	   the	   OIR	  
protocol,	  we	  identified	  genes	  and	  pathways	  that	  are	  associated	  with	  improved	  or	  worse	  OIR	  
outcome.	   This	   work	   was	   additionally	   compared	   to	   the	   current	   body	   of	   literature	  
documenting	  changes	  in	  gene	  expression	  in	  the	  OIR	  model.	  
	   Taken	  together,	  these	  studies	  seek	  to	  identify	  a	  genetic	  component	  to	  susceptibility	  
to	  the	  murine	  OIR	  model	  of	  ROP.	  The	  work	  herein	  describes	  experiments	  seeking	  to	  identify	  
genes	   and	   pathways	   involved	   in	   disease	   development,	   as	   well	   as	   to	   explore	   a	   novel	  
mechanism	  by	  which	  Tyr	  regulates	  retinal	  angiogenesis.	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ABSTRACT	  
	   	  The	  C57BL/6ByJ	  and	  BALB/cByJ	  inbred	  strains	  of	  mice	  are,	  respectively,	  susceptible	  
and	  resistant	  to	  OIR.	  This	  work	  investigates	  the	  genetic	  control	  of	  the	  retinal	  avascular	  area	  
in	   mouse	   OIR	   using	   an	   inbred	   mapping	   cross.	   The	   central	   retinal	   avascular	   area	   was	  
measured	   on	   postnatal	   day	   16	   in	   C57BL/6ByJ,	   BALB/cByJ,	   101	   (C57BL/6ByJ	   x	  
BALB/cByJ)F2,	   and	  116	   (BALB/cByJ	  x	  C57BL/6ByJ)F2	  mice	   that	  had	  been	  subjected	   to	   the	  
established	   murine	   OIR	   protocol.	   Genotyping	   was	   performed	   at	   856	   informative	   single	  
nucleotide	  polymorphisms	  approximately	  evenly	  distributed	  across	  the	  genome	  from	  each	  
of	   85	   selected	   F2	  mice	   to	   determine	   QTLs	   associated	   with	   weight	   and	   avascular	   area.	  
C57BL/6ByJ	  mice	  had	  significantly	  larger	  avascular	  areas	  than	  BALB/cByJ	  ones.	  Albino	  mice	  
of	  the	  F2	  generation	  had	  smaller	  avascular	  areas	  than	  the	  non-­‐albino	  mice.	  Weight,	  gender,	  
and	  the	  paternal	  grandmother	  were	  found	  to	  act	  as	  additive	  covariates	  associated	  with	  the	  
avascular	  area	  on	  P16;	  mapping	  analyses	  that	  used	  a	  model	  incorporating	  these	  covariates	  
found	   a	   QTL	   on	   chromosome	   7	   related	   to	   avascular	   area.	   Analyses	   that	   used	   a	   model	  
without	  covariates	  additionally	  found	  a	  QTL	  on	  chromosome	  9	  related	  to	  avascular	  area.	  A	  
QTL	  for	  bodyweight	  was	  mapped	  to	  chromosome	  5.	  The	  data	  confirm	  that	  retinal	  avascular	  
area	  in	  the	  mouse	  OIR	  model	  is	  under	  genetic	  control,	  and	  identified	  QTLs	  on	  chromosomes	  
7	  and	  9	  that	  modify	  susceptibility	  to	  OIR.	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LIST	  OF	  ABBREVIATIONS	  	  
	  
ANOVA	  –	  analysis	  of	  variance	  
CSPG4	  –	  chondroitin	  sulfate	  proteoglycan	  4,	  or	  NG2	  
D2	  –	  dopamine	  receptor	  2	  
DA	  -­‐	  dopamine	  
Dkk3	  –	  Dickkopf	  3	  
EC	  –	  endothelial	  cell	  
EPO	  –	  erythropoietin	  
F2	  –	  filial	  (intercross)	  2nd	  generation	  
FGF	  –	  fibroblast	  growth	  factor	  	  
FGFr2	  –	  fibroblast	  growth	  factor	  receptor	  2	  
FEVR	  –	  familial	  exudative	  vitreoretinopathy	  
FZD4	  –	  Frizzled	  4	  receptor	  
ICAM-­‐1	  –intracellular	  adhesion	  molecule	  1	  
IGF-­‐1	  –	  insulin-­‐like	  growth	  factor	  1	  
IGF-­‐2	  –	  insulin-­‐like	  growth	  factor	  2	  
IGFBP3	  -­‐	  insulin-­‐like	  growth	  factor	  binding	  protein	  3	  
ITGAL	  –	  integrin	  alpha	  L,	  or	  CD11a	  
ITGALM–	  integrin	  alpha	  M,	  or	  CD11b	  
KO	  –	  knock-­‐out	  
LRP5	  –	  low-­‐density	  lipoprotein	  receptor-­‐related	  protein	  5	  
LOD	  –	  logarithm	  of	  odds	  
NDP	  –	  Norrie	  disease	  protein	  
NV	  -­‐	  neovascularization	  
OIR	  –	  oxygen-­‐induced	  retinopathy	  
P	  –	  post-­‐natal	  day	  	  
QTG	  –	  quantitative	  trait	  gene	  
QTL	  –	  quantitative	  trait	  loci	  
ROP	  –	  Retinopathy	  of	  Prematurity	  
RPE	  –	  retinal	  pigment	  epithelium	  
SNP	  –	  single	  nucleotide	  polymorphism	  
TH	  –	  tyrosine	  hydroxylase	  
Tyr	  –	  Tyrosinase	  	  
VEGF	  –	  vascular	  endothelial	  growth	  factor	  
Xlkd1	  –	  extracellular	  link	  domain	  containing	  1	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INTRODUCTION	  
ROP	  is	  a	  significant	  cause	  of	  vision	  loss	  in	  children	  in	  both	  developed	  and	  developing	  
countries	   (Bizzarro,	  Hussain	  et	  al.,	  2006;	  Gilbert,	  2008;	  Hartnett,	  2010).	  ROP	   is	  a	  complex	  
disease	   where	   disruption	   of	   normal	   developmental	   angiogenesis	   initially	   leads	   to	   a	  
persistent	   avascular	   phase,	   which	   is	   followed	   by	   a	   phase	   of	   pathological	   NV.	   Known	   risk	  
factors	  include	  the	  use	  of	  supplemental	  oxygen	  therapy,	  low	  birth	  weight,	  early	  gestational	  
age	  at	  time	  of	  birth	  (Wheatley,	  Dickinson	  et	  al.,	  2002;	  Kim,	  Sohn	  et	  al.,	  2004),	  and	  low	  serum	  
levels	   of	   IGF-­‐1	   (Perez-­‐Munuzuri,	   Fernandez-­‐Lorenzo	   et	   al.,	   2010)	   and	   IGFBP3	   (Lofqvist,	  
Chen	  et	  al.,	  2007).	  Several	  clinical	  investigations	  have	  found	  that	  rates	  of	  severe	  ROP	  differ	  
between	   ethnic	   groups	   even	   after	   adjusting	   for	   socioeconomic	   factors	   such	   as	   access	   to	  
health	  care,	  suggesting	  a	  heritable	  component	  to	  ROP	  development	  (Tadesse,	  Dhanireddy	  et	  
al.,	   2002;	   Lang,	   Blackledge	   et	   al.,	   2005;	   Bizzarro,	   Hussain	   et	   al.,	   2006;	   Holmstrom,	   van	  
Wijngaarden	  et	  al.,	  2007).	  Polymorphisms	  in	  the	  Wnt	  pathway	  genes	  FZD4,	  LRP5,	  and	  NDP	  
have	  been	  associated	  with	  individual	  cases	  of	  severe	  ROP	  (Hiraoka,	  Berinstein	  et	  al.,	  2001;	  
Hutcheson,	  Paluru	  et	  al.,	  2005;	  Ells,	  Guernsey	  et	  al.,	  2010;	  Hiraoka,	  Takahashi	  et	  al.,	  2010).	  
However,	   as	   yet	   there	   are	  no	   genetic	   factors	   known	   to	   account	   for	   a	  major	  proportion	  of	  
variability	  in	  severity	  of	  ROP	  (Holmstrom,	  van	  Wijngaarden	  et	  al.,	  2007).	  
OIR	  in	  the	  mouse	  was	  developed	  as	  a	  model	  of	  ROP	  (Smith,	  Wesolowski	  et	  al.,	  1994).	  
In	  the	  mouse	  OIR	  model,	  exposure	  to	  hyperoxia	  leads	  to	  central	  vaso-­‐obliteration.	  When	  the	  
mice	  are	  returned	  to	  a	  normoxic	  environment,	  the	  presence	  of	  a	  region	  of	  avascular	  retina	  
creates	   a	   pro-­‐angiogenic	  milieu,	  which	   leads	   to	   retinal	   NV	   (Polverini,	   Cotran	   et	   al.,	   1977;	  
Smith,	  Wesolowski	  et	  al.,	  1994;	  Lutty,	  Chan-­‐Ling	  et	  al.,	  2006).	  The	  hyperoxic	  phase	  of	  OIR	  
creates	  somewhat	  similar	  conditions	  to	  those	  created	  in	  the	  past	  by	  overuse	  of	  oxygen	  in	  the	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treatment	  of	  premature	  infants.	  However,	  hyperoxia	  in	  the	  OIR	  model	  leads	  to	  obliteration	  
of	   central	   retinal	   vessels,	   while	   ROP	   results	   from	   the	   failure	   of	   vascularization	   of	   the	  
peripheral	   retina.	   The	   neovascular	   phases	   of	   OIR	   and	   ROP	   are	   broadly	   analogous.	  When	  
mice	  that	  have	  been	  exposed	  to	  hyperoxia	   in	  the	  OIR	  model	  are	  returned	  to	  normoxia	  the	  
retina	   gradually	   revascularizes	   with	   vessels	   that	   appear	   anatomically	   normal.	   The	   initial	  
stages	   of	   vascular	   regeneration	   are	   seen	   before	   pathological	   neovascular	   tufts	   become	  
evident.	  The	  study	  of	  the	  revascularization	  phase	  of	  OIR	  may	  be	  pertinent	  to	  understanding	  
retinal	  angiogenesis	  in	  the	  pre-­‐proliferative	  phase	  of	  ROP.	  For	  example,	  the	  demonstration	  
that	  exogenous	  IGFBP3	  increased	  vessel	  regrowth	  in	  OIR	  was	  followed	  by	  the	  observation	  
that	  serum	  IGFBP3	  correlates	  with	  less	  severe	  ROP	  in	  humans	  (Lofqvist,	  Chen	  et	  al.,	  2007).	  	  
Inter-­‐strain	   differences	   in	   response	   to	   OIR	  models	   have	   been	   investigated	   in	   both	  
mice	   and	   rats.	   Van	   Wijngaarden	   et	   al.	   (van	   Wijngaarden,	   Brereton	   et	   al.,	   2007)	  
demonstrated	  that	  pigmentation	  status	  is	  associated	  with	  retinal	  avascular	  area	  in	  crosses	  
between	  Fischer	  344	  and	  Dark	  Agouti	  rat	  strains.	  In	  crosses	  between	  these	  2	  strains,	  retinas	  
from	  albino	  animals	  exposed	  to	  OIR	  were	  found	  to	  express	  lower	  levels	  of	  EPO	  than	  retinas	  
from	   pigmented	   animals.	   In	   further	   work	   (van	   Wijngaarden,	   Brereton	   et	   al.,	   2007)	   van	  
Wijngaarden	  et	  al.	   found	   that	  OIR-­‐susceptible	   rat	   strains	  demonstrated	   less	   expression	  of	  
angiogenesis-­‐related	   genes	   in	   early	   retinal	   development	   than	   did	   OIR-­‐resistant	   rats,	   but	  
higher	  expression	  of	  these	  genes	  in	  the	  proliferative	  phase	  of	  OIR.	  Chan	  et	  al.	  performed	  a	  
similar	   study	   comparing	   gene	   expression	   in	   retinas	  of	   different	  mouse	   strains	   exposed	   to	  
the	  OIR	  model	  (Chan,	  Pham	  et	  al.,	  2005).	  Dorrel	  et	  al.	  have	  shown	  that	  the	  astrocytes	  in	  the	  
retinas	  of	  C57BL/6J	  mice	  exposed	  to	  the	  OIR	  protocol,	  unlike	  the	  astrocytes	  of	  BALB/c	  mice,	  
quickly	  degenerate	  after	   the	  mice	  are	  returned	   to	  normoxia	   (Dorrell,	  Aguilar	  et	  al.,	  2010).	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Although	  these	  strain	  specific	  differences	  have	  been	  found,	  no	  previous	  study	  has	  employed	  
a	  genome	  wide	  approach	  to	  investigate	  genetic	  differences	  that	  modify	  OIR.	  	  	  
This	   study	   uses	   a	   known	   difference	   between	   BALB/cByJ	   and	   C57BL/6ByJ	  mice	   to	  
investigate	  the	  genetics	  of	  control	  of	  the	  extent	  of	  avascular	  area	  measured	  four	  days	  after	  
return	   to	  normoxia.	  These	  strains	  were	  used	   in	  a	  mapping	  cross	  designed	   to	   identify	  QTL	  
that	  modify	   this	  phenotype.	   Since	  C57BL/6	  mice	  exposed	   to	   the	  OIR	  model	  develop	  more	  
severe	  NV	  and	   revascularize	  more	   slowly	   than	  BALB/c	  mice,	   despite	  having	   similar	   vaso-­‐
obliterative	   responses	   (Dorrell,	   Aguilar	   et	   al.,	   2010),	   the	   phenotype	   of	   avascular	   area	  
measured	   four	   days	   after	   return	   to	   normoxia	   is	   likely	   to	   be	   largely	   a	  measure	   of	   rate	   of	  
vascular	  regrowth.	  	  
	  
MATERIALS	  AND	  METHODS	  
Animals	  
All	  experimental	  procedures	  were	  approved	  by	  University	  of	  Kansas	  Medical	  Center	  
Institutional	   Animal	   Care	   and	   Use	   Committee.	   BALB/cByJ	   and	   C57BL/6ByJ	   mice	   were	  
purchased	   from	   Jackson	   Laboratories	   (Bar	  Harbor,	  ME).	   All	  mice	  were	   kept	   in	   a	   12-­‐hour	  
light,	   12-­‐hour	   dark	   cycle	   with	   ambient	   room	   temperature	   between	   19oC	   and	   22oC.	   Mice	  
were	   kept	   on	   standard	   diet	   for	   breeding	   pairs	   (8626	   rodent	   diet,	   Harlan	   Laboratories,	  
Indianapolis,	  IN),	  with	  chow	  and	  water	  available	  ad	  libitum.	  	  
An	  F2	  intercross	  population	  was	  bred	  using	  reciprocal	  mating	  strategies	  (Figure	  2.1).	  
Phenotypes	  were	  obtained	  from	  116	  (BALB/cByJ	  x	  C57BL/6ByJ)	  F2	  and	  101	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Figure	  2.1.	  Illustration	  of	  the	  breeding	  scheme	  used	  in	  the	  mapping	  cross.	  	  
The	   BALB/cByJ	   and	   C57BL/6ByJ	   parental	   strains	   are	   crossed	   in	   both	   directions.	   The	  
resulting	   F1	  mice	   are	   inbred	   through	  brother–sister	  mating	   to	   produce	   the	   F2	   generation.	  
This	   figure	   shows	   the	   manner	   in	   which	   the	   Y	   chromosomes	   and	   recombined	   (black	   and	  
white-­‐striped)	   and	   unrecombined	   (solid	   color)	   X	   chromosomes	   are	   passed	   through	   the	  
generations	   of	   the	   cross.	   White	   chromosomes	   are	   inherited	   from	   the	   BALB/cByJ	   albino	  
parent,	  and	  black	  chromosomes	  are	  inherited	  from	  the	  C57BL/6ByJ	  pigmented	  parent.	  The	  
different	  coat	  colors	  shown	  in	  the	  F2	  generation	  are	  for	  illustrative	  purposes	  only.	  The	  color	  
of	  the	  F2	  animals	  is	  unrelated	  to	  either	  gender	  or	  the	  direction	  of	  the	  cross.	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(C57BL/6ByJ	   x	   BALB/cByJ)	   F2	   mice.	   Values	   were	   also	   obtained	   from	   BALB/cByJ	   and	  
C57BL/6ByJ	  mice	  to	  confirm	  differential	  susceptibility	  to	  OIR	  between	  strains.	  	  	  
	  
Avascular	  areas	  in	  OIR	  
OIR	  was	   induced	  by	   exposing	  pups	   to	   75%	  oxygen	  beginning	   on	  P7	   and	   returning	  
them	  to	  normoxia	  after	  120	  hours.	  O2	  levels	  in	  the	  chambers	  were	  continuously	  controlled	  
using	   a	  ProOx	  portable	  monitor	   (Biospherix,	  Redfield,	  NY),	  which	  was	   calibrated	  monthly	  
using	  room	  air	  and	  100%	  O2.	  Retinas	  were	  analyzed	  96	  hours	  after	  return	  to	  hypoxia	  since	  
previous	   unpublished	   observations	   had	   suggested	   that	   at	   this	   time-­‐point	   the	   inter	   strain	  
differences	   were	   greatest.	   This	   experimental	   plan	   allows	   genetic	   modifiers	   of	   vascular	  
regeneration	  to	  be	  investigated.	  On	  P16,	  mice	  were	  weighed,	  anesthetized	  with	  a	  lethal	  dose	  
of	   tribromoethanol	   delivered	   by	   intraperitoneal	   injection,	   perfused	   with	   high	   molecular	  
weight	   fluorescein	   isothiocyanate	   labeled-­‐dextran	   (MW	   2,000,000,	   Sigma,	   St.	   Louis,	  MO,	  
USA)	   via	   the	   left	   ventricle	   to	   visualize	   patent	   vessels,	   and	   then	   enucleated.	   Tail	   samples	  
were	  taken	  and	  stored	  at	  -­‐20oC,	  and	  gender	  was	  documented.	  
Retinas	   were	   dissected,	   fixed	   overnight	   in	   4%	   paraformaldehyde	   at	   4oC,	   and	   flat-­‐
mounted	   using	   anti-­‐fade	   medium	   (Southern	   Biotech).	   Immunofluorescent	   micrographic	  
images	  of	  the	  retinas	  were	  taken	  using	  an	  SMZ	  1500	  microscope	  (Nikon,	  Tokyo,	  Japan)	  and	  
MagnaFire	   Camera	   and	   software	   (Optronics,	   Goleta,	   CA).	   ImageJ	   software	  
(http://rsbweb.nih.gov/ij/)	  was	  used	  to	  manually	  trace	  and	  measure	  nonperfused	  areas.	  A	  
mean	  avascular	  area	  was	  calculated	  for	  each	  mouse	  using	  data	  from	  left	  and	  right	  eyes.	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Genotyping	  Strategy	  
	   	  Selective	  genotyping	  methods	  that	  decrease	  the	  cost	  of	  genotyping	  with	  only	  minor	  
loss	   of	   information	   (Darvasi,	   1997;	   Van	   Gestel,	   Houwing-­‐Duistermaat	   et	   al.,	   2000;	   Ayoub	  
and	   Mather,	   2002)	   were	   used.	   For	   the	   purpose	   of	   selecting	   the	   mice	   to	   genotype,	   the	  
avascular	  area	  was	  adjusted	  for	  the	  weight	  of	  the	  animals	  to	  account	  for	  the	  effect	  of	  weight	  
on	  response	  to	  OIR.	  To	  do	  this,	  a	  correlation	  coefficient	  of	  -­‐0.1743	  mm2/g	  was	  determined	  
using	  linear	  regression	  and	  multiplied	  by	  the	  weight	  to	  create	  an	  adjustment	  factor	  for	  each	  
mouse.	   The	   adjustment	   factor	  was	   then	   subtracted	   from	   the	  measured	   avascular	   area	   to	  
create	  an	  adjusted	  avascular	  area.	  Using	  the	  adjusted	  avascular	  area,	  mice	  were	  selected	  for	  
genotyping.	  
Since	  a	  significant	  difference	  was	  observed	  between	  the	  avascular	  areas	  of	  albino	  and	  
non-­‐albino	  mice,	  these	  groups	  were	  considered	  separately	  when	  choosing	  mice	  to	  genotype.	  
A	   group	  of	  mice	  with	   the	   smallest	   adjusted	   avascular	   areas	   (11	   albino	   and	  32	  non-­‐albino	  
mice)	  and	  a	  group	  with	  the	  largest	  adjusted	  areas	  (11	  albino	  and	  32	  non-­‐albino	  mice)	  were	  
chosen	  for	  genotyping.	  
	  
DNA	  preparation	  	  
DNA	  was	  extracted	  from	  0.5	  cm	  tail	  samples	  using	  the	  DNEasy	  Blood	  and	  Tissue	  Kit	  
(Qiagen,	   Valencia,	   CA);	   concentration	   and	   purity	   (absorbance	   ratio	   at	   260/280	   nm)	  were	  
determined	  using	  a	  NanoDrop-­‐1000	  spectrophotometer	  (ThermoFisher	  Scientific,	  Waltham,	  
MA).	  DNA	  samples	  were	  diluted	  to	  25-­‐150	  ng/µL.	  	  
	  
	  
	   44	  
Genotype	  Analysis	  	  
	   Genotyping	   services	   were	   provided	   by	   the	   Center	   for	   Inherited	   Disease	   Research	  
(Johns	  Hopkins	  University,	  Baltimore,	  MD)	  using	   a	   standard	   linkage	  panel	   containing	  856	  
informative	   autosomal	   and	   X	   chromosomal	   SNPs	   (Mouse	  Medium	  Density	   Linkage	   Panel,	  
Illumina,	  San	  Diego,	  CA).	  For	  each	  chromosome,	  except	  chromosome	  X,	   the	  most	  proximal	  
marker	   genotyped	  was	  within	   13.4	  Mbp	   of	   the	   centromere;	   on	   chromosome	   X,	   the	  most	  
proximal	  marker	  was	  at	  33.5	  Mbp	  from	  the	  centromere.	  The	  most	  distal	  marker	  was	  within	  
5.8Mbp	  of	  the	  telomere	  for	  all	  chromosomes.	  Internal	  markers	  were	  no	  more	  than	  24.6	  Mbp	  
from	   each	   other	   (chromosome	   1)	   except	   on	   chromosome	   2,	   where	   two	   markers	   were	  
spaced	   64.4	   Mbp	   apart.	   	   Mean	   spacing	   was	   approximately	   7.88	   Mbp	   between	   markers.	  
Physical	   distances	   quoted	   in	   this	   paper	   are	   taken	   from	   mouse	   genome	   build	   37.2	  
(http://www.ncbi.nlm.nih.gov/mapview),	   and	   SNP	   data	   is	   taken	   from	   dbSNP	   Build	   128	  
(http://www.ncbi.nlm.nih.gov/projects/SNP/).	  DNA	  samples	  from	  each	  parental	  strain	  and	  
one	  F1	  mouse	  produced	   from	  each	  direction	  were	  used	  as	   control	   samples.	  Data	   checking	  
analyses	  as	  suggested	  by	  Broman	  et	  al.	  (Broman,	  Sen	  et	  al.,	  2009)	  were	  run	  prior	  to	  mapping	  
analysis	   to	   ensure	   quality	   and	   integrity	   of	   both	   phenotype	   and	   genotype	   data.	   Due	   to	  
inconsistencies	  in	  genotyping	  results,	  an	  albino	  female	  mouse	  from	  the	  low	  avascular	  area	  
group	  was	  excluded	  from	  subsequent	  analysis.	  	  
The	   genotype	   of	   the	   tyrosinase	   locus	   of	   the	  mice	   not	   selected	   for	   genotyping	  was	  
inferred	  from	  coat	  color.	  In	  this	  cross,	  albinism	  is	  conferred	  by	  homozygosity	  for	  the	  BALB/c	  
allele	   of	   tyrosinase.	   The	   genotype	   of	   albino	  mice	   at	   the	   tyrosinase	   locus	  was	   encoded	   as	  
AB/cAB/c.	  For	  all	  non-­‐albino	  mice,	  a	  code	  indicating	  “not-­‐	  AB/cAB/c”	  was	  used.	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QTL	  Mapping	  
Identification	  of	   covariates	   Coat	   color,	   paternal	   grandmother,	   gender,	   and	   albinism	  
were	  tested	  using	  analysis	  of	  variance	  (ANOVA)	  models	  to	  identify	  traits	  that	  are	  associated	  
with	  the	  primary	  phenotypes	  of	  interest	  (weight	  and	  unadjusted	  avascular	  area).	  Inclusion	  
of	   covariates	   in	  mapping	   analysis	   reduces	   residual	   variation	   and	   enhances	  QTL	   detection	  
(Broman,	  Sen	  et	  al.,	  2009).	  Any	  variable	  found	  to	  have	  a	  statistically	  significant	  association	  
was	  included	  in	  mapping	  models,	  as	  described	  below.	  
Linkage	  analysis	  The	   data	  were	   analyzed	   using	   R/qtl	   software	   (Broman,	  Wu	   et	   al.,	  
2003).	  Initial	  linkage	  analysis	  was	  performed	  using	  standard	  interval	  mapping	  to	  determine	  
logarithm	   of	   odds	   (LOD)	   score	   correlating	   genotype	   with	   phenotype	   for	   each	   marker.	  
Weight	   and	   unadjusted	   avascular	   area	   were	   analyzed	   separately	   as	   primary	   phenotypes.	  
Analyses	   were	   also	   performed	   using	   gender,	   paternal	   grandmother,	   pigmentation,	   and	  
weight	  as	  covariates.	  All	  covariates	  were	  compared	  as	  additive	  and	  interactive	  covariates	  in	  
separate	   models	   to	   determine	   best	   fit.	   To	   account	   for	   the	   multiple	   testing	   inherent	   in	  
genome-­‐wide	  QTL	  studies,	   and	  control	   the	   type	   I	   error	   rate	   such	   that	   the	  probability	  of	   a	  
false	  positive	  over	   all	   tests	   is	  below	  some	  value,	   significance	   thresholds	  were	  determined	  
empirically	   via	   permutation	   testing	   (Churchill	   and	   Doerge,	   1994).	   We	   estimated	   the	  
experiment-­‐wise	  significance	  thresholds	  using	  1,000	  permutations	  of	  each	  data	  set,	  defining	  
the	  LOD	  thresholds	  for	  highly-­‐significant	  QTL	  (at	  P	  <	  0.05)	  and	  significant	  QTL	  (at	  P	  <	  0.1).	  
One	   thousand	   permutation	   replicates	   has	   been	   shown	   to	   be	   adequate	   to	   estimate	   critical	  
thresholds	   (Churchill	   and	   Doerge,	   1994),	   and	   is	   the	   number	   routinely	   employed	   in	   QTL	  
mapping	  studies.	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Gene-­‐gene	   interactions	  Secondary	   analyses	   included	   composite	   interval	  mapping	   to	  
determine	   influence	   of	   markers	   near	   QTL	   on	   other	   loci	   (i.e.	   gene-­‐gene	   interactions).	  
Additionally,	   two	   dimensional,	   two-­‐QTL	   scans	   were	   performed	   to	   consider	   linked	   or	  
interacting	  QTL.	  	  
Estimating	  QTL	  Effects	  To	  estimate	  the	  contribution	  of	  QTL	   identified	   in	  the	   linkage	  
analysis,	   the	   allelic	   effects	   were	   calculated	   and	   compared	   between	   mice	   categorized	   by	  
genotype	  (AB/cAB/c,	  AB/cAC57,	  AC57AC57).	  Additive	  and	  dominance	  effects	  were	  also	  considered	  
in	  calculations.	  The	  QTL	  effects	  were	  assumed	  to	  correspond	  to	  the	  SNP	  marker	  nearest	  the	  
peak	  LOD	  score.	  	  
	  
RESULTS	  
Differences	  in	  Response	  to	  OIR	  Between	  Strains	  
	   In	   order	   to	   confirm	   response	   of	   parental	   strains	   to	   the	   OIR	  model,	   15	   BALB/cByJ	  
offspring	  from	  3	  litters	  and	  10	  C57BL/6ByJ	  mice	  from	  3	  litters	  were	  exposed	  to	  hyperoxia	  as	  
described.	   Typical	   flat-­‐mounted	   fluorescein-­‐dextran	   perfused	   retinas	   are	   shown	   in	   Figure	  
2.2.	  Measurement	  of	  mean	  retinal	  avascular	  area	  showed	  C57BL/6ByJ	  mice	   to	  have	  a	  2.9-­‐
fold	   greater	   unadjusted	   area	   than	  did	   the	  BALB/cByJ	  mice	   at	   P16	   (1.55	  mm2	   versus	   0.53	  
mm2,	  Student’s	  t-­‐test,	  p	  <	  0.0005,	  Figure	  2.2).	  	  	  
Weight	  ranged	  from	  4.15	  –	  10.95	  g.	  BALB/cByJ	  mice	  weighed	  more	  at	  P16	  than	  did	  
their	  C57BL/6ByJ	  counterparts	  (with	  means	  of	  7.64	  g	  and	  6.05	  g	  respectively,	  ANOVA,	  p	  =	  
0.009).	  After	  adjusting	  avascular	  area	  for	  weight	  as	  described	  above,	  the	  C57BL/6ByJ	  mice	  
were	  still	  found	  to	  have	  greater	  avascular	  areas	  than	  did	  BALB/cByJ	  mice	  (2.60	  mm2	  versus	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Figure	  2.2.	  Retinas	  after	  OIR	  protocol.	  	  
(A)	  Flatmounted	  retina	  of	  a	  BALB/cByJ	  mouse	  on	  P16	  after	  exposure	   to	   the	  OIR	  protocol.	  
The	  retina	  is	  relatively	  well	  vascularized	  at	  this	  time	  point.	  (B)	  A	  retina	  from	  a	  C57BL/6ByJ	  
mouse	   at	   the	   same	   time	   point	   after	   exposure	   to	   the	   OIR	   protocol.	   The	   central	   retina	   has	  
large	  avascular	  areas.	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1.86	  mm2,	  ANOVA,	  p	  =	  0.0002,	  Figure	  2.3),	  suggesting	  that	  the	  difference	  in	  avascular	  area	  is	  
not	  due	  to	  differences	  in	  weight	  alone.	  
No	   difference	   in	   unadjusted	   avascular	   area	   was	   found	   between	   male	   and	   female	  
mice,	  either	  within	  each	  strain	  or	  across	  strains	  (ANOVA,	  BALB/cByJ	  –	  p	  =	  0.4,	  C57BL/6ByJ	  
–	  p	  =	  0.5;	  Student’s	  t-­‐test,	  all	  mice	  -­‐	  p	  =	  0.06).	  The	  same	  was	  true	  when	  comparing	  adjusted	  
avascular	  area	  between	  mouse	  genders	  (ANOVA,	  BALB/cByJ	  –	  p	  =	  0.07,	  C57BL/6ByJ	  –	  p	  =	  
0.15;	  Student’s	  t-­‐test,	  all	  mice	  -­‐	  p	  =	  0.08).	  	  
	  
Effect	  of	  Covariates	  on	  Phenotypes	  in	  F2	  Population	  
Weight	  was	  investigated	  as	  a	  primary	  phenotype	  to	  identify	  potential	  QTL	  related	  to	  
body	  mass	  at	  P16.	  ANOVA	  tests	  were	  performed	  to	  investigate	  the	  correlation	  of	  secondary	  
phenotypes	   with	   weight,	   but	   no	   statistically	   significant	   association	   between	   weight	   and	  
gender,	  strain	  of	  paternal	  grandmother,	  or	  coat	  color	  was	  found.	  
F2	  mice	  had	  unadjusted	  avascular	  areas	  ranging	  from	  0.013	  to	  2.76	  mm2,	  with	  a	  mean	  
of	  1.06	  mm2.	  Mean	  weight	  at	  P16	  was	  6.70	  g,	  with	  a	   range	   from	  3.56	  g	   to	  11.77	  g.	  Linear	  
regression	   analysis	   showed	   that	   avascular	   area	   was	   inversely	   associated	   with	   weight	  
(ANOVA,	  p	  <	  10-­‐8,	  Figure	  2.4).	  
Coat	   color	   pigmentation	   correlated	  with	   adjusted	   retinal	   avascular	   area.	   Albino	   F2	  
mice	   exposed	   to	   the	  OIR	  model	  had	   smaller	   adjusted	   avascular	   areas	   than	  did	  pigmented	  
mice	  (ANOVA,	  p	  <	  5	  x	  10-­‐8,	  Figure	  2.5).	  No	  association	  between	  avascular	  area	  and	  any	  of	  the	  
individual	  non-­‐albino	  coat	  colors	  was	  found	  (ANOVA,	  p	  =	  0.39).	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Figure	  2.3.	  Mean	  avascular	  areas	  of	  parental	  strains	  after	  adjusting	  for	  the	  influence	  
of	  weight.	  	  
The	  BALB/cByJ	  strain	  has	  smaller	  areas	  of	  avascular	  retina	   in	  response	   to	  hyperoxia	   than	  
the	  C57BL/6ByJ	  strain	  (ANOVA,	  p=0.0002).	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Figure	  2.4.	  The	  inverse	  association	  between	  avascular	  area	  and	  weight	  of	  F2	  mice	  at	  
P16	  after	  exposure	  to	  OIR.	  	  
The	  avascular	  area	  was	  shown	  to	  correlate	  with	  weight	  with	  a	  coefficient	  of	  −0.1743.	  This	  
association	  was	  shown	  to	  be	  statistically	  significant	  (ANOVA,	  p<10−8).	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Figure	  2.5.	  Comparison	  of	  avascular	  areas	  for	  albino	  and	  non-­‐albino	  F2	  mice.	  	  
The	  mean	  avascular	  area	  of	  albino	  mice	  was	  found	  to	  be	  0.67	  mm2	  versus	  1.20	  mm2	  for	  non-­‐
albino	  mice,	  a	  statistically	  significant	  difference	  (ANOVA,	  p<0.0001).	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   Strain	  of	   the	  paternal	   grandmother	  was	  associated	  with	  adjusted	  avascular	   area	   in	  
the	   F2	   generation	   (ANOVA,	   p	   =	   0.0004).	   F2	  mice	   produced	   from	   inbreeding	   (BALB/cByJ	   x	  
C57BL/6ByJ)F1	   parents	   had	   smaller	   avascular	   areas	   than	   those	   produced	   from	   the	  
reciprocal	   cross	   (2.12	  mm2	   versus	   2.34	  mm2).	   Paternal	   grandmother	  was	   included	   in	   the	  
mapping	   analysis	   as	   an	   additive	   covariate.	   Segregating	   F2	   mice	   by	   both	   paternal	  
grandmother	  and	  gender	  did	  not	  show	  any	  statistically	  significant	  differences	  (ANOVA,	  p	  =	  
0.41),	  suggesting	  that	  the	  two	  covariates	  did	  not	  interact.	  	  	  
In	   the	   F2	   mice,	   unlike	   in	   the	   parental	   generation,	   gender	   was	   associated	   with	  
avascular	  area	  (avascular	  area	  2.16	  mm2	  for	  males,	  2.28	  mm2	  for	  females,	  ANOVA,	  p	  =	  0.02).	  
Gender	  was	   not	   found	   to	   interact	  with	   other	   secondary	   phenotypes	   such	   as	  weight,	   coat	  
color,	   or	   paternal	   grandmother	   (ANOVA,	   p	   =	   0.08,	   0.52,	   and	   0.40,	   respectively)	   in	   the	   F2	  
generation.	  
ANOVA	   testing	   of	   weight,	   paternal	   grandmother	   and	   gender	   did	   not	   show	   any	  
statistically	  significant	   interaction	  between	   the	  covariates	   (p	  >	  0.05).	  Therefore	   they	  were	  
included	  as	  additive	  covariates	  in	  mapping	  analyses.	  
Analyses	   were	   performed	   to	   identify	   potential	   QTL	   related	   to	   body	   mass	   at	   P16.	  
ANOVA	  tests	  were	  run	  to	  consider	  candidature	  of	  secondary	  phenotypes	  as	  covariates,	  but	  
no	   statistically	   significant	   association	   between	   weight	   and	   gender,	   strain	   of	   paternal	  
grandmother,	  or	  coat	  color	  was	  found.	   	  
	  
Identification	  of	  QTLs	  Related	  to	  OIR	  Response	  
	   Mapping	  without	  covariate	  inclusion:	  	  Initial	  QTL	  analysis	  employed	  a	  covariate-­‐free	  
model.	   This	   analysis	   identified	   2	   LOD	   score	   peaks	   associated	   with	   avascular	   area	   that	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reached	  the	  genome-­‐wide	  threshold	  of	  α	  =	  0.05.	  These	  peaks	  occurred	  on	  chromosomes	  7	  
and	  9	   (Table,	  Figure	  2.6A).	  On	  chromosome	  9,	   the	  peak	  LOD	  score	   (3.75,	  p	  =	  0.05,	  Figure	  
2.6B)	  occurred	  at	  SNP	  rs4135590,	  located	  42.8	  Mbp	  distal	  from	  the	  centromere.	  Genotype	  at	  
this	  QTL	   explained	   6.5%	  of	   the	   variance	   in	   avascular	   area	   (p	   =	   0.0007,	   Table),	  with	   each	  
BALB/cByJ	   allele	   having	   an	   additive	   protective	   effect	   (Figure	   2.6C).	   The	   1.8-­‐LOD	   support	  
interval	  was	  found	  to	  be	  12.4–	  96.0	  Mbp	  distal	  from	  the	  centromere.	  
The	  peak	  on	  chromosome	  7	  was	  located	  at	  SNP	  rs13479427,	  107.2	  Mbp	  distal	  from	  
the	  centromere.	  The	  LOD	  score	  of	  this	  peak	  was	  8.90	  (p	  <0.004).	  The	  QTL	  on	  chromosome	  7	  
explained	  17.5%	  of	  the	  phenotypic	  variance	  (Table,	  p	  <	  0.004).	  At	  this	  locus,	  the	  BALB/cByJ	  
allele	   had	   a	   recessive	   protective	   effect.	   A	   1.8-­‐LOD	   support	   interval	  was	   determined	   to	   lie	  
81.2-­‐146.5	   Mbp	   distal	   from	   the	   centromere.	   The	   marker	   at	   146.5	   Mbp	   was	   the	   most	  
telomeric	  marker	  included	  in	  the	  SNP	  panel,	  therefore	  we	  cannot	  exclude	  the	  possibility	  that	  
the	  support	  interval	  may	  extend	  as	  far	  as	  the	  telomere.	  
A	   2	  QTL	  model	   including	   the	   peaks	   on	   chromosome	   7	   and	   9	   found	   that	   these	   loci	  
explain	  23.2%	  of	   the	  phenotypic	  variance	  (p	  =	  1.8	  x	  10-­‐11),	  with	  a	  combined	  LOD	  score	  of	  
12.4.	  
Mapping	  with	  Covariates.	  Using	  weight,	   the	  strain	  of	   the	  paternal	  grandmother,	  and	  
gender	  as	  additive	  covariates,	  a	  single	  LOD	  score	  peak	  associated	  with	  unadjusted	  avascular	  
area	  was	  identified	  on	  chromosome	  7	  at	  a	  genome-­‐wide	  threshold	  of	  α	  =	  0.05	  (Table,	  Figure	  
2.6D).	  This	  QTL	  is	  located	  at	  134.2	  Mbp,	  between	  SNPs	  rs13479506	  and	  CEL-­‐7_115892950.	  
The	  LOD	  score	  of	  this	  peak	  was	  9.83	  (p	  <	  0.004).	  The	  QTL	  on	  chromosome	  7	  in	  conjunction	  
with	  the	  covariates	  explained	  34.2%	  of	  the	  phenotypic	  variance	  (Table,	  p	  <	  0.004).	  At	  this	  
locus,	  the	  BALB/cByJ	  allele	  had	  an	  additive	  protective	  effect	  (Figure	  2.6E)	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Figure	  2.6.	  The	  results	  of	  genetic	  linkage	  mapping	  using	  central	  retinal	  avascular	  area	  
as	  the	  phenotype.	  	  
(A)	   Linkage	  map	   of	   avascular	   area	   across	   the	  whole	   genome	   created	   using	   no	   covariates	  
(blue)	   and	   using	  weight,	   paternal	   grandmother,	   and	   gender	   as	   additive	   covariates	   in	   the	  
analysis	   (red).	   Empirically	   derived	   genome-­‐wide	   (α	   =	   0.05)	   thresholds	   of	   significance	   are	  
shown	  as	  horizontal	  lines.	  For	  mapping	  without	  covariates	  the	  threshold	  of	  significance	  was	  
a	  LOD	  score	  of	  3.75.	  For	  mapping	  with	  covariates,	  the	  threshold	  of	  significance	  LOD	  score	  of	  
3.81.	  Mapping	  without	  covariates	   identified	  peaks	  on	  chromosomes	  7	   (LOD	  =	  8.90)	  and	  9	  
(LOD	  =	  3.75).	  Mapping	  with	  covariates	  identified	  a	  peak	  on	  chromosome	  7	  (LOD	  =	  9.83).	  (B)	  
Linkage	   map	   of	   avascular	   area	   across	   chromosome	   9	   created	   without	   inclusion	   of	  
covariates,	   showing	   a	   peak	   at	   SNP	   rs4135590	   (LOD=3.75,	   p=0.05).	   (C)	   Effect	   plots	   of	  
primary	   peak	   on	   chromosome	   9.	   The	   BALB/cByJ	   allele	   is	   designated	   AB/c,	   and	   the	  
C57BL/6ByJ	  alleles	  is	  designated	  AC57.	  The	  BALB/cByJ	  allelotype	  was	  found	  to	  be	  additively	  
protective	   against	   the	   development	   of	   OIR.	   (D)	   Linkage	   map	   of	   avascular	   area	   across	  
chromosome	  7	  created	  by	  including	  weight,	  paternal	  grandmother,	  and	  gender	  as	  additive	  
covariates,	  showing	  a	  peak	  between	  SNPs	  rs13479506	  and	  CEL-­‐7_115892950	  (LOD	  =	  9.83,	  
p	   <	   0.004).	   (E)	   Effect	   plot	   of	   the	   peak	   on	   chromosome	   7	   at	   the	   nearest	   marker,	   CEL-­‐
7_115892950.	  The	  BALB/cByJ	  allelotype	  at	  this	  locus	  is	  shown	  to	  have	  a	  protective	  effect	  in	  
a	  recessive	  manner.	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Table.	  2.1	  QTL	  associated	  with	  retinal	  avascular	  area	  in	  oxygen-­‐induced	  retinopathy.	  	  
†	  mapping	   analysis	   excluded	   covariates;	   *	  mapping	   analysis	   included	  weight,	   gender,	   and	  
paternal	   grandmother	   as	   covariates.	   ‡	   the	   two	  markers	   flanking	   the	   LOD	   score	   peak	   are	  
reported.	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The	  1.8-­‐LOD	  support	  interval	  was	  calculated	  to	  extend	  from	  88.2	  to	  146.2	  Mbp	  distal	  from	  
the	  centromere.	  The	  distal	  boundary	  of	  this	  interval	  coincided	  with	  the	  most	  distal	  marker	  
tested.	  Therefore	  it	  is	  possible	  that	  if	  a	  marker	  at	  the	  telomere	  had	  been	  tested	  it	  would	  have	  
been	  found	  that	  the	  interval	  extends	  as	  far	  as	  the	  telomere.	  
	   Locus-­‐Locus	  Interactions:	  Composite	  interval	  mapping	  was	  conducted	  using	  genotype	  
at	  the	  putative	  QTL	  on	  chromosome	  7	  as	  an	  additive	  or	  interactive	  covariate	  with	  other	  loci;	  
this	  model	  reduces	  residual	  variation	  in	  order	  to	  clarify	  evidence	  for	  further	  QTL,	  allowing	  
detection	   of	   background	   loci	   with	   weak	   main	   effects	   (Broman,	   Sen	   et	   al.,	   2009).	   No	  
additional	   loci	   were	   discovered.	   A	   two-­‐dimensional,	   two-­‐QTL	   scan	   was	   conducted	   to	  
identify	   any	   epistatic	   interactions.	  No	   statistically	   significant	   linked	  or	  multiple	  QTL	  were	  
found.	  
	  
Identification	  of	  a	  QTL	  Related	  to	  Weight	  
Standard	   interval	   mapping	   identified	   a	   LOD	   score	   peak	   on	   chromosome	   5	   that	  
reached	   the	   genome-­‐wide	   threshold	   for	   high	   significance	   (α	   =	   0.05,	   as	   determined	   by	  
permutation	  tests).	  The	  peak	  occurred	  at	  the	  SNP	  CEL-­‐5_9395748,	  approximately	  97.1	  Mbp	  
distal	   from	   the	   centromere	   (LOD	   =	   3.91,	   p	   =	   0.024,	   Figure	   2.7).	   	   At	   this	   locus,	   the	  
C57BL/6ByJ	   allele	  was	   found	   to	   be	   associated	  with	   greater	  weight	   at	   P16	   in	   a	   dominant	  
fashion.	  Using	  this	  single-­‐QTL	  model,	  genotype	  at	  this	  locus	  was	  estimated	  to	  explain	  4.1%	  
of	   the	   variance	   in	   weight	   (p	   =	   0.01).	   A	   1.8-­‐LOD	   support	   interval	   was	   derived	   using	   an	  
algorithm	   in	   R/qtl	   by	   interpolating	   between	   markers	   on	   the	   basis	   of	   recombination	  
frequency	  and	  was	  found	  to	  be	  52.8	  –	  133.6	  Mbp	  distal	  from	  the	  centromere.	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Figure	   2.7.	   The	   results	   of	   genetic	   linkage	   mapping	   using	   bodyweight	   at	   P16	   after	  
exposure	  to	  hyperoxia	  as	  the	  phenotype.	  	  
(A)	  A	   genome-­‐wide	   linkage	  map	  of	  weight	   on	  postnatal	   day	  16	   after	   exposure	   to	   the	  OIR	  
model.	   The	   threshold	   of	   significance	   was	   found	   to	   be	   3.86	   (α	   =	   0.05),	   as	   determined	   by	  
permutation	   tests.	   (B)	   Shows	   linkage	   across	   chromosome	   5,	   with	   significant	   linkage	   at	  
marker	  CEl-­‐5_93945748	  (LOD	  =	  3.91,	  p	  =	  0.024).	  (C)	  Effect	  plot	  of	  genotypes	  at	  this	  marker	  
on	  postnatal	  day	  16;	  homozygosity	  for	  the	  BALB/cByJ	  allelotype	  at	  this	   locus	  is	  associated	  
with	   reduced	  weight	   in	   a	   recessive	  manner	   (ANOVA,	   p	   <	   0.001).	   The	   BALB/cByJ	   allele	   is	  
designated	  AB/c,	  and	  the	  C57BL/6ByJ	  alleles	  is	  designated	  AC57.	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Identification	  of	  Candidate	  Genes	  
	   A	   list	  of	  candidate	  genes	   located	  within	   the	  1.8	  LOD	  support	   intervals	   for	   the	  QTLs	  
was	   created	   using	   a	   web-­‐based	   virtual	   positional	   cloning	   program,	   Positional	   Medline	  
(Yoshida,	   Makita	   et	   al.,	   2009	   Database	   queried	   March	   15,	   2011).	   The	   program	   identifies	  
candidate	   genes	   for	   the	   LOD	   support	   interval	   of	   putative	   QTLs	   related	   to	   keywords	  
(Yoshida,	  Makita	   et	   al.,	   2009).	   The	   search	   region	   on	   chromosome	   7	  was	   extended	   to	   the	  
telomere	  (152	  Mbp);	  160	  candidate	  genes	  were	  identified	  in	  this	  interval	  using	  “retina	  AND	  
angiogenesis”	   as	   keywords	   in	   the	   query.	   The	   10	   genes	   most	   correlated	   with	   the	   search	  
terms	   were	  mitogen-­‐activated	   protein	   kinase	   3,	   antigen	   KI-­‐67,	   fibroblast	   growth	   factor	   4,	  
fibroblast	   growth	   factor	   receptor	   2,	   insulin-­‐like	   growth	   factor	   2,	   tyrosine	   hydroxylase,	  
fibroblast	   growth	   factor	   3,	   extra	   cellular	   link	   domain-­‐containing	   1,	   BCL2/adenovirus	   E1B	  
interacting	  protein	  3,	  and	  cyclin	  D1.	  Using	  “oxidative	  stress”	  as	  keywords	  in	  the	  query	  over	  
the	   same	   interval	   to	   identify	   potential	   candidate	   genes	   related	   specifically	   to	   vaso-­‐
obliteration,	  Positional	  Medline	  identified	  231	  genes;	  the	  top	  10	  included:	  mitogen-­‐activated	  
protein	  kinase	  3,	  tyrosine	  hydroxylase,	  antigen	  KI-­‐67,	  cytochrome	  P450	  2E1,	  amyloid	  beta	  A4,	  
parathyroid	  hormone,	   integrin	  alpha	  M,	   integrin	  alpha	  L,	   integrin-­‐linked	  kinase,	  and	   insulin-­‐
like	  growth	  factor	  2.	  	  
	   Twenty-­‐five	   genes	   were	   found	   within	   the	   support	   interval	   of	   the	   QTL	   on	  
chromosome	   9	   using	   “retina	   AND	   angiogenesis”,	   including	   alpha	   disintegrin	   and	  
metallopeptidase	   domain	   10,	   chondroitin	   sulfate	   proteoglycan	   4,	   alpha	   crystallin	   B,	  
sphingosine-­‐1-­‐phosphate	   receptor	   2,	   Pbx/knotted	   1	   homeobox	   2,	   erythropoietin	   receptor,	  
dopamine	  receptor	  2,	  heat	  shock	  protein	  2,	  cytochrome	  P450	  family	  1	  subfamily	  a	  polypeptide	  
2,	  and	  cytochrome	  P450	  family	  1	  subfamily	  a	  polypeptide	  1;	  “oxidative	  stress”	  identified	  246	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candidates,	   including	   kelch-­‐like	   ECH-­‐associated	   protein	   1,	   apolipoprotein	   A-­‐I,	   beta-­‐site	   APP	  
cleaving	   enzyme	   1,	   dopamine	   receptor	   2,	   low	   density	   lipoprotein	   receptor,	   intercellular	  
adhesion	  molecule	  1,	  cytochrome	  P450	  family	  19	  subfamily	  a	  polypeptide	  1,	  amyloid	  beta	  (A4)	  
precursor-­‐like	  protein	  2,	  cytochrome	  P450	  family	  1	  subfamily	  a	  polypeptide	  2,	  and	  cytochrome	  
P450	  family	  1	  subfamily	  a	  polypeptide	  1.	  	  
	   For	   the	   support	   interval	   found	   on	   chromosome	   5	   using	   weight	   as	   the	   primary	  
phenotype,	   “birth	  weight”	  was	  used	  as	   the	  keyword	   in	   the	  query	   to	  derive	  101	   candidate	  
genes,	   including	   scavenger	   receptor	   class	   B,	   member	   1,	   alpha	   fetoprotein,	   group	   specific	  
component,	  chemokine	  (C-­‐X-­‐C	  motif)	  ligand	  2,	  heparanase,	  chemokine	  (C-­‐X-­‐C	  motif)	  ligand	  1,	  




ROP	  remains	  a	  significant	  cause	  of	  vision	   loss	   in	  the	  pediatric	  population.	  Although	  
some	   risk	   factors	   have	   been	   identified,	   its	   development	   is	   complex	   and	   involves	   both	  
environmental	   and	  genetic	   factors.	  This	   study	  aimed	   to	   initiate	   the	   identification	  of	   genes	  
that	  may	   play	   a	   role	   in	   ROP	   susceptibility.	   Using	   the	  murine	   OIR	  model,	   we	   developed	   a	  
mapping	  cross	  between	  C57BL/6ByJ	  and	  BALB/cByJ	  inbred	  mouse	  strains.	  These	  mice	  were	  
confirmed	   to	   have	   significantly	   different	   vascular	   responses	   to	   OIR	   at	   P16,	   with	   the	  
BALB/cByJ	  strain	  having	  smaller	  avascular	  areas	  than	  the	  C57BL/6ByJ	  strain.	  These	  results	  
support	   those	  published	  by	  Dorrell,	   et	   al.	   (Dorrell,	   Aguilar	   et	   al.,	   2010),	  which	   found	   that	  
while	  both	  strains	  have	  similar	  vaso-­‐obliterative	  areas	  upon	  return	  to	  normoxia	  at	  P12,	  the	  
BALB/cByJ	  strain	  revascularizes	  more	  rapidly	  than	  the	  C57BL/6J	  strain.	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Genetically	  determined	  differences	  in	  retinal	  ocular	  morphology	  between	  the	  strains	  
may	   play	   a	   role	   in	   response	   to	   OIR.	   Recent	   reports	   using	   confocal	   scanning	   laser	  
ophthalmoscopy	   confirm	   physiological	   differences	   in	   retinal	   structure	   between	   adult	  
C57BL/6J	  and	  BALB/c	  mice,	  with	  BALB/c	  mice	  having	  significantly	  thinner	  central	  retinas	  
(211	  μm	  versus	  237	  μm)	  (Huber,	  Beck	  et	  al.,	  2009).	  The	  differences	  between	  C57BL/6J	  and	  
BALB/c	   mice	   are	   at	   least	   partially	   related	   to	   C57BL/6J	   being	   a	   pigmented	   strain	   while	  
BALB/c	  is	  an	  albino	  strain	  (Jeffery,	  1997;	  Ilia	  and	  Jeffery,	  1999;	  Rachel,	  Dolen	  et	  al.,	  2002),	  
and	  this	  issue	  is	  discussed	  further	  below.	  
The	   mapping	   cross	   revealed	   QTL	   associated	   with	   susceptibility	   to	   OIR	   on	  
chromosomes	   7	   and	   9.	   The	   BALB/cByJ	   allele	   of	   the	   chromosome	   7	   QTL	  was	   found	   to	   be	  
protective	   in	   a	   recessive	  manner.	   In	   a	   mapping	  model	   that	   includes	   weight,	   gender,	   and	  
paternal	   grandmother	   as	   additive	   covariates,	   allelotype	   at	   this	   marker	   is	   estimated	   to	  
explain	  34%	  of	   the	  phenotypic	  variation.	  The	  BALB/cByJ	  allele	  of	   the	   chromosome	  9	  QTL	  
was	   also	   found	   to	   be	   protective	   in	   a	   recessive	  manner;	   this	   peak	   only	   reached	   statistical	  
significance	   when	   covariates	   were	   excluded	   from	   the	  model.	   In	   a	   single	   QTL	  model,	   this	  
allele	  was	  estimated	  to	  explain	  7%	  of	  the	  variation	  in	  phenotype.	  	  
No	  QTL	  was	  identified	  on	  the	  X	  chromosome,	  despite	  evidence	  that	  the	  strain	  of	  the	  
paternal	  grandmother	  was	  associated	  with	  avascular	  area.	  It	  was	  noted	  that,	  when	  initially	  
performing	  mapping	  analyses	  with	  single	  covariates	   to	  confirm	  their	   inclusion	   in	   the	   final	  
model,	  inclusion	  of	  paternal	  grandmother	  alone	  caused	  a	  loss	  of	  the	  peak	  on	  chromosome	  9.	  
This	  suggests	  that	  directionality	  of	  the	  cross	  may	  influence	  susceptibility	  via	  an	  epigenetic	  
effect	   on	   a	   gene	  or	   genes	  within	   this	   locus,	   rather	   than	   through	  a	  modifier	   gene	  on	   the	  X	  
chromosome.	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A	  QTL	   related	   to	  weight	   at	  P16	  was	   identified	  on	   chromosome	  5.	  The	  C57BL/6ByJ	  
allele	  was	   found	   to	  be	  associated	  with	  greater	  weight	   in	  a	  dominant	  manner;	  genotype	  at	  
this	   locus	  was	  estimated	   to	  explain	  4.1%	  of	   the	  variance	   in	  weight	  at	   this	   time	  point.	  The	  
selective	   genotyping	   model	   based	   on	   avascular	   area,	   rather	   than	   weight,	   may	   have	  
introduced	  bias	   in	  estimating	  the	  effect	  of	  this	  QTL	  on	  weight	  and	  avascular	  area.	   	   In	  both	  
human	   ROP	   and	   murine	   OIR,	   increased	   birth	   weight	   and	   subsequent	   weight	   gain	   are	  
protective	  against	  NV	  (Coats,	  2005;	  Chen	  and	  Smith,	  2007);	  although	  C57BL/6ByJ	  mice	  have	  
larger	  avascular	  areas	  at	  P16	  than	  their	  BALB/cByJ	  counterparts,	  the	  data	  suggest	  that	  the	  
C57BL/6ByJ	  genome	  does	  contain	  an	  allele	  related	  to	  weight	  that	  serves	  to	  protect	  against	  
OIR.	  	  
Initial	   analysis	   of	   F2	  mice	   revealed	   significantly	   different	   retinal	   avascular	   areas	   in	  
albino	   and	   non-­‐albino	   mice.	   This	   result	   supports	   findings	   from	   a	   rat	   backcross	   (van	  
Wijngaarden,	   Brereton	   et	   al.,	   2007)	   as	   well	   as	   across	   different	   strains	   of	   rats	   (van	  
Wijngaarden,	  Coster	  et	  al.,	  2005).	  As	  albinism	  in	  this	  cross	  is	  caused	  by	  homozygous	  loss	  of	  
function	  of	  Tyr,	  the	  rate-­‐limiting	  enzyme	  in	  the	  biosynthesis	  of	  melanin	  (Jeffery,	  1997),	  these	  
data	  suggest	  that	  Tyr	  or	  a	  linked	  gene	  might	  play	  a	  role	  in	  disease	  susceptibility.	   	  The	  QTL	  
identified	  on	   chromosome	  7	  by	  mapping	  analysis	   includes	  Tyr	   (located	  94.58-­‐94.64	  Mbp)	  
within	  the	  1.8-­‐LOD	  support	   interval.	  The	  association	  between	  albinism	  and	  avascular	  area	  
demonstrated	  here	  supports	  a	  similar	  observation	  in	  rats	  (van	  Wijngaarden,	  Brereton	  et	  al.,	  
2007).	  An	  intriguing	  possibility	  is	  that	  Tyr	  itself	  is	  a	  modifier	  of	  the	  area	  of	  avascular	  retina	  
in	   rodent	   OIR.	   The	  Tyr	   gene	   has	   various	   roles	   in	   ocular	   physiology.	   There	   are	   numerous	  
morphological	  differences	  between	  the	  retinas	  of	  albino	  and	  non-­‐albino	  mice,	  and	  it	   is	  not	  
clear	  whether	  these	  may	  be	  associated	  with	  responses	  to	  hyperoxia.	   It	   is	  possible	  that	  the	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thicker	  C57BL/6	  retina	  becomes	  more	  hypoxic	  than	  the	  BALB/c	  retina,	  and	  that	  this	  leads	  to	  
greater	  astrocyte	  degeneration	  and	  slower	  revascularization	  (Jeffery,	  1997;	  Ilia	  and	  Jeffery,	  
1999;	  Rachel,	  Dolen	  et	  al.,	  2002).	  The	  absence	  of	  melanin	  in	  the	  RPE	  may	  alter	  the	  response	  
of	  the	  retina	  to	  oxidative	  stress	  (van	  Wijngaarden,	  Brereton	  et	  al.,	  2007).	  Alternatively,	  since	  
the	   absence	   of	   melanin	   in	   the	   iris	   increases	   the	   amount	   of	   light	   reaching	   the	   retina	  
(Summers,	   1996),	   it	   is	   possible	   that	   greater	   retinal	   light	   exposure	   affects	   the	  
revascularization	  process,	  even	  though	  light	  has	  not	  previously	  been	  demonstrated	  to	  play	  a	  
role	  in	  modifying	  the	  severity	  of	  OIR	  (Wesolowski	  and	  Smith,	  1994).	  Furthermore,	  Tyr	  can	  
form	  L-­‐3,4-­‐dihydroxyphenylalanine	   (L-­‐dopa),	   the	   immediate	  precursor	  of	  DA	   (Ito,	  Kato	   et	  
al.,	  1984).	  The	  role	  of	  dopamine	  metabolism	  in	  OIR	  is	  currently	  unknown,	  but	  DA	  is	  known	  
to	  modulate	   tumor	  angiogenesis	   (Chakroborty,	  Sarkar	  et	  al.,	  2009)	  and	  may	  play	  a	  role	   in	  
angiogenesis	   in	   OIR.	   However,	   neither	   our	   experiment	   nor	   the	   work	   that	   found	   an	  
association	  between	  albinism	  and	  OIR	  in	  rats	  (van	  Wijngaarden,	  Brereton	  et	  al.,	  2007)	  were	  
designed	  to	  test	  the	  candidature	  of	  any	  particular	  gene.	  	  
	   Positional	   Medline	   identified	   several	   other	   interesting	   candidate	   genes	   located	  
within	  the	  support	   interval	  of	   the	  QTL	  on	  chromosome	  7	  using	  the	  keywords	  “retina	  AND	  
angiogenesis”.	  MAPK3,	  or	  ERK-­‐1,	  is	  a	  mitogen-­‐activated	  kinase	  that	  is	  activated	  by	  fibroblast	  
growth	  factor	  (FGF)	  to	  induce	  EC	  proliferation	  in	  retinal	  angiogenesis	  (Zubilewicz,	  Hecquet	  
et	  al.,	  2001)	  and	  has	  been	  shown	  to	  play	  a	  role	  in	  regulating	  VEGF	  expression	  in	  response	  to	  
oxidative	  stress	  (Klettner	  and	  Roider,	  2009).	  FGF4,	  a	  member	  of	  the	  FGF	  family,	  is	  a	  mitogen	  
that	  is	  involved	  in	  development	  and	  morphogenesis	  of	  various	  cell	  and	  tissue	  types	  (Kosaka,	  
Sakamoto	   et	   al.,	   2009).	   Over-­‐expression	   of	   FGFR2,	   a	   receptor	   for	   FGF,	   has	   been	  
demonstrated	   in	   several	   types	   of	   neoplasia,	   including	   breast	   cancer,	   prostate	   cancer	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(Schwertfeger,	  2009),	  renal	  cell	  carcinoma	  (Tsimafeyeu,	  Demidov	  et	  al.,	  2011),	  and	  gastric	  
cancer	   (Katoh,	   2009).	   Within	   the	   retina,	   insulin-­‐like	   growth	   factor	   2	   (IGF-­‐2)	   is	   present	  
almost	   exclusively	   in	   the	   photoreceptors	   and	   vasculature,	   where	   it	   is	   the	   major	   locally	  
expressed	   growth	   factor.	  However,	   it	   is	   not	   expressed	   in	   the	   vascular	   ECs	   in	   neovascular	  
tufts	  formed	  in	  response	  to	  OIR	  (Lofqvist,	  Willett	  et	  al.,	  2009).	  Tyrosine	  hydroxylase,	  TH,	  is	  
the	  enzyme	  primarily	   responsible	   for	  dopamine	  production	   in	   the	  central	  nervous	  system	  
and	   retina;	   in	   the	   eye,	   it	   is	   found	  primarily	   in	   amacrine	   cells	   in	   the	   inner	  plexiform	   layer	  
(Reis,	   Ventura	   et	   al.,	   2007).	   	  Xlkd1,	   or	   extra-­‐cellular	   link	   domain	   containing	   1,	   encodes	   a	  
hyaluronan	   receptor	   expressed	   on	   lymphatic	   endothelium	   in	   both	   adult	   and	   embryonic	  
vessels	  and	  XLKD1	  positive	  cells	  were	  recently	  identified	  in	  the	  hyaloid	  vascular	  system	  of	  
the	  developing	  murine	  eye	  (Zhang,	  Tse	  et	  al.,	  2010).	  
	   Four	  of	   the	   top	  10	  putative	   genes	   identified	  using	   the	  key	   terms	   “oxidative	   stress”	  
(Mapk3,	  Th,	  Mki67,	  and	  Igf2)	  were	  also	  identified	  in	  the	  prior	  search.	  Integrin	  alphas	  L,	  and	  
M	  	  (ITGAL,	  or	  CD11a,	  and	  ITGAM,	  or	  CD11b,	  respectively)	  are	  expressed	  on	  neutrophils	  and,	  
when	  complexed	  with	  beta	  2	   integrin	  CD18,	   function	  to	  modulate	  migration	  of	  the	  cells	  to	  
the	  site	  of	  injury	  by	  binding	  ICAM-­‐1	  on	  ECs	  (Mazzone	  and	  Ricevuti,	  1995).	  VEGF-­‐A	  has	  been	  
shown	   to	   stimulate	   neutrophil	   and	   T	   cell	   recruitment	   in	   an	   Itgal-­‐	   and	   Itgam-­‐dependent	  
manner	  (Chidlow,	  Glawe	  et	  al.,	  2010).	   	   Integrin	   linked	  kinase	  signaling	  has	  been	  shown	  to	  
mediate	  production	  of	  brain-­‐derived	  neurotrophic	  factor	  by	  ECs	  (Guo,	  Kim	  et	  al.,	  2008),	  and	  
oxidative	  stress	  disrupts	  this	  signaling	  pathway	  (Saito,	  Hayashi	  et	  al.,	  2004).	  	  
Although	  ranked	  less	  highly	  by	  the	  Positional	  Medline	  algorithm,	  3	  genes	  related	  to	  
Wnt	  signaling	  pathways	  were	  included	  in	  the	  list	  of	  candidate	  genes.	  Wnt	  signaling	  plays	  an	  
essential	   role	   in	   cell	   survival,	   proliferation,	   and	   migration,	   and	   has	   an	   important	   role	   in	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controlling	  retinal	  angiogenesis	   (Ye,	  Wang	  et	  al.,	  2009).	  Mutations	   in	  genes	  related	   to	   this	  
pathway	   have	   been	   implicated	   in	   several	   ocular	   neovascular	   diseases	   with	   phenotypic	  
similarities	  to	  ROP,	  including	  FEVR	  and	  Norrie	  disease	  (Nikopoulos,	  Venselaar	  et	  al.,	  2010).	  
Mutations	  in	  FZD4	  have	  been	  identified	  as	  a	  cause	  of	  familial	  FEVR	  (Robitaille,	  MacDonald	  et	  
al.,	  2002)	  and	  have	  been	  confirmed	  in	  cases	  worldwide	  (Nallathambi,	  Shukla	  et	  al.,	  2006;	  Jia,	  
Li	  et	  al.,	  2010).	  More	  recently,	  FZD4	  mutations	  have	  been	  found	  in	  a	  small	  number	  (3%)	  of	  a	  
cohort	  of	  infants	  with	  severe	  ROP	  (Ells,	  Guernsey	  et	  al.,	  2010).	  Interestingly	  the	  mouse	  Fzd4	  
gene	  lies	  within	  the	  QTL	  found	  on	  chromosome	  7.	  Wnt11	  is	  another	  gene	  involved	  in	  Wnt	  
signaling	   that	   is	   encoded	   within	   the	   QTL	   on	   chromosome	   7;	   WNT11	   is	   a	   non-­‐canonical	  
ligand	  in	  the	  pathway.	  Within	  the	  retina	  specifically,	  mutations	  in	  Wnt11	  have	  been	  shown	  
to	   result	   in	   increased	   angiogenesis	   and	   branching	   (Stefater,	   Lewkowich	   et	   al.,	   2011).	  
Dickkopf	   3	   (DKK3)	  belongs	   to	   a	   family	   of	   secreted	   glycoproteins	   that	   act	   as	   regulators	   of	  
Wnt	  signaling.	  In	  the	  retina,	  Dkk3	  is	  expressed	  by	  Muller	  glia	  and	  retinal	  ganglion	  cells	  and	  is	  
a	  cell-­‐type	  specific	  positive	  regulator	  of	  Wnt	  signaling.	  In	  response	  to	  photoreceptor	  death	  
in	   a	  murine	  model	   of	   retinal	   degeneration,	  Dkk3	   expression	   is	   up-­‐regulated	   and	   inhibited	  
caspase	  activation	  in	  Muller	  glia	  (Nakamura,	  Hunter	  et	  al.,	  2007).	  
	   The	   LOD	   support	   interval	   on	   chromosome	   9	   also	   contains	   several	   interesting	  
candidates	   identified	   by	   Positional	  Medline	   related	   to	   retina	   and	   angiogenesis.	   CSPG4,	   or	  
chondroitin	   sulfate	  proteoglycan	  4,	   also	  known	  as	  NG2,	   is	   expressed	  by	  nascent	  pericytes	  
early	   in	  angiogenesis.	  Studies	  of	   ischemic	  retinal	  NV	  have	  shown	  decreased	  ectopic	  vessel	  
protrusion	   into	  the	  vitreous	  and	  decreased	  proliferation	  of	  both	  pericytes	  and	  ECs	   in	  NG2	  
knock-­‐out	  (KO)	  mice	  (Ozerdem	  and	  Stallcup,	  2004).	  Similarly	  to	  MAPK3,	  MAP2K1	  (MEK1)	  
mediates	   FGF-­‐stimulated	   EC	   proliferation	   in	   tumor	   models	   (Zubilewicz,	   Hecquet	   et	   al.,	  
	   72	  
2001).	   IL18	   has	   been	   shown	   to	   play	   a	   role	   in	   regulating	   regression	   of	   pathological	  NV	   in	  
mice	  after	  exposure	   to	   the	  OIR	  model	   (Qiao,	  Sonoda	  et	  al.,	  2007);	  additional	  studies	  using	  
KO	   mice	   suggest	   that	   IL18	   plays	   a	   role	   in	   regulation	   of	   retinal	   vessel	   formation	   (Qiao,	  
Sonoda	   et	   al.,	   2004).	   CRYAB,	   or	   crystalline	   alpha	   B,	   is	   a	   chaperone	  within	   the	   small	   heat	  
shock	   protein	   family	   and	   has	   been	   shown	   using	   KO	   mouse	   models	   to	   play	   a	   role	   in	  
intraocular	  angiogenesis	  by	  acting	  as	  a	  chaperone	   for	  VEGF-­‐A	  (Kase,	  He	  et	  al.,	  2010).	  EPO	  
has	   been	   linked	   to	   both	   ROP	   and	   diabetic	   retinopathy.	   Local	   tissue	   EPO	   levels	   are	  
suppressed	  during	  retinal	  vessel	   loss	   in	  OIR	  and	  elevated	  during	  NV,	  and	  pharmacological	  
use	  of	  EPO	  was	   shown	   to	  protect	   against	  hypoxia-­‐induced	  apoptosis	   (Chen,	  Connor	   et	   al.,	  
2008).	   siRNA	   inhibition	   of	   EPO	   expression	   during	   the	   neovascular	   phase	   successfully	  
inhibited	  NV	  (Chen,	  Connor	  et	  al.,	  2009).	  Human	  and	  murine	  studies	  have	  both	  found	  that	  
vitreal	   EPO	   expression	  was	   associated	  with	   proliferative	   diabetic	   retinopathy	   (Watanabe,	  
Suzuma	  et	  al.,	  2005).	  	  
	   Candidates	  derived	  using	  the	  key	  terms	  “oxidative	  stress”	  included	  several	  adhesion	  
molecules.	   ICAM1	   is	   expressed	   by	   ECs	   and	   plays	   a	   critical	   role	   in	   leukocyte	   stasis	   and	  
migration	   to	   the	   site	   of	   injury	   (Long,	   2011).	   	   D2	   (dopamine	   receptor	   2)	   acts	   as	   an	  
antioxidant	   in	   physiological	   conditions;	   it	   has	   been	   found	   to	   regulate	   the	   production	   of	  
reactive	   oxidative	   species,	   and	   KO	   mice	   have	   higher	   blood	   pressure	   in	   part	   due	   to	   the	  
increased	   oxidative	   damage	   in	   the	   kidney	   (Armando,	   Wang	   et	   al.,	   2007).	   LDLR	   is	   also	  
involved	   in	  mediating	  oxidative	   stress;	  KO	  mouse	  models	  have	   increased	  oxidative	   stress,	  
inflammation,	  and	  atherosclerosis	   (Holvoet,	  2008).	  Furthermore,	  oxidative	  modification	  of	  
this	  receptor	  has	  been	  associated	  with	  EC	  dysfunction	  (Sakurai	  and	  Sawamura,	  2003).	  Three	  
different	   cytochrome	   P450	   genes	   were	   also	   found	   to	   be	   candidates	   by	   the	   Positional	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Medline	  program;	  however,	   this	  may	  be	  a	  spurious	  result	  due	  to	  the	   large	  amount	  of	  data	  
published	  regarding	  oxidative	  stress	  generated	  in	  the	  metabolism	  of	  various	  drugs.	  	  
The	  support	   interval	  of	   the	  QTL	  on	  chromosome	  5	  associated	  with	  weight	   includes	  
101	   candidate	   genes	   related	   to	   “birth	   weight.”	   Low	   maternal	   serum	   α-­‐fetoprotein	   (AFP)	  
levels	  have	  been	  shown	  in	  humans	  to	  be	  associated	  with	  large	  birth	  weight	  infants	  (Baschat,	  
Harman	  et	  al.,	  2002).	  Heparanase,	  HPSE,	  plays	  a	  role	   in	  placental	  development	  and	  affects	  
both	   structure	   and	   nutrient	   transport	   (Vallet,	  Miles	   et	   al.,	   2009).	   CXCL1,	   2,	   4,	   and	   10	   are	  
chemokines	   that	   have	   been	   studied	   extensively	   in	   regards	   to	   their	   role	   in	   inflammation	  
(Horuk	   and	   Peiper,	   1996;	   Romagnani,	   Lasagni	   et	   al.,	   2004),	   development,	   angiogenesis	  
(Romagnani,	   Lasagni	   et	   al.,	   2004;	   Strieter,	   Belperio	   et	   al.,	   2004),	   and	   neoplasia	   (Strieter,	  
Belperio	  et	  al.,	  2004).	  	  
	  
CONCLUSIONS	  
Revascularization	  in	  OIR	  is	  related	  to	  weight,	  strain	  of	  paternal	  grandmother,	  gender,	  
and	   albinism.	   Our	   data	   support	   the	   existence	   of	   a	   QTL	   on	   chromosome	   5	   that	   influences	  
weight	  after	  exposure	  to	  hyperoxia,	  as	  well	  as	  QTLs	  on	  chromosomes	  7	  and	  9	  that	  modify	  
susceptibility	   to	   OIR.	   Ongoing	   studies	   are	   investigating	   the	   role	   of	   candidate	   QTGs	   as	  
modifiers	   of	   the	   progression	   of	   OIR.	   It	   is	   hoped	   that	   investigation	   of	   QTGs	   will	   help	   to	  
elucidate	   the	   pathogenesis	   of	   ROP.	   These	   modifier	   genes	   may	   also	   be	   candidates	   for	  
susceptibility	   genes	   in	   other	   complex	   ocular	   diseases	   involving	   aberrant	   angiogenic	  
responses,	  such	  as	  diabetic	  retinopathy	  and	  neovascular	  age-­‐related	  macular	  degeneration.	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ABSTRACT	  
	   ROP	  is	  a	  leading	  cause	  of	  vision	  loss	  in	  the	  pediatric	  population.	  ROP	  has	  a	  phase	  of	  
arrest	   of	   vascularization	   of	   the	   peripheral	   retina	   followed	   by	   a	   stage	   of	   pathological	  
angiogenesis.	   Our	   prior	   work	   identified	   Tyr	   as	   a	   candidate	   QTG	   associated	   with	  
revascularization	  of	  the	  retina	  after	  hyperoxic	  vaso-­‐obliteration	  in	  the	  murine	  model	  of	  ROP,	  
OIR.	  This	  study	  tests	  the	  candidature	  and	  mechanism	  of	  action	  of	  Tyr	  in	  modulating	  retinal	  
revascularization	   and	   investigates	   a	   putative	   mechanism.	   Compared	   with	   Tyr	  wild-­‐type	  
mice,	   Tyr-­‐null	   mice	   have	   lower	   serum	   DA	   higher	   levels	   of	   CD45-­‐	   and	   lo/CD34+/CD133+	  
endothelial	   progenitor	   cells	   in	   their	   bone	   marrow	   and	   blood,	   greater	   recruitment	   of	  
CD34+/CD133+	   cells	   to	   the	   revascularizing	   retina,	   and	   faster	   retinal	   revascularization.	  
Pharmacological	  administration	  of	  DA	  inhibits	  endothelial	  progenitor	  cell	  recruitment	  to	  the	  
retina	  and	  revascularization	  in	  both	  Tyr	  null	  and	  wild-­‐type	  animals.	  Real-­‐time	  PCR	  analysis	  
of	  DA	  receptor	  expression	  and	  experiments	  using	  receptor	  agonists	  suggest	  D1-­‐like	  family	  
of	  receptors	  mediates	  these	  effects.	  The	  suggested	  role	  of	  dopaminergic	  inhibition	  of	  retinal	  
revascularization	  and	  of	  endothelial	  progenitor	  cell	  recruitment	  has	  important	  implications	  
for	  ROP	  and	  other	  diseases	  of	  premature	  infants,	  and	  potentially	  for	  the	  pathophysiology	  of	  
other	  retinal	  vasculopathies.	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LIST	  OF	  ABBREVIATIONS	  	  
	  
ANOVA	  –	  analysis	  of	  variance	  
BM	  –	  bone	  marrow	  
c-­‐2J	  –	  B6(Cg)-­‐Tyrc-­‐2J/J	  
D2	  –	  dopamine	  receptor	  2	  
DA	  -­‐	  dopamine	  
EC	  –	  endothelial	  cell	  
EPC	  –	  endothelial	  progenitor	  cell	  
HPLC–ED	  –	  high	  performance	  liquid	  chromatography	  with	  electrochemical	  detection	  	  
ISHAGE	  -­‐	  International	  Society	  for	  Hematotherapy	  and	  Graft	  Engineering	  
N2	  –	  backcross	  2nd	  generation	  	  
OIR	  –	  oxygen-­‐induced	  retinopathy	  
P	  –	  post-­‐natal	  day	  	  
QTG	  –	  quantitative	  trait	  gene	  
QTL	  –	  quantitative	  trait	  loci	  
ROP	  –	  Retinopathy	  of	  Prematurity	  
RPE	  –	  retinal	  pigment	  epithelium	  
rt-­‐PCR	  –	  real	  time	  polymerase	  chain	  reaction	  
TH	  –	  tyrosine	  hydroxylase	  
Tyr	  –	  Tyrosinase	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INTRODUCTION	  
ROP	   is	   a	   leading	   cause	   of	   blindness	   in	   children	   in	   the	  US	   (Gilbert,	   2008).	   ROP	   is	   a	  
complex	  disease	  where	  a	  phase	  of	  arrest	  of	  peripheral	  retinal	  vascularization	  is	  followed	  by	  
a	  phase	  of	  pathological	  neovascularization.	  OIR	  in	  the	  mouse	  was	  developed	  as	  a	  model	  of	  
ROP	  (Smith,	  Wesolowski	  et	  al.,	  1994).	  In	  the	  mouse	  OIR	  model,	  exposure	  to	  hyperoxia	  leads	  
to	   central	   vaso-­‐obliteration.	   When	   mice	   are	   returned	   to	   a	   normoxic	   environment,	   the	  
presence	   of	   a	   region	   of	   avascular	   retina	   creates	   a	   pro-­‐angiogenic	   milieu,	   which	   leads	   to	  
retinal	  NV	  (Polverini,	  Cotran	  et	  al.,	  1977;	  Smith,	  Wesolowski	  et	  al.,	  1994;	  Lutty,	  Chan-­‐Ling	  et	  
al.,	   2006).	   The	   current	   study	   used	   the	   OIR	   model	   to	   investigate	   the	   genetics	   of	   retinal	  
vascular	   regeneration	   in	   the	   aftermath	   of	   hyperoxia-­‐induced	   central	   retinal	   vaso-­‐
obliteration.	   Retinal	   vascular	   regeneration	   was	   studied	   in	   order	   to	   find	   pathways	   that	  
potentially	  may	  be	  therapeutically	  modulated	  to	  improve	  retinal	  vascularization	  in	  ROP,	  and	  
which	  may	   play	   a	   role	   in	   other	   retinal	   vasculopathies	   and	   vascular	   regeneration	   in	   other	  
organs.	  
Our	   previous	   work	   used	   an	   inter-­‐strain	   difference	   between	   C57BL/6ByJ	   and	  
BALB/cByJ	  mice	   to	  map	  QTL	   controlling	   retinal	   revascularization.	   C57BL/6ByJ	  mice	   have	  
larger	  avascular	  areas	  in	  response	  to	  hyperoxic	  vaso-­‐obliteration	  in	  the	  OIR	  model	  than	  do	  
BALB/cByJ	  at	  both	  P12	  (Symons,	  Swaim	  et	  al.,	  2009)	  and	  P16	  (O'Bryhim,	  Radel	  et	  al.,	  2012).	  
Tyr	   is	   located	   at	   94.5	   Mbp	   on	   chromosome	   7,	   within	   a	   significant	   QTL	   identified	   in	   a	  
mapping	   study	   (O'Bryhim,	   Radel	   et	   al.,	   2012),	   with	   albino	   mice	   in	   this	   cross	   exhibiting	  
smaller	   vaso-­‐obliterative	   areas	   than	   non-­‐albino	   mice.	   A	   similar	   association	   between	  
albinism	   and	   decreased	   retinal	   avascular	   area	   in	   OIR	   has	   been	   found	   in	   rats	   (van	  
Wijngaarden,	  Coster	   et	   al.,	   2005;	   van	  Wijngaarden,	  Brereton	  et	   al.,	   2007).	  Albinism	   in	   the	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BALB/cByJ	  strain	  is	  caused	  by	  homozygous	  loss	  of	  function	  of	  Tyr,	  the	  rate-­‐limiting	  enzyme	  
in	   the	  biosynthesis	  of	  melanin	   (Jeffery,	   1997).	  Therefore,	   these	  data	   suggest	   that	  Tyr	   or	   a	  
linked	  gene	  might	  play	  a	  role	  in	  disease	  susceptibility.	  	  
Tyr	   has	   been	   shown	   by	   independent	   groups	   to	   contribute	   to	   production	   of	   DA	   in	  
peripheral	   tissues	   (i.e.,	   outside	   of	   the	   central	   nervous	   system).	   Pigmented	   TH-­‐null	  
transgenic	   mice	   produced	   18%	   more	   catecholamines	   than	   did	   albino	   littermates	   (Rios,	  
Habecker	  et	  al.,	  1999).	  Additionally,	  pigmented	  mice	  have	  been	  shown	  to	  have	  significantly	  
higher	  levels	  of	  DA	  specifically	  compared	  to	  albino	  mice	  regardless	  of	  presence	  or	  absence	  
of	  functional	  TH	  (Eisenhofer,	  Tian	  et	  al.,	  2003).	  In	  the	  eye	  specifically,	  L-­‐dopa	  produced	  by	  
TYR	   can	   be	   secreted	   from	   the	   RPE	   and	   converted	   into	   DA	   by	   amacrine	   cells,	   and	   DA	  
receptors	   are	   expressed	   as	   early	   as	   embryonic	   day	   14	   in	   gestation	   (Reis,	   Ventura	   et	   al.,	  
2007).	   Both	   DA	   and	   L-­‐dopa	   are	   thought	   to	   influence	   retina	   differentiation	   in	   early	  
development	  (Kralj-­‐Hans,	  Tibber	  et	  al.,	  2006).	  	  
Outside	   of	   the	   eye,	   DA	   is	   known	   to	   inhibit	   angiogenesis.	   Several	   studies	   in	   tumor	  
models	  showed	  that	  DA	  signaling	  through	  D2	  inhibits	  angiogenesis	  (Basu,	  Nagy	  et	  al.,	  2001;	  
Gomez	  R	  Fau	   -­‐	  Gonzalez-­‐Izquierdo,	  Gonzalez-­‐Izquierdo	  M	  Fau	   -­‐	  Zimmermann	  et	  al.,	  2006;	  
Chakroborty,	  Chowdhury	  et	  al.,	  2008).	  DA	  can	  influence	  angiogenesis	  through	  its	  actions	  on	  
both	  EPCs	  and	  vascular	  ECs	  (Chakroborty,	  Sarkar	  et	  al.,	  2009).	  	  
This	   study	   was	   conducted	   to	   explore	   the	   role	   of	   Tyr	   as	   a	   modifier	   gene	   in	  
revascularization	  following	  hyperoxic	  vaso-­‐obliteration	  induced	  by	  the	  OIR	  model.	  Given	  the	  
evidence	  for	  Tyr’s	  candidature,	  the	  series	  of	  experiments	  here	  investigate	  the	  mechanism	  of	  
action	  by	  which	  Tyr	  modulated	  revascularization,	   in	  particular	   testing	   the	  hypothesis	   that	  
modulation	  of	  dopaminergic	  pathways	  may	  influence	  retinal	  revascularization.	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MATERIALS	  AND	  METHODS	  
Animals	  
	   All	  experimental	  procedures	  were	  approved	  by	  University	  of	  Kansas	  Medical	  Center	  
Institutional	   Animal	   Care	   and	   Use	   Committee.	   c-­‐2J	  mice	   are	   a	   substrain	   of	   the	   C57BL/6J	  
mouse	   strain	   that	   has	   a	   spontaneous	   loss	   of	   function	   mutation	   in	   Tyr	   that	   was	   bred	   to	  
homozygosity.	   Both	   C57BL/6J	   and	   c-­‐2J	   mice	   were	   purchased	   from	   Jackson	   Laboratories	  
(Bar	  Harbor,	  ME).	  All	  mice	  were	  kept	   in	  a	  12-­‐hour	   light,	  12-­‐hour	  dark	  cycle	  with	  ambient	  
room	  temperature	  between	  19oC	  and	  22oC.	  Breeding	  pairs	  were	  maintained	  on	  a	  higher-­‐fat	  
diet	   (8626	   rodent	   diet,	   Harlan	   Laboratories,	   Indianapolis,	   IN),	   with	   chow	   and	   water	  
available	   ad	   libitum.	   All	   experiments	   except	   described	   used	   mice	   from	   a	   minimum	   of	   3	  
litters	  to	  avoid	  strain-­‐specific	  bias.	  
	  
Oxygen-­‐Induced	  Retinopathy	  
	   OIR	  was	  induced	  according	  to	  protocol	  (Smith,	  Wesolowski	  et	  al.,	  1994)	  by	  exposing	  
pups	  to	  75%	  oxygen	  beginning	  on	  P7	  and	  returning	  them	  to	  normoxia	  after	  120	  hours.	  O2	  
levels	   in	   the	   chambers	   were	   continuously	   controlled	   using	   a	   ProOx	   portable	   monitor	  
(Biospherix,	  Redfield,	  NY),	  which	  was	  calibrated	  monthly	  using	  room	  air	  and	  100%	  O2.	  Mice	  
were	   weighed,	   anesthetized	   with	   a	   lethal	   dose	   of	   tribromoethanol	   via	   intraperitoneal	  
injection,	  and	  sacrificed	  at	  P12,	  P13,	  or	  P16.	  
	  
Avascular	  Areas	  in	  OIR	  
	   After	   induction	  of	  anesthesia,	  C57BL/6J,	  c-­‐2J,	  and	  backcross	  animals	  were	  perfused	  
with	   high-­‐molecular	   weight	   fluorescein	   isothiocyanate-­‐labeled	   dextran	   (MW≥2,000,000;	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Sigma,	  St.	  Louis,	  MO)	  via	  the	  left	  ventricle	  to	  visualize	  patent	  vessels	  and	  enucleated.	  Retinas	  
were	  fixed	  overnight	  in	  4%	  paraformaldehyde,	  dissected,	  and	  flat-­‐mounted	  using	  anti-­‐fade	  
medium	   (Southern	   Biotech,	   Birmingham,	   AL).	   Immunofluorescent	   micrographic	   images	  
were	   taken	  using	   an	   SMZ	  1500	  microscope	   (Nikon,	  Tokyo,	   Japan)	   and	  MagnaFire	  Camera	  
and	   software	   (Optronics,	   Goleta,	   CA).	  ImageJ	   (http://rsbweb.nih.gov/ij/)	   was	   used	   to	  
manually	  trace	  and	  measure	  avascular	  areas.	  	  	  
	  
Backcross	  Breeding	  Strategy	  
	   An	  N2	  backcross	  population	  was	  bred	  by	  mating	  female	  C57BL/6J	  mice	  to	  male	  c-­‐2J	  
mice	  to	  derive	  a	  (C57BL/6J	  x	  c-­‐2J)N1	  generation.	  Female	  N1	  mice	  were	  bred	  with	  male	  c-­‐2J	  
mice	  to	  create	  the	  N2	  generation	  (Figure	  3.1).	  N2	  mice	  were	  exposed	  to	  the	  OIR	  model	  and	  
sacrificed	  on	  P13	  for	  enucleation	  as	  described	  above.	  
	  
Flow	  Cytometry	  
	   After	   induction	   of	   anesthesia	   on	   P13,	   blood	   samples	   from	  C57BL/6J	   and	   c-­‐2J	  mice	  
were	  taken	  via	  cardiac	  puncture.	  Samples	  were	  incubated	  in	  3x	  volume	  of	  RBC	  lysis	  buffer	  
(Biolegend,	  San	  Diego,	  CA)	  according	  to	  instructions,	  centrifuged	  at	  300	  g,	  and	  re-­‐suspended	  
in	   1	  mL	   1%	  BSA	   in	   PBS.	   BM	  was	   harvested	   by	   aspiration	   from	   the	   same	  mice	   from	  both	  
femurs	  and	  tibias.	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Figure	  3.1	  Illustration	  of	  the	  breeding	  scheme	  used	  in	  the	  backcross.	  	  
Female	   C57BL/6J	  mice,	   represented	   in	   red,	   were	   bred	   to	   male	   c-­‐2J	   mice,	   represented	   in	  
blue,	  to	  derive	  a	  (C57BL/6J	  x	  B6(Cg)-­‐Tyrc-­‐2J/J)N1	  generation.	  Female	  N1	  mice	  were	  bred	  with	  
male	  c-­‐2J	  mice	  to	  create	  the	  N2	  generation.	  N2	  mice	  were	  exposed	  to	  OIR,	  and	  avascular	  area	  
was	  compared	  between	  albino	  and	  non-­‐albino	  (black)	  littermates.	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   BM	  and	  blood	  samples	  were	  filtered	  through	  a	  70	  µM	  mesh	  filter	  and	  centrifuged	  at	  
300	  g	  for	  10	  minutes	  at	  4oC.	  Given	  the	  rarity	  of	  EPCs,	  bone	  marrow	  and	  blood	  samples	  were	  
stained	  for	  flow	  cytometric	  analysis	  of	  EPCs	  using	  modifications	  of	  the	  International	  Society	  
for	   Hematotherapy	   and	   Graft	   Engineering	   (ISHAGE)	   protocol	   as	   described	   previously	  
(Balasubramaniam,	   Mervis	   et	   al.,	   2007).	   This	   procedure	   has	   been	   used	   to	   successfully	  
isolate	  CD133+	  progenitor	   cells	   from	   small	   samples	   of	   both	  BM	  and	  blood.	   Samples	  were	  
incubated	  in	  CD45-­‐FITC,	  CD34-­‐APC,	  CD133-­‐PE	  (Biolegend,	  San	  Diego,	  CA)	  for	  30	  minutes	  on	  
ice.	  Cells	  were	  washed	  with	  1%	  BSA,	  centrifuged	  at	  300	  g	  for	  10	  minutes,	  and	  re-­‐suspended	  
in	  DAPI	  (Invitrogen,	  Grand	  Island,	  NY)	  for	  10	  minutes	  to	  differentiate	  live	  cells.	  After	  a	  final	  
wash	   and	   spin,	   samples	  were	   re-­‐suspended	   in	   1%	  BSA	   and	   analyzed	   at	   the	  University	   of	  
Kansas	  Medical	  Center	  Flow	  Cytometry	  Core	  with	  a	  Beckman	  LSRII	  Flow	  Cytometer	  (Miami,	  
FL).	   Single-­‐stain	   positive	   controls	   and	   negative	   controls	   were	   used	   to	   set	   the	   gates	   and	  
determine	   voltage	   compensation	   for	   fluorescent	   intensity.	   A	   minimum	   of	   1,000,000	   cells	  
was	  counted	  from	  each	  sample,	  and	  samples	  were	  run	  until	  3,000,000	  cells	  were	  counted	  or	  
the	  sample	  was	  exhausted.	  Cells	  were	  gated	   to	  exclude	  DAPI	  positive	  dead	  cells,	   and	   then	  
gated	  to	  select	  for	  the	  CD45-­‐negative	  and	  -­‐lo	  population.	  Of	  these,	  CD133	  and	  CD34	  double	  
positive	  cells	  were	  counted	  as	  a	  percentage	  of	  all	  live,	  CD45-­‐/lo	  cells.	  
	  
Immunofluorescent	  Staining	  
	   Retinae	  were	  permeablilized	  overnight	  in	  0.5%	  Triton	  X-­‐100,	  washed,	  and	  incubated	  
in	  20	  µg/mL	  Griffonia	  simplicifolia	  isolectin	  B4	  (Sigma,	  St.	  Louis,	  MO)	  in	  PBLec	  (PBS,	  pH	  6.8,	  
1%	  Triton	   X-­‐100,	   0.1	  mM	  CaCl2,	   0.1	  mM	  MgCl2,	   0.1	  mM	  MnCl2)	   overnight.	   After	   blocking,	  
retinae	  were	   incubated	   in	  hamster	  anti-­‐murine	  CD34	  (1:100,	  Biolegend,	  San	  Diego,	  CA)	  or	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rabbit	   anti-­‐Ki67	   (1:50,	   Abcam,	   Cambridge,	   MA),	   and	   rat	   anti-­‐murine	   CD133	   (1:200,	  
Biolegend,	   San	   Diego,	   CA)	   overnight.	   Retinae	   were	   subsequently	   stained	   with	   Texas	   Red	  
anti-­‐rat	   IgG	   (1:400,	   Abcam,	   Cambridge,	   MA)	   or	   Texas	   Red	   anti-­‐rabbit	   (1:200,	   Abcam,	  
Cambridge,	  MA)	  and	  Dylight	  649	  anti-­‐hamster	   IgG	  (1:200,	  Biolegend,	  San	  Diego,	  CA)	   for	  1	  
hour	   at	   room	   temperature,	   washed,	   and	   flatmounted	   using	   anti-­‐fade	   medium	   (Southern	  
Biotech,	  Birmingham,	  AL).	  Two	  micrographic	  images	  of	  each	  retina	  was	  taken	  using	  a	  Nikon	  
Digital	  Eclipse	  C1Si	  confocal	  microscope	  (Tokyo,	   Japan)	  and	  Nikon	  EZC1	  software	   (Tokyo,	  
Japan).	  The	  number	  of	  CD34+/CD133+	  cells	  were	  counted	  and	  averaged	  for	  each	  retina.	  
	  
Quantification	  of	  dopamine	  concentration	  in	  serum	  
	   Peripheral	  blood	  samples	  were	  collected	  by	  cardiac	  puncture	  on	  P13,	  allowed	  to	  sit	  
at	   room	   temperature	   for	   10-­‐15	  minutes,	   and	   centrifuged	   at	   2,200	   g	   for	   10	  minutes.	   The	  
supernatant	  serum	  was	  collected,	  snap	  frozen	  on	  dry	  ice,	  and	  stored	  at	  -­‐80oC	  until	   further	  
processing.	   Samples	   were	   thawed	   on	   ice	   and	   catecholamines	   were	   extracted	   using	   ESA	  
Catecholamine	   Analysis	   Kits	   (ESA,	   Chelmsford,	   MA)	   according	   to	   protocol.	   DA	  
concentrations	   were	   determined	   using	   an	   isocratic	   high	   performance	   liquid	  
chromatography	   system	   (ESA	  Coulochem	   III,	   Chelmsford,	  MA)	   coupled	   to	  a	  Coulochem	   III	  
dual-­‐channel	   electrochemical	   array	  detector	   (HPLC-­‐ED)	   (E1	  +	  0.35	  mV	  and	  E2	  −	  0.25	  mV	  
using	  a	  5011	  dual	  analytical	  cell	  ESA	  Model	  5100A).	  DA	  was	  separated	  with	  a	  C18	  reverse	  
phase	  column	  (ESA	  HR-­‐80	  C18,	  4.6	  mm	  ×	  80	  mm,	  3	  μm)	  with	  a	  pH	  4.0	  citrate-­‐acetate	  mobile	  
phase	  containing	  4.0%	  methanol	  and	  ~0.35	  mM	  1-­‐octane-­‐sulfonic	  acid	  at	  a	  flow	  rate	  of	  1.8	  
ml/min.	   3,4-­‐dihydroxy-­‐benzylamine	   was	   used	   as	   the	   internal	   standard.	   Plasma	   DA	  
concentrations	  were	  expressed	  as	  pg/mL	  serum.	  
	   85	  
Gene	  expression	  studies	   	   	  
	   Tyr	   and	   DA	   receptor	   expression	   were	   determined	   using	   real-­‐time	   PCR	   (rt-­‐PCR)	  
expression	  analysis.	  BM	  and	  blood	  samples	  from	  3	  litters	  were	  harvested	  as	  described	  and	  
pooled	   for	   each	   litter.	   BM	   samples	   from	   an	   additional	   litter	   were	   pooled,	   incubated	   in	  
antibodies	  as	  described	  above	  to	  allow	  sorting	  of	  CD45-­‐/CD34+/CD133+	  and	  Cd45-­‐/CD34-­‐
/CD133-­‐	   cells	   on	   a	   BD	   FACSAria	   IIu	   	   (San	   Jose,	   CA)	   at	   the	   University	   of	   Kansas	   Medical	  
Center	  Flow	  Cytometry	  Core.	  
	   For	  all	   samples,	  RNA	  was	   isolated	  using	  an	  RNEasy	  Mini	  Kit	   (Qiagen,	  Valencia,	  CA)	  
according	  to	  the	  manufacturer's	  protocol.	  Extracted	  RNA	  was	  reverse-­‐transcribed	  in	  20	  μL	  
reactions	  using	  an	  iScript	  cDNA	  synthesis	  kit	  (Bio-­‐Rad,	  Hercules,	  CA);	  negative	  controls	  used	  
nuclease-­‐free	   H2O	   in	   place	   of	   reverse	   transcriptase.	   Primers	   were	   designed	   to	   flank	   an	  
intron	   using	   Primer3	   software	  and	   tested	   for	   specificity	  using	   BLAST	   software	   (NCBI,	  
Bethesda,	  MD).	  Primers	  were	   then	  commercially	   synthesized	   (IDT	  Technology,	  Skokie,	   IL)	  
(Table	   3.1).	   S16	   was	   used	   as	   an	   endogenous	   control	   from	  which	   relative	   level	   of	   mRNA	  
expression	  was	  estimated.	  
	   Each	  20	  μL	   reaction	  mixture	   contained	  10	  μL	  2x	   SYBR	  Green	  master-­‐mix	   (Applied	  
Biosystems,	   Foster	   City,	   CA),	   1	   μL	   each	   of	   forward	   and	   reverse	   primers	   (0.5	   μM	   final	  
concentration),	  and	  2	  μL	  cDNA	  sample	  diluted	  1:2	  with	  nuclease-­‐free	  H2O.	  An	  Eco	  Real-­‐Time	  










Gene	  Name	   Forward	  Primer	   Reverse	  Primer	  
Dopamine	  
receptor	  1	   TCC	  AAG	  TCA	  TAG	  CCT	  GGA	  CTG	  CAA	   GCA	  GCT	  GCT	  TCC	  AAA	  GAA	  CAC	  CTT	  
Dopamine	  
receptor	  2	   TCT	  TCT	  GGT	  GGC	  CAC	  ACT	  GGT	  TAT	   GCA	  CAC	  AGG	  TTC	  AAG	  ATG	  CTT	  GCT	  
Dopamine	  
receptor	  3	   TGG	  CAG	  GTT	  ATC	  CAC	  ATC	  CCT	  GAA	   TGG	  CAT	  GCC	  TGA	  CAG	  TGG	  GTA	  TTA	  
Dopamine	  
receptor	  4	   TGC	  AGA	  CAC	  CCA	  CCA	  ACT	  ACT	  TCA	   AGT	  AGA	  CAA	  AGA	  GAG	  GCA	  GCA	  CCA	  
Dopamine	  
receptor	  5	   GCT	  GCT	  GCT	  TTA	  GTG	  CAG	  GTT	  GAA	   AAC	  ACT	  GAG	  CAC	  CAA	  CTG	  GCA	  AAG	  
S16	   AGG	  AGC	  GAT	  TTG	  CTG	  GTG	  TGG	  ATA	   TTT	  GAG	  ATG	  GAC	  TGT	  CGG	  ATG	  GCA	  
	  	   	  




















Table	  3.1.	  Primer	  sequences	  used	  in	  rt-­‐PCR	  gene	  expression	  analyses.	  	  
Primers	   were	   designed	   using	   Primer3	   software	   and	   tested	   for	   specificity	   using	   BLAST	  
software.	  Sequences	  expressed	  as	  5’	  to	  3’.	   	  
	   88	  
conditions	   included	   an	   initial	   denaturation	   (95oC,	   10	   minutes)	   followed	   by	   40	   cycles	   of	  
denaturation	   (95oC,	   15	   seconds),	   annealing	   (60oC,	   10	   minutes),	   and	   extension	   (72oC,	   35	  
seconds).	  Samples	  were	  tested	  in	  duplicate	  for	  each	  candidate	  gene,	  as	  were	  standard	  cDNA	  
pool	   and	   water	   samples	   to	   provide	   positive	   and	   negative	   controls,	   respectively.	  Melting	  
curves	  were	  analyzed	  to	  confirm	  amplicon	  specificity.	  A	  threshold	  was	  established	  for	  each	  
plate	  of	  reactions,	  and	  the	  cycle	  number	  where	  the	  fluorescence	  curve	  intersected	  with	  the	  
threshold	  was	  calculated	  (Ct).	  The	  Ct	  values	   for	  the	  genes	  of	   interest	  were	  compared	  with	  
the	  Ct	  for	  the	  transcripts	  of	  the	  ribosomal	  S16	  protein	  (ΔCt).	  	  
	  
Pharmacological	  Studies	   	   	  
	   All	   pharmacological	   agents	   used	   in	   these	   studies	   were	   dissolved	   in	   saline	   and	  
administered	   by	   intraperitoneal	   injection	   on	   P11.	  We	   chose	   this	   time	   point	   since	   retinal	  
revascularization	   starts	   prior	   to	   the	   customary	   end-­‐point	   of	   exposure	   to	  hyperoxia	   in	   the	  
OIR	  model	  (Lange,	  Ehlken	  et	  al.,	  2009)	  and	  our	  additional	  work	  suggests	   that	   the	  greatest	  
influx	  of	  EPCs	  into	  the	  retina	  occurs	  at	  this	  time	  point.	  Drugs	  assessed	  in	  this	  study	  included	  
DA	   hydrochloride	   (50mg/kg)	   (Sigma,	   St.	   Louis,	  MO),	   D2	   antagonist	   eticlopride	   (1mg/mL)	  
(Sigma,	  St.	  Louis,	  MO),	  D1/5	  antagonist	  SCH39166	  (3mg/kg)	  (Tocris,	  Ellisville,	  MO),	  and	  D4	  
antagonist	   L745,870	   (3mg/kg	   and	   6mg/kg)	   (Tocris,	   Ellisville,	   MO).	   Receptor-­‐specific	  
antagonists	   were	   tested	   in	   C57BL/6J	   mice.	   Each	   litter	   was	   divided	   into	   2	   groups,	   which	  
received	   either	   drug	   or	   a	   corresponding	   volume	   of	   vehicle	   control	   (saline).	   Mice	   were	  
sacrificed	   24	   hours	   after	   injection	   and	   enucleated	   for	   retinal	   flat-­‐mounting	   and	  
Immunofluorescent	  staining	  as	  described	  previously.	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Statistical	  Analysis	  
	   The	   data	   are	   presented	   as	   means.	   Statistical	   analyses	   were	   performed	   using	   R	  
software	  package,	  using	  Student’s	  t-­‐test	  and	  ANOVA	  tests	  where	  appropriate.	  P	  <	  0.05	  was	  
considered	  statistically	  significant.	  
	  
RESULTS	  
Tyr	  function	  inhibits	  retinal	  revascularization	  after	  OIR-­‐induced	  vascular	  damage	  
	   Retinal	  avascular	  area	  from	  C57BL/6J	  and	  c-­‐2J	  mice	  were	  measured	  upon	  return	  to	  
normoxia,	  at	  P12,	  and	  96	  hours	  after	  return,	  on	  P16.	  We	  found	  that	  the	  c-­‐2J	  retinae	  had	  10%	  
smaller	   avascular	   areas	   than	   C57BL/6J	   mice	   at	   P12	   that	   just	   reached	   the	   threshold	   of	  
significance	  (2.80	  mm2	  vs.	  3.12	  mm2,	  p	  =	  0.05,	  Student’s	  t-­‐test).	  Four	  days	  later,	  there	  was	  a	  
nearly	  50%	  difference	  in	  mean	  avascular	  areas	  between	  strains	  (0.94	  mm2	  vs.	  1.81	  mm2,	  p	  =	  
2.5	  x	  10-­‐10,	  Student’s	  t-­‐test)	  (Figure	  3.2A).	  	  
	   We	   performed	   a	   (C57BL/6J	   x	   c-­‐2J)	   x	   c-­‐2J	   backcross	   to	   ascertain	   whether	   the	  
difference	   in	   revascularization	  was	   related	   to	  Tyr	   function	  or	  another,	  unknown	  mutation	  
carried	  by	  the	  c-­‐2J	  strain.	  Albino	  N2	  mice	  produced	  in	  this	  cross	  had	  a	  mean	  avascular	  area	  
of	   2.54	   mm2.	   Pigmented	   littermates	   had	   mean	   avascular	   area	   of	   3.30	   mm2	   (p	   =	   0.0005,	  
Student’s	   t-­‐test,	   Figure	   2.B),	   demonstrating	   that	   avascular	   area	   segregated	  with	   albinism.	  
Therefore	  the	  gene	  causing	  altered	  retinal	  avascular	  area	  is	  Tyr	  or	  is	  tightly	  linked	  to	  Tyr.	  
	  
Tyr	  function	  alters	  EPC	  recruitment	  to	  the	  retina	  but	  not	  EC	  proliferation	  
	  	   To	  determine	  whether	   the	  difference	   in	   avascular	   area	   related	   to	  Tyr	   function	  was	  
due	  to	  increased	  proliferation	  of	  existing	  retinal	  ECs	  or	  was	  related	  to	  differences	  in	  EPC	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Figure	  3.2.	  Tyr	  function	  is	  associated	  with	  reduced	  retinal	  revascularization	  and	  EPC	  
recruitment.	  	  
(A)	   Avascular	   area	   in	   the	   central	   retina	   on	   P12	   and	   P16.	   C57BL/6J	  mice	   (n	   =15	   and	   18,	  
respectively)	  had	  larger	  avascular	  areas	  than	  Tyr-­‐null	  c-­‐2J	  (n	  =19	  at	  both	  time	  points).	  The	  
difference	   was	   greater	   and	   more	   significant	   at	   P16	   (Student’s	   t-­‐test),	   suggesting	   Tyr	  
modifies	  revascularization.	  (B)	  N2	  albino	  mice	  (n	  =	  13)	  created	  in	  a	  (C57BL/6J	  x	  c-­‐2J)	  x	  c-­‐2J	  
backcross	   had	   smaller	   avascular	   areas	   than	   pigmented	   littermates	   (n	   =	   12).	   (C)	   No	  
difference	   in	  number	  of	  proliferating	  ECs	  was	   found	  between	  C57BL/6J	   (n	  =	  16)	  and	  c-­‐2J	  
retina	  (n	  =	  10).	  (D)	  C57BL/6J	  mice	  (n	  =	  7)	  had	  fewer	  CD34+/CD133+	  cells	  recruited	  to	  the	  
retina	   than	   c-­‐2J	   (n	   =	   11),	   with	   representative	   photomicrographs	   (arrowheads	   indicated	  
double-­‐positive	   cells).	   (E)	   Flow	   cytometry	   gates	   used	   to	   quantify	   DAPI-­‐/CD34+/CD133+	  
EPCs	   as	   a	   fraction	   of	   all	   live,	   CD45-­‐/lo/CD34+/CD133+	  EPCs	   from	  BM	   (upper)	   and	  blood	  
(lower).	   (F)	   C57BL/6J	  mice	   had	   fewer	   CD45-­‐/lo/CD34+/CD133+	   cells	   in	   the	   BM,	   both	   in	  
normoxic	  and	  OIR	  conditions	   (n	  =	  18	  and	  12,	   respectively)	   than	  c-­‐2J	   (n	  =	  13	  and	  18).	   (G)	  
C57BL/6J	  mice	  have	   fewer	  circulating	  CD45-­‐/dim/CD34+/CD133+	  cells,	  both	   in	  normoxic	  
and	  OIR	  conditions	  (n	  =	  14	  and	  18,	  respectively)	  than	  c-­‐2J	  mice	  (n	  =	  16	  and	  19).	  Scale	  Bar:	  
100μm.	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recruitment,	  we	  performed	  confocal	  microscopy.	  We	  co-­‐stained	  with	  GS	  isolectin	  B4	  and	  Ki-­‐
67	  to	  quantify	  proliferation	   in	  ECs,	  or	  with	   isolectin,	  CD34	  and	  CD133	  to	   identify	  putative	  
EPCs.	   No	   differences	   were	   found	   in	   frequency	   of	   EC	   proliferation	   between	   c-­‐2J	   and	  
C57BL/6J	  strains	  (10.4	  vs.	  11.4	  cells/field,	  p	  =	  0.73,	  Student’s	  t-­‐test).	  Interestingly,	  BALB/c	  
mice	  have	  higher	  numbers	  of	  both	  EPCs	  and	  proliferating	  ECs	  than	  C57BL/6J	  (Figure	  3.2C).	  
However,	   c-­‐2J	   mice	   have	   higher	   numbers	   of	   putative	   EPCs	   than	   C57BL/6J	   (27.0	   vs.	   10.0	  
cells/field,	  p	  =	  0.002,	  Student’s	  t-­‐test)	  (Figure	  3.2D).	  	  
	  
Flow	  cytometric	  quantification	  of	  EPCs	  
	   We	  performed	  flow	  cytometry	  to	  detect	  DAPI-­‐/CD45-­‐/CD34+/CD133+	  EPCs	  in	  bone	  
marrow	  and	  in	  peripheral	  blood.	  In	  BM	  samples,	  c-­‐2J	  mice	  had	  higher	  proportions	  of	  EPCs	  
amongst	  their	  total	  mononuclear	  cells	  than	  did	  C57BL/6J	  mice	  both	  in	  normoxic	  conditions	  
(0.61%	  vs.	  0.40%,	  p	  =	  7	  x	  10-­‐5,	  Student’s	  t-­‐test)	  and	  after	  exposure	  to	  OIR	  (0.28%	  vs.	  0.20%,	  
p	  =	  0.04,	  Student’s	  t-­‐test)	  (Figure	  3.2E).	  Mice	  exposed	  to	  OIR	  had	  reduced	  fraction	  of	  EPCs	  in	  
BM	   samples	   compared	   to	   normoxic	   controls	   in	   both	   strains	   (C57BL/6J	   –	   p	   <	   1	   x	   10-­‐4,	  
Student’s	  t-­‐test;	  c-­‐2J	  –	  	  p	  <	  1	  x	  10-­‐7,	  Student’s	  t-­‐test).	  
	   Similarly,	  c-­‐2J	  mice	  had	  increased	  fraction	  of	  circulating	  EPCs	  compared	  to	  C57BL/6J	  
both	   in	   normoxia	   (0.10%	   vs.	   0.040%,	   p	   =	   0.02,	   Student’s	   t-­‐test)	   and	   after	   OIR	   exposure	  
(0.17%	  vs.	  0.090%,	  p	  =	  0.04,	  Student’s	  t-­‐test)	  (Figure	  3.2F).	  However,	  OIR	  exposure	  led	  to	  an	  
increase	   in	   the	  number	  of	  circulating	  EPCs	  compared	  to	  normoxic	  controls	   in	  both	  strains	  
that	  did	  not	  reach	  statistical	  significance.	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Serum	  DA	  concentration	  
	   Using	   HPLC-­‐ED,	   c-­‐2J	   mice	   were	   found	   to	   have	   approximately	   75%	   lower	   serum	  
concentration	  of	  DA	  than	  C57BL/6J	  (0.75	  ng/mL	  vs.	  2.92	  ng/mL,	  p	  =	  0.01,	  Student’s	  t-­‐test)	  
(Figure	   3.3A),	   confirming	   data	   from	   other	   studies	   suggesting	   that	   Tyr	   contributes	   to	  
peripheral	  DA	  production	  early	  in	  murine	  life.	  	  
	  
DA	  receptor	  expression	  	  
	   Whole	  (unsorted)	  BM	  samples	  expressed	  gene	  transcripts	  for	  D1,	  D4,	  and	  D5	  (Table	  
3.2).	   Sorted	   CD45-­‐/CD34+/CD133+	   EPCs	   from	  mice	   of	   both	   strains	   also	   expressed	   these	  
receptors,	   and	  had	   greater	   expression	   of	   these	  DA	   receptors	   than	  did	   non-­‐hematopoietic,	  
non-­‐EPC	  BM	  cells.	  Expression	  of	  D2	  and	  D3	  was	  very	  low	  or	  undetectable	  in	  all	  sample	  types	  
from	  mice	  of	  both	  strains.	  	  
	  
Inhibition	  of	  revascularization	  by	  DA	  through	  Drd1/5	  	  
	   Intraperitoneal	   DA	   administration	   reduced	   retinal	   revascularization	   in	   both	   the	  
C57BL/6J	  (3.71	  vs.	  3.43	  mm2,	  p	  =	  0.01,	  Student’s	  t-­‐test)	  and	  c-­‐2J	  strains	  (3.28	  vs.	  2.96	  mm2,	  
p	   =	   0.006,	   Student’s	   t-­‐test)	   (Figure	   3.3B).	   DA	   treatment	  was	   additionally	   associated	  with	  
reduced	  EPC	  recruitment	  to	  the	  retina	  in	  both	  strains	  (C57:	  7.7	  vs.	  14.4	  cells/field,	  p	  =	  0.008,	  
Student’s	  t-­‐test;	  c-­‐2J:	  12.9	  vs.	  29.3	  cells/field,	  p	  =	  0.005,	  Student’s	  t-­‐test)	  (Fig.	  2C).	  	  
	   Administration	  of	  SCH39166,	  a	  D1	  and	  D5	  antagonist,	   in	  C57BL/6J	  mice	  resulted	  in	  
improved	   resistance	   to	   OIR.	   Retinal	   avascular	   area	   24	   hours	   after	   administration	   was	  
significantly	   smaller	   than	   in	   control	   saline-­‐treated	   littermates	   (3.69	   mm2	   vs.	   4.04	   mm2,	  
Student’s	  t-­‐test,	  p	  =	  0.029,	  Figure	  3.4A).	  This	  finding	  was	  associated	  with	  improved	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Figure	  3.3	  DA	  inhibits	  EPC	  recruitment	  and	  retinal	  revascularization.	  	  
(A).	  C57	  mice	  (n	  =	  15)	  had	  greater	   levels	  of	  serum	  DA	  than	  Tyr-­‐null	  c-­‐2J	  mice	  (n	  =	  8).	  (B)	  
Intraperitoneal	   injection	   of	   DA	   (50mg/kg)	   was	   associated	   with	   increased	   avascular	   area	  
compared	  to	  vehicle	  control	  mice	  for	  both	  the	  C57BL/6J	  strain	  (control,	  n	  =	  15;	  DA,	  n	  =	  12)	  
and	  the	  c-­‐2J	   (control,	  n	  =	  11;	  DA,	  n	  =	  12).	   (C)	  DA	  administration	  was	  also	  associated	  with	  
decreased	  recruitment	  of	  CD34+/CD133+	  EPCs	  to	  the	  retina	  for	  both	  the	  C57BL/6J	  (control,	  
n	   =	   13;	   DA,	   n	   =	   9)	   and	   the	   c-­‐2J	   strains	   (n	   =	   9	   for	   both	   groups),	   with	   representative	  
photomicrographs	  (arrowheads	  indicated	  double-­‐positive	  cells).	  	  Scale	  Bar:	  100μm.	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1.63	   -­‐1.98	   0.35	   4.39	   -­‐1.87	   -­‐1.72	  
Dopamine	  
receptor	  2	  
16.08	   ND	   ND	   17.24	   ND	   ND	  
Dopamine	  
receptor	  3	  
14.04	   ND	   ND	   ND	   ND	   ND	  
Dopamine	  
receptor	  4	  
2.32	   -­‐3.42	   -­‐0.84	   4.91	   -­‐5.31	   1.77	  
Dopamine	  
receptor	  5	  
2.27	   -­‐1.32	   -­‐0.68	   5.62	   -­‐4.04	   3.20	  
Tyrosinase	   1.31	   	  	   	  	   1.94	   	  	   	  	  




















Table	  3.2.	  rt-­‐PCR	  results	  of	  DA	  receptor	  gene	  expression	  in	  3	  BM	  cell	  populations.	  
BM	   from	   an	   entire	   litter	  was	   pooled	   to	   generate	   individual	   samples.	   Data	   from	  unsorted,	  
whole	  BM	  was	  derived	  from	  3	  litters	  per	  strain.	  Data	  from	  sorted	  cells	  were	  collected	  from	  
one	   litter	   of	   each	   strain.	   The	   data	   presented	   are	   ΔCt	   values.	   EPCs	   from	   both	   strains	  
demonstrate	  greater	  expression	  of	  D1,	  D4,	  and	  D5	  compared	  to	  non-­‐hematopoietic,	  non-­‐EPC	  
BM	  cells.	  Expression	  of	  D2	  and	  D3	  was	  very	  low	  or	  undetectable	  in	  all	  sample	  types,	  and	  is	  
indicated	  as	  “ND”	  .	  Blank	  cells	  indicate	  that	  the	  test	  was	  not	  performed	  on	  the	  given	  sample.	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Figure	   3.4.	   DA	   signals	   through	   D1/5	   to	   inhibit	   retinal	   revascularization	   and	   EPC	  
recruitment.	  	  
(A)	   Treatment	   of	   C57BL/6J	   mice	   with	   D1/5	   antagonist	   SCH39166	   (n	   =	   10)	   resulted	   in	  
improved	   retinal	   revascularization	   compared	   to	   saline-­‐treated	   controls	   (n	   =	   8).	   (B)	  
Administration	   of	   SCH39166	   in	   C57BL/6J	   mice	   was	   also	   associated	   with	   increased	  
recruitment	   of	   CD34+/CD133+	   EPCs	   to	   the	   retina	   compared	   to	   vehicle-­‐treated	   control	  
littermates	  (n	  =	  11,	  both	  groups).	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recruitment	   of	   CD34+/CD133+	   EPCs	   to	   the	   retina	   at	   this	   time	   point	   (11.55	   vs.	   4.55	  
cells/field,	   Student’s	   t-­‐test,	   p	   =	   0.01,	   Figure	   3.4B).	   Testing	   of	   D2	   and	   D4	   antagonists	   in	  
C57BL/6J	   mice	   showed	   no	   difference	   in	   avascular	   area	   compared	   to	   control-­‐treated	  
littermates	  (data	  not	  shown).	  	  
	  
DISCUSSION	  
	   ROP	   is	   a	   significant	   and	   growing	   cause	   of	   vision	   loss	   in	   children.	   The	   etiology	   and	  
pathophysiology	  of	  ROP	  are	  complex	  and	  incompletely	  understood.	  In	  particular,	  the	  factors	  
that	  determine	  whether	  ROP	  in	  an	  individual	  patient	  will	  spontaneously	  resolve	  or	  progress	  
to	  severe,	  vision-­‐threatening	  vasoproliferation	  are	  only	  partially	  determined	  (Coats,	  2005;	  
Lofqvist,	  Hansen-­‐Pupp	  et	  al.,	  2009).	  We	  performed	  genome	  wide	  mapping	  using	  murine	  OIR,	  
a	  model	  of	  ROP,	   in	  order	  to	   identify	  pathways	  that	  may	  influence	  the	  rate	  of	  physiological	  
retinal	  vascularization	  after	  an	  oxidative	  insult.	  In	  our	  earlier	  genetic	  work,	  we	  mapped	  loci	  
that	   influenced	   the	   extent	   of	   central	   retinal	   vaso-­‐obliteration	   4	   days	   after	   mice	   were	  
removed	   from	   the	  normoxic	   environment	   (O'Bryhim,	  Radel	   et	   al.,	   2012).	   Since	   the	  mouse	  
strains	   that	   we	   used,	   C57BL/6J	   and	   BALB/cByJ,	   show	   only	   small	   differences	   in	   vaso-­‐
obliteration	  immediately	  after	  removal	  from	  the	  hyperoxic	  environment	  (Dorrell,	  Aguilar	  et	  
al.,	   2010),	   we	   anticipated	   that	   any	   genetic	   loci	   found	   would	   predominantly	   affect	   the	  
revascularization	  process.	  The	  principal	  QTL	  identified	  in	  this	  experiment,	  with	  a	  LOD	  score	  
of	  9.83,	  was	  on	  chromosome	  7	  and	  included	  the	  Tyr	  gene.	  This	  result	  supported	  experiments	  
in	  the	  rat	  model	  (van	  Wijngaarden,	  Brereton	  et	  al.,	  2007)	  that	  identified	  Tyr	  or	  a	  linked	  gene	  
as	  a	  modifier	  of	  avascular	  area	  in	  OIR.	  The	  studies	  described	  here	  confirm	  the	  role	  of	  Tyr	  in	  
modulation	  of	  OIR	  and	  demonstrate	  a	  mechanism	  by	  which	  it	  alters	  disease	  susceptibility.	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   We	  compared	  B6(Cg)-­‐Tyrc-­‐2J/J	  Tyr	  null	  mice	  with	  C57BL/6J,	  the	  appropriate	  Tyr	  wild-­‐
type	   background	   strain,	   to	   demonstrate	   that	  Tyr	   inactivity	  was	   associated	  with	   increased	  
retinal	  revascularization.	  A	  backcross	  confirmed	  that	  the	  genetic	  locus	  surrounding	  Tyr	  was	  
responsible	   for	   this	   effect.	   It	   is	   possible	  but	  unlikely	   that	   a	   further	   spontaneous	  mutation	  
has	  arisen	  that	  is	  linked	  to	  Tyr	  and	  has	  an	  effect	  on	  revascularization.	  	  
	   Experiments	   using	   proliferation	   markers	   suggested	   that	   Tyr	   exerted	   an	   effect	  
independent	  of	  vascular	  EC	  proliferation.	  Therefore	  we	  sought	  differential	  effects	  on	  EPCs	  
using	   CD34,	   which	   has	   previously	   been	   used	   to	   identify	   this	   cell	   population	   in	   murine	  
retinae	  (Lofqvist,	  Chen	  et	  al.,	  2007)	  and	  in	  mice	  identifies	  a	  population	  that	  includes	  highly	  
functional	   EPCs	   (Yang,	   Ii	   et	   al.,	   2011),	   and	   CD133	   which	   identifies	   tissue	   EPCs	   in	   mice	  
(Balasubramaniam,	  Mervis	  et	  al.,	  2007;	  Suriano,	  Chaudhuri	  et	  al.,	  2008;	  Zeng,	  Li	  et	  al.,	  2012).	  
Confocal	   microscopy	   found	   a	   significant	   difference	   in	   CD34+/CD133+	   EPCs	   between	   Tyr	  
wild-­‐type	   and	   null	   retinae.	   Subsequent	   investigations	   found	   that	   CD45-­‐/CD34+/CD133+	  
cells	  were	  also	  more	  common	  in	  BM	  and	  peripheral	  blood	  of	  Tyr	  null	  mice	   than	  wild-­‐type	  
mice.	   Further	   experiments	  will	   demonstrate	  whether	   there	   are	   also	   differences	   in	   retinal	  
recruitment	   of	   other	   BM-­‐derived	   angiogenic	   cells,	   and	   whether	   there	   are	   functional	  
differences	  in	  circulating	  EPCs	  that	  can	  be	  demonstrated	  in	  tissue	  culture.	  	  	  
Previously	   published	   studies	   (Rios,	   Habecker	   et	   al.,	   1999;	   Eisenhofer,	   Tian	   et	   al.,	  
2003),	   show	   that	  Tyr	   function	   in	   the	   C57BL/6J	   strain	   contributes	   to	   increased	   serum	  DA	  
concentration	   compared	   to	  Tyr-­‐null	   c-­‐2J	  mice.	  We	   confirmed	   that	   this	   effect	   is	   also	   seen	  
after	  mice	  are	  exposed	  to	  hyperoxia	  in	  the	  OIR	  model.	  Administration	  of	  exogenous	  DA	  in	  c-­‐
2J	  mice	  inhibits	  recruitment	  of	  EPCs	  and	  decreases	  revascularization	  compared	  to	  vehicle-­‐
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treated	   controls,	   such	   that	   their	   response	   to	   OIR	   is	   similar	   to	   that	   of	   C57BL/6J	   mice.	  
Treatment	  in	  the	  C57BL/6J	  strain	  further	  delayed	  vascular	  regeneration.	  	  
	   Subsequent	   pharmacological	   studies	   suggest	   that	   dopaminergic	   regulation	   of	   this	  
process	   occurs	   via	   the	   D1-­‐like	   family	   of	   receptors.	   This	   family	   includes	   D1	   and	   D5.	  
SCH39166	  is	  an	  antagonist	  of	  both	  receptors;	  administration	  of	  this	  drug	  in	  C57BL/6J	  mice	  
resulted	  in	  increased	  recruitment	  of	  EPCs	  and	  decreased	  avascular	  area	  24	  hours	  later.	  Due	  
to	   the	   large	   amount	   of	   sequence	   homology	   between	   D1	   and	   D5,	   currently	   available	  
pharmacological	  agents	  have	  limited	  selectivity	  between	  the	  receptors.	  	  	  
Studies	   in	   an	   adult	   murine	   tumor	   model	   have	   suggested	   that	   DA	   inhibits	   CD45-­‐
/VEGFR2+/CD34+	  EPC	  recruitment	  via	  D2	  (Chakroborty,	  Chowdhury	  et	  al.,	  2008).	  Work	  by	  
Spiegel,	  et	  al.	   indicated	   that	  EPC	  receptor	  expression	  was	  dynamic,	  and	   that	  expression	  of	  
D3	  and	  5	  on	  EPCs	  was	  up-­‐regulated	  after	  stimulation	  with	  granulocyte	  colony	  stimulating	  
factor	   (Spiegel,	   Shivtiel	   et	   al.,	   2007).	   It	   is	  possible	   that	   the	  presence	  of	   cytokines	  or	  other	  
growth	   factors	   in	   young	  mice	   may	   influence	   DA	   receptor	   expression	   and	   therefore	   their	  
response	  to	  DA.	  	  
	  	   The	   possibility	   that	   DA	   may	   inhibit	   recruitment	   of	   EPCs	   to	   the	   retina	   in	   human	  
neonates	  requires	   further	   investigation	   in	  order	   to	  determine	  DA’s	  safety	   in	   the	  setting	  of	  
neonatal	  intensive	  care	  units.	  Intravenous	  infusion	  of	  DA	  is	  used	  pharmacologically	  to	  treat	  
systemic	   hypotension	   that	   is	   resistant	   to	   volume	   expansion.	   An	   association	   between	   DA	  
treatment	  and	  increased	  risk	  of	  ROP	  in	  premature	  infants	  has	  been	  found	  (Mizoguchi,	  Chu	  et	  
al.,	   1999).	   However,	   multivariate	   analysis	   suggested	   that	   the	   apparent	   effect	   of	   DA	   in	  
univariate	  analyses	  was	  explained	  by	  other	  known	  risk	  factors	  for	  ROP	  (Allegaert,	  Cossey	  et	  
al.,	  2004).	  In	  light	  of	  the	  current	  data,	  further	  investigation	  of	  the	  impact	  of	  DA	  on	  EPCs	  in	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premature	  neonates	  is	  required,	  and	  increased	  screening	  efforts	  for	  infants	  who	  receive	  DA	  
infusions	  may	  be	  warranted.	  	  
	  
CONCLUSIONS	  
	   This	   study	   is	   the	   first	   to	   demonstrate	   that	   that	   dopaminergic	   signaling	  modulates	  
retinal	   revascularization,	   and	   is	   the	   first	   evidence	   that	  Tyr	  modifies	   this	   system.	   Further	  
research	  will	   determine	  whether	   these	   findings	   have	   relevance	   to	   the	   control	   of	   vascular	  
regeneration	  in	  other	  retinal	  vasculopathies,	  and	  especially	  in	  diabetic	  retinopathy.	  Further	  
studies	  will	  be	  required	   to	  determine	  whether	  selective	  DA	  antagonists	  may	   improve	  EPC	  
function	  and	  recruitment	  in	  premature	  human	  neonates,	  thus	  mitigating	  the	  arrest	  of	  retinal	  
vascular	  development	  in	  early	  ROP,	  consequently	  leading	  to	  reduced	  vascular	  proliferation	  
and	  improved	  visual	  outcomes.	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ABSTRACT	  
	   New	   evidence	   suggests	   that	   EPCs	   contribute	   to	   the	   development	   of	  ROP,	   a	   leading	  
cause	   of	   blindness	   in	   infants.	   This	   study	   seeks	   to	   characterize	   their	   involvement	   in	   ROP	  
using	  C57BL/6J	  and	  Tyr-­‐null	  c-­‐2J	  mice	  in	  the	  murine	  OIR	  model.	  The	  number	  of	  live,	  CD45-­‐
/CD34+/CD133+	   putative	   EPCs	   was	   quantified	   in	   BM	   and	   blood	   using	   flow	   cytometry.	  
CD34+/CD133+	   cells	   in	   retina	  were	  measured	   using	   confocal	  microscopy.	   Avascular	   area	  
was	  measured	   from	  GS	   isolectin	  B4-­‐stained	   retinal	   flat-­‐mounts.	  Data	  was	   collected	  on	  P7,	  
P7.5,	  P8,	  P9,	  P9.5,	  P10,	  P11,	  P12,	  and	  P13.	  In	  the	  C57BL/6J	  strain,	  overall	  numbers	  of	  CD45-­‐
/CD34+/CD133+	   cells	   increase	   in	   the	   bone	   marrow	   by	   P9	   and	   then	   gradually	   decline	  
through	   P13.	   Circulating	   cells	   follow	   a	   sinusoidal	   pattern,	   whereas	   recruitment	   of	   this	  
population	   to	   the	   retina	   does	   not	   greatly	   vary	   from	   normoxic	   numbers.	   c-­‐2J	   mice	   have	  
increased	   numbers	   of	   CD45-­‐/CD34+/CD133+	   cells	   in	   the	   bone	  marrow	   through	   P11.	   The	  
number	  of	  cells	  in	  circulation	  increases	  significantly	  upon	  exposure	  to	  hyperoxia	  but	  drop	  to	  
normoxic	  baseline	  levels	  by	  P8,	  and	  subsequently	  increase	  throughout	  the	  remainder	  of	  the	  
study.	  Recruitment	  of	  CD34+/CD133+	  cells	  to	  the	  retina	  peaks	  at	  P9	  and	  stabilizes	  at	  lower	  
levels	  through	  the	  remainder	  of	  the	  study.	  Avascular	  area	  increases	  from	  P7	  through	  P9	  and	  
then	  plateaus.	  CD34+/CD133+	  putative	  EPCs	  are	  a	  dynamic	  population	  of	  cells	  that	  appear	  
to	   initially	   respond	   to	   hyperoxia	   from	   P7	   through	   P9.	   Retinal	   vascularization	   and	   EPCs	  
patterns	  change	  at	  approximately	  P9	  in	  the	  c-­‐2J	  strain	  and	  P11	  in	  the	  C57BL/6J	  strain.	  This	  
suggests	   that	   the	   traditional	   time	  points	  used	   to	  characterize	  OIR	  should	  be	  reconsidered,	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LIST	  OF	  ABBREVIATIONS	  	  
	  
ANOVA	  –	  analysis	  of	  variance	  
BM	  –	  bone	  marrow	  
c-­‐2J	  –	  B6(Cg)-­‐Tyrc-­‐2J/J	  
D2	  –	  dopamine	  receptor	  2	  
DA	  -­‐	  dopamine	  
EC	  –	  endothelial	  cell	  
EPC	  –	  endothelial	  progenitor	  cell	  
ISHAGE	  -­‐	  International	  Society	  for	  Hematotherapy	  and	  Graft	  Engineering	  
OIR	  –	  oxygen-­‐induced	  retinopathy	  
NV	  –	  neovascularization	  
P	  –	  post-­‐natal	  day	  	  
ROP	  –	  Retinopathy	  of	  Prematurity	  
Tyr	  –	  Tyrosinase	  	  
VEGFR2	  –	  vascular	  endothelial	  growth	  factor	  2	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PURPOSE	  	  
ROP	   is	   a	   leading	   cause	   of	   visual	   impairment	   in	   the	   pediatric	   population	   (Hartnett,	  
2010).	   This	   disease	   occurs	  when	   an	   infant	   is	   born	   prior	   to	   the	   completion	   of	   the	   retinal	  
vascular	   system.	   The	   relative	   hyperoxia	   of	   the	   extrauterine	   environment	   arrests	   further	  
vascular	  development,	  the	  first	  stage	  of	  ROP.	  As	  the	  child	  matures	  and	  the	  retina	  becomes	  
more	  metabolically	  active,	  the	  resulting	  avascular	  areas	  subsequently	  become	  ischemic	  and	  
can	  lead	  to	  the	  second	  stage	  of	  ROP,	  which	  is	  characterized	  by	  pathological	  NV.	  	  	  
Processes	  in	  the	  pathogenesis	  of	  ROP	  can	  be	  investigated	  using	  a	  mouse	  OIR	  model	  
(Smith,	  Wesolowski	  et	  al.,	  1994;	  Lutty,	  Chan-­‐Ling	  et	  al.,	  2006).	  Our	  prior	  work	   (O'Bryhim,	  
Radel	   et	   al.,	   2012)	   and	   that	   by	   others	   (Dorrell,	   Aguilar	   et	   al.,	   2010)	   have	   documented	  
differences	   in	   response	   to	   OIR	   between	   inbred	   strains	   of	  mice.	   Notably,	   we	   identified	   an	  
association	  between	  Tyr	  function	  in	  the	  C57BL/6J	  strain	  and	  increased	  susceptibility	  to	  OIR	  
compared	  to	  Tyr-­‐null	  c-­‐2J	  mice	  of	  the	  same	  genetic	  background,	  as	  described.	  These	  findings	  
are	  in	  line	  a	  backcross	  in	  rats	  that	  found	  Tyr-­‐null	  albino	  N2	  rats	  to	  be	  more	  resistant	  to	  OIR	  
compared	  to	  pigmented	  littermates	  (van	  Wijngaarden,	  Brereton	  et	  al.,	  2007).	  The	  responses	  
of	  these	  strains	  may	  serve	  as	  a	  model	  for	  differences	  in	  susceptibility	  to	  ROP	  in	  humans.	  
EPCs	  contribute	  to	  post-­‐natal	  angiogenesis	  in	  wound	  healing	  (Asahara,	  Murohara	  et	  
al.,	  1997),	   tumor	  metastases	  (Asahara,	  Masuda	  et	  al.,	  1999),	  and	   in	  tissue	  remodeling	  (e.g.	  
diabetes	  mellitus)	   (Fadini,	  Agostini	   et	   al.,	   2005;	  Gallagher,	   Liu	   et	   al.,	   2007).	   EPCs	   are	  BM-­‐
derived	   cells	   that	   constitute	   a	   subpopulation	   of	   mononuclear	   cells	   (Case,	   Ingram	   et	   al.,	  
2008).	   Murine	   EPCs	   are	   commonly	   defined	   as	   cells	   that	   express	   surface	   markers	   CD34	  
(Asahara,	   Masuda	   et	   al.,	   1999;	   Sekiguchi,	   Ii	   et	   al.,	   2011;	   Yang,	   Ii	   et	   al.,	   2011),	   CD133	  
(Balasubramaniam,	  Mervis	  et	  al.,	  2007;	  Zeng,	  Li	  et	  al.,	  2012;	  Zeng,	  Ding	  et	  al.,	  2012),	  VEGFR2	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(Sekiguchi,	  Ii	  et	  al.,	  2011),	  and	  Sca-­‐1	  (Nakagawa,	  Masuda	  et	  al.,	  2011;	  Yang,	  Ii	  et	  al.,	  2011).	  As	  
no	  EPC-­‐specific	  markers	  have	  been	  identified	  to	  date,	  there	  is	  considerable	  discrepancy	  over	  
the	  exact	  definition	  of	  this	  cell	  population	  (Case,	  Ingram	  et	  al.,	  2008)	  
Recent	   evidence	   suggests	   that	   this	   cell	   population	   also	   plays	   a	   role	   in	   the	  
development	  of	  ROP.	  Work	  by	  Ligi	  and	  colleagues	  suggests	  that	  EPCs	  isolated	  from	  very-­‐low	  
birth	  weight	   infants	  have	   altered	   gene	   expression	   and	   functional	   changes	   that	   discourage	  
angiogenesis,	   although	  no	   statistically	   significant	  difference	  were	   found	   in	   the	  quantity	  of	  
circulating	  CD34+	  EPCs	  (Ligi,	  Simoncini	  et	  al.,	  2011).	  Machalinska,	  et	  al.,	  however,	  found	  an	  
increase	   in	   number	   of	   circulating	   CD144	   (VE-­‐Cadherin)+/CD133+/CD34+	   EPCs	   in	   infants	  
with	   Phase	   2	   ROP	   compared	   to	   premature	   infants	   without	   ROP	   and	   compared	   to	   term	  
infants	  (Machalinska,	  Kotowski	  et	  al.,	  2011).	  	  	  
It	  is	  likely	  that	  differences	  in	  the	  various	  sets	  of	  published	  results	  are	  related	  to	  the	  
time	  at	  which	  EPCs	  are	  examined	  in	  relation	  to	  the	  stage	  of	  disease.	  Therefore,	  we	  sought	  to	  
characterize	   changes	   in	   EPC	   recruitment	   and	   angiogenesis	   over	   the	   course	   of	   OIR.	   We	  
additionally	   examined	   EPC	   patterns	   in	   both	   resistant	   and	   susceptible	   strains	   of	   mice	   to	  
compare	  patterns	  that	  contribute	  to	  a	  more	  or	  less	  successful	  vascular	  response.	  This	  allows	  
for	   a	   comprehensive	   assessment	   of	   the	   dynamic	   role	   of	   EPCs	   in	   OIR,	   which	   will	   both	  
elucidate	   their	   role	   in	  disease	  progression	  and	  will	   also	   serve	   to	  optimize	   time	  points	   for	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MATERIALS	  AND	  METHODS	  
Animals	  
All	  experimental	  procedures	  were	  approved	  by	  University	  of	  Kansas	  Medical	  Center	  
Institutional	   Animal	   Care	   and	   Use	   Committee.	   C57BL/6J	   and	   B6(Cg)-­‐Tyrc-­‐2J/J	   mice	   were	  
purchased	   from	   Jackson	   Laboratories	   (Bar	  Harbor,	  ME).	   All	  mice	  were	   kept	   in	   a	   12-­‐hour	  
light,	   12-­‐hour	   dark	   cycle	   with	   ambient	   room	   temperature	   between	   19oC	   and	   22oC.	   Mice	  
were	   kept	   on	   standard	   breeding	   pair	   diet	   (8626	   rodent	   diet;	   Harlan	   Laboratories,	  
Indianapolis,	  IN),	  with	  food	  and	  water	  available	  ad	  libitum.	  	  
	  
Oxygen-­‐Induced	  Retinopathy	  
OIR	  was	  induced	  according	  to	  established	  protocols	  (Smith,	  Wesolowski	  et	  al.,	  1994)	  
by	  exposing	  pups	  to	  75%	  oxygen	  beginning	  on	  P7.	  Mice	  were	  returned	  to	  normoxia	  either	  
immediately	   prior	   to	   sacrifice,	   or	   after	   120	   hours	   of	   exposure	   (P12).	   O2	   levels	   in	   the	  
chambers	   were	   continuously	   controlled	   using	   a	   ProOx	   portable	   monitor	   (Biospherix,	  
Redfield,	  NY),	  which	  was	  calibrated	  monthly	  using	  100%	  O2	  and	  room	  air	  (~21%).	  	  
	  
Tissue	  Harvest	  
Mice	  were	  weighed	  and	  anesthetized	  with	  a	  lethal	  dose	  of	  tribromoethanol	  delivered	  
by	   intraperitoneal	   injection	   at	   the	   following	   time	   points:	   P7	   (prior	   to	   exposure	   to	  
hyperoxia),	  P7.5,	  P8,	  P9,	  P9.5,	  P10,	  P11,	  P12,	  and	  P13	  (24	  hours	  after	  return	  to	  normoxia).	  
After	  induction	  of	  anesthesia,	  blood	  samples	  were	  collected	  by	  puncturing	  the	  left	  ventricle	  
with	  27	  G	  needle;	  samples	  were	  incubated	  in	  3x	  volume	  of	  RBC	  lysis	  buffer	  (Biolegend,	  San	  
Diego,	  CA)	  according	  to	  instructions,	  centrifuged	  at	  300	  g,	  and	  resuspended	  in	  1	  mL	  1%	  BSA	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in	   PBS	   (Balasubramaniam,	  Mervis	   et	   al.,	   2007).	   BM	  was	   harvested	   from	  both	   femurs	   and	  
tibias	  by	  removing	  the	  ends	  of	  each	  bone	  and	  aspirating	  the	  contents	  with	  200	  µL	  of	  Hank’s	  
Balanced	  Salt	  Solution	  (Sigma,	  St.	  Louis,	  MO,	  USA).	  Mice	  were	  subsequently	  enucleated	  and	  
eyes	  were	  stored	  overnight	  in	  4%	  PFA	  at	  4oC.	  
	  
Flow	  Cytometry	  
	   Bone	   marrow	   and	   blood	   samples	   were	   filtered	   through	   a	   70	   µM	   mesh	   filter	   and	  
subsequently	  centrifuged	  at	  300	  g	  for	  10	  minutes	  at	  4oC.	  Given	  the	   rarity	  of	  EPCs,	  BM	  and	  
blood	  samples	  were	  stained	  for	  flow	  cytometric	  analysis	  of	  EPCs	  using	  modifications	  of	  the	  
ISHAGE	   protocol	   as	   previously	   described	   (Balasubramaniam,	   Mervis	   et	   al.,	   2007).	   This	  
procedure	  has	  been	  used	  to	  successfully	  isolate	  CD133+	  progenitor	  cells	  from	  small	  (100	  µL)	  
samples	  of	  both	  BM	  and	  blood.	  Samples	  were	  incubated	  in	  CD45-­‐FITC	  (Biolegend,	  San	  Diego,	  
CA),	   CD34-­‐APC	   (Biolegend,	   San	   Diego,	   CA),	   CD133-­‐PE	   (Biolegend,	   San	   Diego,	   CA)	   for	   30	  
minutes	  on	  ice.	   	  Cells	  were	  washed	  with	  1%	  BSA,	  centrifuged	  at	  300	  g	  for	  10	  minutes,	  and	  
resuspended	  in	  DAPI	  (Sigma,	  St.	  Louis,	  MO)	  for	  10	  minutes	  to	  detect	  dead	  cells.	  After	  a	  final	  
wash	   and	   spin,	   samples	   were	   resuspended	   in	   1%	   BSA	   and	   analyzed	   at	   the	   University	   of	  
Kansas	  Medical	  Center	  Flow	  Cytometry	  Core	  with	  a	  Beckman	  LSRII	  Flow	  Cytometer	  (Miami,	  
FL).	   Single-­‐stain	   (positive)	   controls	   and	   negative	   controls	  were	   used	   to	   set	   the	   gates	   and	  
determine	   voltage	   compensation	   for	   fluorescent	   intensity.	   A	   minimum	   of	   1,000,000	   cells	  
was	  counted	  from	  each	  sample,	  and	  samples	  were	  run	  until	  3,000,000	  cells	  were	  counted	  or	  
the	  sample	  was	  exhausted.	  As	  previously	  described	  (Balasubramaniam,	  Mervis	  et	  al.,	  2007),	  
cells	  were	  gated	   to	  exclude	  DAPI	  positive	  dead	  cells,	  and	  then	  gated	   to	  select	   for	   the	  non-­‐
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hematopoietic	  CD45-­‐/dim	  population.	  Of	  these,	  CD133	  and	  CD34	  double	  positive	  cells	  were	  
counted	  as	  a	  percentage	  of	  all	  live,	  non-­‐hematopoietic	  cells.	  
	  
Retinal	  Avascular	  Area	  and	  Immunofluorescent	  Staining	  
Retinas	   from	   both	   eyes	   were	   dissected	   and	   stained	   with	   Griffonia	   simplicifolia	  
isolectin	  B4	  (Sigma,	  St.	  Louis,	  MO)	  according	  to	  established	  protocols	  (Gerhardt,	  Golding	  et	  
al.,	  2003).	  Briefly,	  retinae	  were	  permeablilized	  overnight	   in	  0.5%	  Triton	  X-­‐100,	  1%	  BSA	  at	  
4oC.	  After	  washing,	  retinae	  were	  incubated	  in	  20	  µg/mL	  isolectin	  in	  PBLec	  (PBS,	  pH	  6.8,	  1%	  
Triton	  X-­‐100,	  0.1	  mM	  CaCl2,	  0.1	  mM	  MgCl2,	  0.1	  mM	  MnCl2)	  overnight	  at	  4oC.	  	  
Retinae	  from	  left	  eyes	  of	  each	  mouse	  were	  then	  washed	  and	  flat-­‐mounted	  using	  anti-­‐
fade	  medium	  (Southern	  Biotech,	  Birmingham,	  AL).	  Immunofluorescent	  micrographic	  images	  
of	   the	   retinas	   were	   taken	   using	   an	   SMZ	   1500	   microscope	   (Nikon,	   Tokyo,	   Japan)	   and	  
MagnaFire	   Camera	   and	   software	   (Optronics,	   Goleta,	   CA).	   ImageJ	   software	  
(http://rsbweb.nih.gov/ij/)	  was	  used	  to	  manually	  trace	  and	  measure	  avascular	  areas.	  	  	  
Retinae	   from	   right	   eyes	   were	   washed	   and	   blocked	   with	   Superblock	  
(ThermoScientific,	  Rockford,	  IL)	  for	  1	  hour	  at	  room	  temperature,	  followed	  by	  incubation	  in	  
1:100	  hamster	  anti-­‐murine	  CD34	  and	  1:200	  rat	  anti-­‐murine	  CD133	  (Biolegend,	  San	  Diego,	  
CA)	  ON	  at	  4oC.	  After	  washing	  with	  PBS,	  retinae	  were	  incubated	  with	  1:200	  Dylight	  649	  anti-­‐
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Statistical	  Analysis	  
	   Analyses	  were	  performed	  using	  R	  software	  package.	  Statistical	  comparisons	  between	  
time	   points	   were	   made	   using	   Two-­‐Way	   ANOVA	   tests	   with	   pairwise	   comparisons;	  
comparisons	  between	  strains	  were	  made	  using	  Student’s	  t-­‐test	  at	  each	  time	  point.	  P	  <	  0.05	  
was	  considered	  statistically	  significant.	  Data	  are	  expressed	  graphically	  as	  modified	  boxplots,	  
where	  the	  box	  represents	  the	  median,	  first	  and	  third	  quartiles.	  The	  “whiskers”	  represent	  1.5	  
times	   the	   interquartile	   range,	   and	   data	   points	   outside	   of	   this	   range	   are	   denoted	   as	   open	  
circles.	  Asterisks	  indicate	  statistically	  significant	  differences	  in	  value	  compared	  to	  the	  value	  
observed	  on	  P7.	  
	  
RESULTS	  
BM	  CD45-­‐/CD34+/CD133+	  Cells	  
	   At	   all	   time	  points	   examined,	   c-­‐2J	  mice	  had	  more	  BM	  EPCs	  than	  did	  C57BL/6J	  mice	  
(Figure	  4.1A).	  This	  difference	  reached	  significance	  at	  all	  time	  points	  except	  P7.5	  and	  P9.	  In	  
the	  C57BL/6J	  strain,	  CD45-­‐/CD34+/CD133+	  numbers	  initially	  increased	  within	  12	  hours	  of	  
exposure	   to	   hyperoxia	   but	   subsequently	   declined	   to	   below	   normoxic	   levels	   by	   P8.	   The	  
number	  of	  putative	  EPCs	  increased	  2.5-­‐fold	  from	  P8	  to	  P9	  and	  then	  declined	  through	  P13.	  	  
	   The	   response	   of	   the	   bone	  marrow	  CD45-­‐/CD34+/CD133+	  population	   to	   hyperoxia	  
differed	   between	   C57BL/6J	   and	   c-­‐2J	  mice;	   in	   c-­‐2J	   the	   fraction	   of	   putative	   EPCs	   gradually	  
increased	   30%	   from	   P7	   through	   P9.	   After	   a	   slight	   decrease	   over	   the	   next	   12	   hours,	   the	  
number	  of	  EPCs	  then	  rose	  to	  a	  maximum	  on	  P11,	  but,	  similar	  to	  patterns	  in	  C57BL/6J	  BM,	  
declined	  significantly	  in	  the	  last	  days	  of	  the	  experiment.	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Figure	  4.1.	  Response	  of	  EPCs	   in	  BM,	  blood	  and	  retina	  and	  changes	   in	  avascular	  area	  
during	  OIR	  in	  C57BL/6J	  and	  c-­‐2J	  mice.	  	  
(A)	  Patterns	  of	  CD34+/CD133+	  EPCs	  present	  in	  the	  BM	  of	  C57BL/6J	  ad	  c-­‐2J	  mice	  during	  the	  
OIR	  model.	  c-­‐2J	  mice	  had	  more	  BM	  putative	  EPCs	  than	  did	  C57BL/6J	  mice	  at	  all	  time	  points	  
except	  P7.5	  and	  P9.	  (B)	  Patterns	  of	  CD34+/CD133+	  EPCs	  present	  in	  the	  blood	  of	  C57BL/6J	  
and	   c-­‐2J	   mice	   during	   the	   OIR	   model.	   Cells	   in	   circulation	   of	   C57BL/6J	   mice	   followed	   a	  
sinusoidal	   pattern;	   in	   the	   c-­‐2J	   strain,	   cell	   numbers	   increased	   significantly	   in	   response	   to	  
exposure	   to	  hyperoxia,	  declined	   to	  a	  minimum	  and	  then	  rose	  during	   the	  remainder	  of	   the	  
study.	  (C)	  Patterns	  of	  CD34+/CD133+	  EPCs	  recruited	  to	  the	  retina	  of	  C57BL/6J	  mice	  during	  
the	  OIR	  model.	  The	  number	  of	  recruited	  cells	  did	  not	  vary	  greatly	  from	  values	  seen	  on	  P7	  in	  
the	   C57BL/6J	   strain.	   The	   c-­‐2J	   strain	   had	   a	   significant	   increase	   in	   cells	   on	   P9.	   (D)	   Central	  
avascular	  area	  of	  C57BL/6J	  and	  c-­‐2J	  mice	  during	  the	  OIR	  model.	  C57BL/6J	  mice	  had	  greater	  
avascular	   area	   at	   all	   time	   points.	   Both	   strains	   respond	   to	   initial	   exposure	   to	   hyperoxia	  
similarly.	  Differences	  in	  avascular	  area	  do	  not	  reach	  statistical	  significance	  until	  P9.	  Data	  are	  
presented	   as	   modified	   box	   plots;	   open	   circles	   represent	   outlying	   data	   points.	   Asterisks	  
denote	  statistically	  significant	  differences	  compared	  to	  values	  at	  P7	  (Two-­‐way	  ANOVA	  with	  
pair	  wise	  comparison,	  p	  <	  0.05).	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Circulating	  CD45-­‐/CD34+/CD133+	  Cells	  
	   The	  size	  of	  the	  circulating	  CD45-­‐/CD34+/CD133+	  cell	  population	  was	  volatile	  in	  both	  
strains	  (Figure	  4.1B).	  In	  C57BL/6J	  mice,	  the	  cell	  fraction	  increased	  from	  P7	  through	  P8	  and	  
then	  declined	  to	  a	  minimum	  on	  P10.	  The	  number	  of	  cells	  increased	  to	  a	  maximum	  48	  hours	  
later,	  on	  P12.	  One	  day	  after	  return	  to	  normoxia,	  however,	  the	  number	  of	  EPCs	  dropped	  80%.	  
In	  the	  c-­‐2J	  strain,	   the	  number	  of	  circulating	  cells	   increased	  10-­‐fold	   in	  the	   first	  12	  hours	  of	  
exposure	  to	  hyperoxia	  but	  dropped	  by	  P8	  and	  continued	  to	  decline	  to	  a	  minimum	  on	  P9.	  The	  
number	  steadily	  rose	  during	  the	  last	  4	  days	  of	  the	  study.	  
	   In	  the	  c-­‐2J	  strain,	  the	  number	  of	  circulating	  CD45-­‐/CD34+/CD133+	  cells	  substantially	  
increased	  upon	  exposure	  to	  hyperoxia,	  but	  then	  subsided	  by	  P8	  and	  dropped	  further	  by	  P9.	  
After	  P9,	  the	  number	  of	  circulating	  cells	  increased	  steadily	  through	  the	  rest	  of	  the	  study.	  c-­‐2J	  
mice	   had	   fewer	   circulating	   cells	   compared	   to	   C57BL/6J	  mice	   at	  most	   time	   points	   tested,	  
except	  at	  P7.5,	  P10,	  and	  P13.	  This	  difference	  between	  strains	  reached	  statistical	  significance	  
at	  all	  time	  points	  except	  P7.5	  and	  P10.	  
	  
Retinal	  CD34+/CD133+	  Cells	  
	   The	  pattern	  of	  CD34+/CD133+	  cell	  recruitment	  to	  the	  retina	  varied	  largely	  between	  
the	   strains	   of	   mice	   (Figure	   4.1C).	   In	   the	   C57BL/6J	   strain,	   there	   were	   no	   statistically	  
significant	  differences	  in	  cell	  numbers	  over	  time,	  although	  a	  small	  increase	  was	  seen	  from	  	  
P10	  to	  P11.	  In	  c-­‐2J	  mice	  significant	  recruitment	  occurred	  between	  P8	  and	  P9,	  and	  thereafter	  
CD34+/CD133+	   cell	   numbers	   subsided	   to	   near	   the	   level	   seen	   on	   P8.	   c-­‐2J	  mice	   had	  more	  
EPCs	  in	  the	  retina	  at	  all	  time	  points	  except	  P7.5.	  The	  difference	  reached	  significance	  on	  P9,	  
P9.5,	  P10,	  and	  P13.	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Avascular	  Area	  
	   The	  initial	  vaso-­‐obliterative	  response	  was	  nearly	   identical	   in	  the	  two	  strains.	  There	  
was	   no	   significant	   difference	   in	   avascular	   area	   between	   un-­‐exposed	   mice	   at	   P7	   (Figure	  
4.1D).	   No	   vaso-­‐obliteration	   was	   apparent	   in	   either	   strain	   12	   hours	   after	   exposure	   to	  
hyperoxia.	   In	   the	   following	   36	   hours,	   however,	   the	   central	   avascular	   area	   had	   increased	  
approximately	  8	  times	  compared	  to	  the	  area	  at	  P7	  in	  both	  strains.	  This	  difference	  reached	  
statistical	  significance	  on	  P9,	  and	  avascular	  areas	  then	  diverged	  between	  the	  strains.	  In	  the	  
C57BL/6J	  mice,	  the	  central	  avascular	  area	  continued	  to	  increase	  peripherally	  to	  a	  maximum	  
on	  P11.	  The	  retina	  began	  to	  revascularize	  after	  this	  time	  point	  as	  avascular	  area	  decreased	  
27%	   by	   P12.	   In	   the	   c-­‐2J	   strain,	   the	   central	   area	   increased	   only	   until	   P9.	   After	   P9,	   the	  
avascular	  area	  remained	  relatively	  stable	  with	  a	  small	  increase	  (10%)	  between	  P10	  and	  P11	  
and	  subsequent	  decrease	  following	  return	  to	  normoxia.	   	  
	  
Weight	  
	   The	  patterns	  of	  change	  in	  weight	  over	  the	  time	  course	  of	  the	  experiment	  were	  very	  
similar	   in	  C57BL/6J	  and	  c-­‐2J	  mice	  (Figure	  4.2).	  By	  P11,	  both	  strains	  gained	  approximately	  
150%	   of	   their	   weight	   at	   P7.	   Weight	   plateaued	   from	   P11	   to	   P12	   and	   then	   decreased	  
significantly	   upon	   return	   to	   normoxia.	   At	   all	   time	   points	   except	   P9.5,	   the	   C57BL/6J	  mice	  
weighed	   more	   than	   their	   c-­‐2J	   counterparts.	   	   However,	   this	   difference	   was	   statistically	  
significant	  only	  on	  P8;	   it	   is	   likely	  that	  the	  significance	  of	  this	   is	  related	  to	  the	  use	  of	  a	  c-­‐2J	  



















	   	  




















Figure	  4.2	  Weight	  of	  mouse	  pups	  throughout	  the	  OIR	  model.	  	  
Weight	  gain	  of	  C57BL/6J	  and	  c-­‐2J	  mice	   from	  P7	   through	  P13.	  Mice	  of	  both	   strains	  gained	  
weight	   in	  a	  similar	  manner.	  Although	  C57BL/6J	  mice	  weighed	  more	  at	  every	  time	  point	   in	  
the	   study,	   this	   difference	   was	   statistically	   significant	   only	   on	   P8.	   Data	   are	   expressed	   as	  
modified	   box	   plots,	   and	   open	   circles	   denote	   outlying	   observations.	   Asterisks	   denote	  
statistically	   significant	   differences	   compared	   to	  weight	   at	   P7	   (Two-­‐way	  ANOVA	  with	   pair	  
wise	  comparison,	  p	  <	  0.05).	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DISCUSSION	  
	   EPCs	   play	   an	   important	   role	   in	   post-­‐natal	   angiogenesis	   in	   both	   pathological	   and	  
physiological	  processes	   (Asahara,	  Murohara	  et	  al.,	  1997).	  Recent	   reports	   suggest	   that	  EPC	  
function	   is	   altered	   in	  pre-­‐term	  and	   low-­‐birth	  weight	   infants	   (Balasubramaniam,	  Mervis	   et	  
al.,	  2007;	  Ligi,	  Simoncini	  et	  al.,	  2011;	  Machalinska,	  Kotowski	  et	  al.,	  2011;	  Safranow,	  Kotowski	  
et	  al.,	  2012).	  As	  these	  infants	  are	  at	  risk	  of	  developing	  ROP	  (Good,	  Hardy	  et	  al.,	  2005),	  it	   is	  
likely	  that	  alteration	  in	  EPCs	  function	  contributes	  to	  disease	  development.	  Early	  evidence	  in	  
the	   murine	   OIR	   model	   of	   ROP	   supports	   this	   hypothesis	   (Lofqvist,	   Chen	   et	   al.,	   2007;	  
Nakagawa,	  Masuda	  et	  al.,	  2011),	  but	  their	  role	  and	  significance	  have	  not	  been	  established.	  As	  
these	   cells	   offer	   a	   potential	   pharmacological	   target	   for	   improving	   ROP	   outcome,	   a	   better	  
understanding	  of	   their	   recruitment	   and	  participation	   in	   revascularization	  will	   allow	  more	  
precise	   targeting.	   For	   these	   reasons,	   this	   observational	   study	   seeks	   to	   characterize	   EPC	  
recruitment	   from	   the	  bone	  marrow	   to	   the	   retina	   as	  well	   as	   to	   compare	  patterns	  between	  
susceptible	  and	  resistant	  strains	  of	  mice.	  
	   The	   C57BL6/J	   and	   c-­‐2J	   mice	   were	   chosen	   for	   use	   in	   this	   study	   as	   they	   represent	  
strains	  that	  are	  more	  or	  less	  susceptible	  to	  OIR,	  respectively.	  Our	  prior	  work	  indicated	  that	  
c-­‐2J	  mice	   revascularize	  more	   rapidly	   after	   exposure	   to	   hyperoxia	   compared	   to	   C57BL/6J,	  
and	  that	   this	   improved	  response	   is	  associated	  with	   increased	  numbers	  of	  EPCs	   in	   the	  BM,	  
blood,	   and	   retina	   at	   P13.	   This	   suggests	   that	   recruitment	   of	   these	   cells	   playa	   a	   role	   in	  
improving	  outcomes	  after	  exposure	  to	  OIR.	  	  
	   Systemic	   differences	   in	   EPC	   mobilization	   may	   have	   consequences	   outside	   of	   the	  
retina	  For	  example,	  data	   in	  a	  murine	  model	  of	  bronchopulmonary	  dysplasia	   suggests	   that	  
EPCs	  are	  recruited	  to	  the	  developing	  lung	  (Balasubramaniam,	  Mervis	  et	  al.,	  2007).	  Effects	  on	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other	   organ	   systems	   should	   therefore	   be	   evaluated	  when	   testing	   pharmacological	   agents	  
that	  are	  designed	  to	  alter	  EPC	  proliferation,	  mobilization,	  or	  retinal	  recruitment.	  
	   The	  murine	  OIR	  model	  was	  developed	  by	  Smith	  and	  colleagues	  (Smith,	  Wesolowski	  
et	  al.,	  1994)	  is	  traditionally	  divided	  into	  2	  phases:	  hyperoxia-­‐induced	  vaso-­‐obliteration	  from	  
P7	  to	  P12,	  and	  subsequent	  revascularization	  and	  NV	  upon	  return	  to	  normoxia	  on	  P12	  until	  
resolution,	   at	   approximately	   P25	   (Smith,	   Wesolowski	   et	   al.,	   1994).	   However,	   our	   data	  
measuring	  avascular	  area,	  in	  conjunction	  with	  a	  previously	  published	  report	  (Lange,	  Ehlken	  
et	  al.,	  2009),	   suggest	   that	   the	  vaso-­‐obliterative	  phase	   terminates	   several	  days	  prior	   to	   the	  
customary	   endpoint.	   Moreover,	   changes	   in	   CD34+/CD133+	   cells	   in	   the	   bone	   marrow,	  
circulating	   blood,	   and	   retina	   related	   to	   recovery	   from	   hyperoxic	   stress	   and	   vascular	  
regeneration	   also	   start	   to	   occur	   prior	   to	   removal	   of	   the	   mice	   from	   the	   hyperoxic	  
environment.	  	  
	   In	   the	   c-­‐2J	   strain,	   the	   shift	   from	   vaso-­‐obliteration	   to	   vascular	   regrowth	   occurs	  
between	  P8	  and	  P9.	  After	  P9,	  putative	  EPC	  numbers	  increase	  in	  blood	  and	  BM,	  while	  in	  the	  
retina	   both	   avascular	   area	   and	   the	   number	   of	   retinal	   CD34+/CD133+	   cells	   plateaus.	   The	  
inhibition	  of	  further	  vaso-­‐obliteration	  is	  possibly	  due	  to	  protection	  by	  the	  recruited	  cells,	  or	  
may	  represent	  a	  balance	  between	  continued	  vessel	  destruction	  and	  newly	  initiated	  vascular	  
regeneration,	  with	  the	  recruited	  cells	  likely	  playing	  a	  role.	  
	   In	   the	   C57BL/6J	   strain,	   the	   transition	   from	   the	   acute	   response	   to	   hyperoxia	   to	   a	  
recuperative	   response	   occurs	   later,	   and	   the	   timing	   varies	   between	   the	   tissues	   studied.	  
Peripherally,	   EPCs	   appear	   to	   undergo	   a	   shift	   in	   behavior	   at	   P9.5	   or	   P10.	   In	   the	   BM,	   this	  
change	   from	   a	   volatile	   pattern	   to	   one	   of	   gradual	   and	   steady	   decline	   occurs	   at	   P9.5.	   The	  
number	   of	   mobilized	   EPCs	   follows	   a	   sinusoidal	   pattern	   that	   reaches	   a	   minimum	   at	   P10.	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Within	   the	   retina	   specifically,	   this	   transition	   appears	   to	   occur	   when	   the	   avascular	   area	  
reaches	   its	   maximum	   at	   P11,	   which	   coincides	   with	   the	   maximal	   recruitment	   of	  
CD34+/CD133+	  cells	  to	  the	  retina.	  As	  in	  the	  c-­‐2J	  strain,	  it	  is	  likely	  that	  avascular	  area	  begins	  
to	   decline	   as	   recruited	   cells	   contribute	   to	   the	   developing	   vessels	   in	   the	   revascularizing	  
retina.	  
	   Retinal	   avascular	   area	   data	   from	   Lange,	   et	   al.	   show	   that	   revascularization	  
commences	  at	  P10	  for	  C57BL/6J	  mice	  (Lange,	  Ehlken	  et	  al.,	  2009),	  a	  day	  earlier	  than	  found	  
in	  our	  study.	   It	   is	   likely	   that	  subtle	  differences	   in	   the	  execution	  of	   the	  OIR	  model	  between	  
different	   laboratories	   are	   responsible	   for	   this	   difference.	   It	   is	   also	   possible	   that	   genetic	  
differences	   responsible	   for	   this	   change	   in	   phenotype	   have	   arisen	   between	   the	   C57BL/6J	  
strains	   held	   by	   Charles	   River	   and	   the	   Jackson	   Laboratories,	   respectively	   the	   sources	   of	  
Lange’s	  and	  our	  mice.	  
	   It	   is	   difficult	   to	   draw	   conclusions	   regarding	   the	   role	   of	   EPC	   mobilization	   on	   OIR	  
outcome	   due	   to	   the	   volatility	   of	   this	   population	   during	   the	   6-­‐day	   period	   of	   study.	   The	  
number	  of	  circulating	  EPCs	  increases	  within	  12	  or	  24	  hours	  after	  exposure	  to	  hyperoxia	  in	  
both	   strains	   of	   mice.	   This	   finding	   supports	   previous	   reports	   from	   mice	   exposed	   to	  
hyperbaric	   oxygen	   chamber	   (Gallagher,	   Liu	   et	   al.,	   2007).	   As	   there	   are	   no	   other	   published	  
reports	   characterizing	   EPCs	   over	   time	   in	   response	   to	   a	   disease,	   no	   comparisons	   between	  
changes	  in	  this	  population	  in	  OIR	  and	  other	  disease	  models	  can	  be	  made.	  
	   Our	  prior	  work	  performed	  at	  P13	  and	  two	  additional	  reports	  (Rios,	  Habecker	  et	  al.,	  
1999;	   Eisenhofer,	   Tian	   et	   al.,	   2003)	   indicate	   that	   Tyr	   function	   contributes	   to	   peripheral	  
production	   of	   dopamine	   (DA).	   Studies	   on	   the	   role	   of	   DA	   on	   EPC	   function	   have	   been	  
conflicting;	   in	   tumor	   models,	   administration	   of	   high	   doses	   of	   DA	   resulted	   in	   reduced	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numbers	  of	  circulating	  CD45-­‐/CD34+/CD133+	  EPCs	  in	  adult	  C57BL/6J	  mice	  (Chakroborty,	  
Chowdhury	   et	   al.,	   2008).	   Conversely,	   circulating	   EPCs	   stimulated	  with	   cytokines	   prior	   to	  
collection	  had	  increased	  proliferative	  capacity	  when	  subsequently	  treated	  with	  DA	  in	  vitro,	  
suggesting	   that	   receptor	   expression	   by	   EPCs	   is	   dynamic	   and	   influenced	   by	   cytokines	  
(Spiegel,	  Shivtiel	  et	  al.,	  2007).	  It	  is	  feasible	  that	  consistent	  exposure	  of	  cells	  to	  physiological	  
levels	  of	  DA	  as	  opposed	   to	  a	  short	  course	  of	  DA	  administered	  at	   supraphysiological	  doses	  
alters	  the	  ability	  of	  EPCs	  to	  be	  recruited	  from	  the	  circulation	  into	  vascularizing	  tissues.	  This	  
may	  explain	  the	  reduced	  recruitment	  of	  CD34+/CD133+	  cells	   to	  the	  retina	  despite	  greater	  
number	   of	   circulating	   cells	   compared	   to	   the	   c-­‐2J	   strain.	   Alternatively,	   the	   growth	   factors	  
present	  in	  developing	  mice	  may	  alter	  EPC	  mobilization.	  As	  the	  growth	  factor	  milieu	  would	  
change	  both	  as	  the	  mouse	  grows	  and	  in	  response	  to	  hyperoxic	  stress,	  this	  may	  account	  for	  
variability	  in	  the	  number	  of	  circulating	  EPCs	  over	  time.	  	  
	   Birth	  weight	  and	  post-­‐natal	  growth	  are	  known	  risk	  factors	  of	  ROP	  (Chen	  and	  Smith,	  
2008),	   and	   we	   were	   therefore	   interested	   to	   see	   if	   weight	   contributed	   to	   differences	   in	  
susceptibility	   between	   strains.	   However,	   mice	   gained	   weight	   in	   a	   very	   similar	   pattern,	  
indicating	   that	  weight	  was	  not	  responsible	   for	  differences	   in	  avascular	  area	  seen	  between	  
C57BL/6J	   and	   c-­‐2J	   mice.	   In	   both	   strains,	   pups	   lost	   a	   significant	   amount	   of	   weight	   upon	  
return	  to	  normoxia.	  This	  change	  may	  be	  related	  to	  alterations	  in	  eating	  patterns	  of	  the	  pups	  
or	  feeding	  behavior	  by	  the	  dam	  induced	  by	  the	  stress	  of	  returning	  to	  normoxia	  after	  5	  days	  
at	  hyperoxic	  conditions.	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CONCLUSIONS	  
	   This	   study	   describes	   a	   particular	   cell	   population	   that	   likely	   contains	   EPCs	   and	  
characterizes	   their	   response	   to	   the	   OIR	  model	   in	   relation	   to	   changes	   in	   retinal	   avascular	  
area.	  Our	  results	  have	  a	  number	  of	  lessons	  for	  further	  studies	  in	  OIR:	  
i) there	  appears	  to	  be	  an	  early	  phase	  of	  hyperoxic	  vaso-­‐obliteration	  that	  is	  identical	  
between	  C57BL/6J	  and	  c-­‐2J	  mice,	   followed	  by	  a	   later	  phase	  of	  vaso-­‐obliteration	  
that	  our	  other	  work	  suggests	  can	  be	  protected	  against	  by	  a	  more	  adequate	  EPC	  
response.	  
ii) OIR	   can	   no	   longer	   be	   considered	   a	   2-­‐stage	   process	   with	   vaso-­‐obliteration	  
followed	   by	   regeneration	   and	   revascularization	   in	   normoxia.	   Rather,	   there	   are	  
several	  stages:	  early	  vaso-­‐obliteration,	  late	  vaso-­‐obliteration,	  EPC	  response	  in	  the	  
presence	   of	   hyperoxia,	   EPC	   response	   in	   the	   presence	   of	   normoxia,	   and	  
pathological	  vascularization.	  The	  duration	  of	  exposure	  to	  hyperoxia	  can	  be	  varied	  
with	  a	  view	  to	  the	  phenomena	  being	  investigated.	  The	  timing	  of	  interventions	  can	  
also	  be	  planned	  with	  this	  sequence	  in	  mind.	  	  	  
As	  improving	  retinal	  vascularization	  will	  decrease	  retinal	  hypoxia	  and	  subsequent	  NV,	  EPC	  
recruitment	   may	   serve	   as	   a	   novel	   target	   for	   treatment	   for	   the	   prevention	   of	   ischemic	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ABSTRACT	  
	   Using	  microarray	  analysis,	   this	  study	  compares	  the	  retinal	   transcriptional	  response	  
of	  BALB/cByJ	  and	  C57BL/6ByJ	  mice	  exposed	  to	  OIR.	  These	  strains	  were	  chosen	  to	  identify	  
gene	  expression	  patterns	  associated	  with	  OIR	  resistance	  or	  susceptibility,	  respectively.	  Total	  
retinal	  RNA	  was	  isolated	  at	  P13	  from	  mice	  from	  3	  different	  litters	  of	  each	  strain	  from	  both	  
normoxic	   control	   mice	   and	   mice	   exposed	   to	   the	   OIR	   model.	   The	   expression	   of	   69	   gene	  
transcripts	   was	   significantly	   altered	   in	   C57BL/6ByJ	   mice	   exposed	   to	   OIR	   compared	   to	  
normoxic	   controls.	   Sixty-­‐five	  were	   significantly	   altered	   in	  BALBC/cByJ	   experimental	  mice.	  
Comparison	   of	   experimental	   mice	   between	   strains	   identified	   significant	   alteration	   in	  
expression	   of	   55	   genes.	   Gene	   set	   enrichment	   analysis	   (GSEA)	   of	   KEGG-­‐defined	   pathways	  
revealed	  up-­‐regulation	  of	  genes	  related	  to	  various	  neoplastic	  diseases,	  cell	  communication,	  
and	  extracellular	  matrix	  receptor	  interaction	  in	  C57BL/6ByJ	  mice	  exposed	  to	  OIR	  compared	  
to	   BALB/cByJ;	   BALB/cByJ	   mice	   up-­‐regulated	   expression	   of	   genes	   related	   to	   metabolic	  
pathways.	  Quantitative	  rt-­‐PCR	  results	  were	  in	  agreement	  with	  the	  microarray.	   	  These	  data	  
were	   similar	   to	   those	   published	   by	   others	   profiling	   gene	   expression	   of	   C57BL/6N	   mice	  
exposed	  to	  hyperoxia	  at	  P12.	  Alterations	  in	  gene	  expression	  may	  determine	  the	  differential	  
response	   between	   these	   strains	   to	   murine	   OIR,	   and	   these	   data	   contribute	   to	   our	  
understanding	  of	  pathways	  involved	  in	  this	  process.	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LIST	  OF	  ABBREVIATIONS	  	  
	  
Ccl3	  	  -­‐	  chemokine	  (C-­‐C	  motif)	  ligand	  3,	  or	  Mip-­‐1a	  
Ctgf	  –	  connective	  tissue	  growth	  factor	  
Cxcr4	  -­‐	  chemokine	  (C-­‐X-­‐C	  motif)	  receptor	  4,	  or	  SDF-­‐1	  
EPC	  –	  endothelial	  progenitor	  cell	  
GSEA	  –	  gene	  set	  enrichment	  analysis	  
HIF-­‐1α	  –	  hypoxia-­‐inducible	  factor	  1	  α	  
IGFBP3	  –	  insulin-­‐like	  growth	  factor	  binding	  protein	  3	  
KEGG	  –	  Kyoto	  Encyclopedia	  of	  Genes	  and	  Genomes	  
MHC	  –	  major	  histocompatibility	  complex	  
Mip-­‐1a	  –	  macrophage	  inhibitory	  protein	  1	  alpha,	  or	  Ccl3	  
NV	  -­‐	  neovascularization	  
OIR	  –	  oxygen-­‐induced	  retinopathy	  
P	  –	  post-­‐natal	  day	  	  
PPAR	  –	  peroxisome	  proliferator-­‐activated	  receptor	  
rt-­‐PCR	  –	  real	  time	  polymerase	  chain	  reaction	  
ROP	  –	  Retinopathy	  of	  Prematurity	  
SDF-­‐1	  –	  stromal	  cell-­‐derived	  factor	  1,	  or	  Cxcr4	  
Tnfrsf12a	  –	  Tumor	  necrosis	  factor	  receptor	  superfamily	  member	  12A,	  or	  Fn14	  
VEGF	  –	  vascular	  endothelial	  growth	  factor	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INTRODUCTION	  
As	   described	   in	   chapter	   1,	   ROP	   is	   a	   leading	   cause	   of	   blindness	   in	   the	   pediatric	  
population	  (Gilbert,	  2008).	  The	  murine	  model,	  called	  oxygen-­‐induced	  retinopathy	  (OIR),	   is	  
the	   most	   commonly	   used	   animal	   model	   for	   the	   study	   of	   ROP	   (Smith,	   Wesolowski	   et	   al.,	  
1994).	  In	  this	  model,	  hyperoxic	  conditions	  result	  in	  central	  retinal	  vaso-­‐obliteration	  that	  is	  
later	  followed	  by	  revascularization	  and	  NV.	  	  
	   There	  are	  known	  differences	  in	  susceptibility	  to	  OIR	  between	  inbred	  strains	  of	  mice.	  
Specifically,	   the	   BALB/c	   strain	   responds	   more	   favorably	   than	   does	   the	   C57BL/6J	   strain	  
(Dorrell,	  Aguilar	   et	   al.,	   2010;	  O'Bryhim,	  Radel	   et	   al.,	   2012).	  While	  both	   strains	   respond	   to	  
hyperoxia	  with	  similar	  degree	  of	  vaso-­‐obliteration	  measured	  on	  P12	  	  after	  exposure	  to	  the	  
OIR	  model	   (Ritter,	  Banin	  et	  al.,	  2006)	  (Dorrell,	  Aguilar	  et	  al.,	  2010),	  BALB/cByJ	  mice	  have	  
smaller	  avascular	  areas	  at	  P16	  (O'Bryhim,	  Radel	  et	  al.,	  2012)	  and	  P17	  (Dorrell,	  Aguilar	  et	  al.,	  
2010).	   To	   date,	   several	  microarray	   studies	   examining	   gene	   expression	   profiles	   in	  murine	  
OIR	  have	  been	  published,	  but	  all	  use	  sub-­‐strains	  of	  the	  more	  susceptible	  C57BL	  strain	  (Sato,	  
Kusaka	   et	   al.,	   2009;	   Ishikawa,	   Yoshida	   et	   al.,	   2010;	   Recchia,	   Xu	   et	   al.,	   2010).	   No	   genes	  
expression	  assays	  have	  been	  reported	  using	  the	  resistant	  BALB/c	  strain.	  
Here	   we	   report	   the	   results	   of	   a	   microarray	   analysis	   designed	   to	   compare	   gene	  
expression	   of	  whole	   retinal	   RNA	   from	  C57BL/6ByJ	   and	   BALB/cByJ	  mice.	   For	   each	   strain,	  
samples	  were	  taken	  from	  animals	  raised	  in	  normoxia	  and	  from	  animals	  exposed	  to	  OIR.	  This	  
allowed	   for	   four	   comparisons:	   i)	   C57BL/6ByJ	   control	   versus	   OIR,	   ii)	   BALB/cByJ	   control	  
versus	   OIR,	   iii)	   C57BL/6ByJ	   control	   versus	   BALB/cByJ	   control,	   and	   iv)	   C57BL/6ByJ	   OIR	  
versus	  BALB/cByJ	  OIR.	  We	  used	  GSEA	  to	  describe	  the	  pathways	  and	  processes	  that	  differed	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between	  experimental	  groups	  and	  strains.	  This	  approach	  allowed	  us	  to	  identify	  factors	  and	  
pathways	  that	  are	  associated	  with	  susceptibility	  to	  OIR.	  
	  
MATERIALS	  AND	  METHODS	  
Animals	  
All	   experimental	   procedures	   conformed	   to	   the	   ARVO	   Statement	   for	   the	   Use	   of	  
Animals	  in	  Ophthalmic	  and	  Vision	  Research	  and	  were	  approved	  by	  the	  University	  of	  Kansas	  
Medical	  Center	   Institutional	  Animal	  Care	  and	  Use	  Committee.	  BALB/cByJ	  and	  C57BL/6ByJ	  
were	  purchased	   from	   Jackson	  Laboratories	   (Bar	  Harbor,	  ME).	  All	  mice	  were	  kept	   in	  a	  12-­‐
hour	   light,	   12-­‐hour	   dark	   cycle	   with	   ambient	   room	   temperature	   between	   19oC	   and	   22oC.	  
Mice	  were	   fed	   a	   standard	   diet	   for	   breeding	  mice	   (8626	   rodent	   diet;	   Harlan	   Laboratories,	  
Indianapolis,	  IN),	  with	  chow	  and	  water	  available	  ad	  libitum.	  	  
	  
Oxygen-­‐induced	  retinopathy	  
OIR	   was	   induced	   in	   experimental	   mice	   according	   to	   standard	   protocol	   (Smith,	  
Wesolowski	   et	   al.,	   1994);	   briefly,	   pups	  were	   exposed	   to	   75%	   oxygen	   beginning	   on	   P7	   to	  
induce	   central	   vaso-­‐obliteration	   and	   returned	   to	   normoxia	   after	   120	   hours.	   Age-­‐matched	  
normoxic	  control	  mice	  were	  not	  exposed	  to	  the	  hyperoxic	  environment.	  	  
	  
Tissue	  preparation	  and	  retinal	  vascular	  analysis	  
Mice	  were	  anesthetized	  with	  a	  lethal	  dose	  of	  tribromoethanol	  and	  enucleated	  on	  P13.	  
Retinae	   were	   isolated	   and	   snap	   frozen	   on	   dry	   ice	   prior	   to	   storage	   in	   -­‐80oC.	   Mice	   were	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weighed	   prior	   to	   anesthetization	   and	   gender	   was	   documented;	   only	   male	   mice	   in	   the	  
median	  range	  of	  weight	  of	  their	  respective	  litter	  were	  used	  in	  the	  microarray	  study.	  
	  
	  
Microarray	  Analysis	  	  
	   RNA	  extraction	   from	  collected	   retinal	   tissue	  was	  performed	  using	  RNEasy	  Mini	  Kit	  
(Qiagen,	  Valencia,	  CA).	  Two	  retinae	  from	  one	  mouse	  were	  pooled	  to	  create	  one	  sample;	  one	  
sample	   from	   3	   different	   litters	   was	   used	   for	   each	   OIR	   group,	   and	   one	   sample	   from	   3	  
different	  litters	  was	  used	  for	  each	  control	  group	  for	  a	  total	  of	  12	  samples.	  Concentration	  and	  
quality	   of	   each	   sample	   was	   determined	   using	   a	   NanoDrop-­‐1000	   Spectrophotometer	  
(Thermo	  Scientific,	  Wilmington,	  DE).	  All	  samples	  were	  kept	  at	  -­‐80oC	  until	  use	  for	  microarray	  
hybridization	  or	  rt-­‐PCR	  analysis.	  	  
	   Samples	   were	   analyzed	   at	   the	   University	   of	   Kansas	   Medical	   Center	   Microarray	  
Facility.	  Affymetrix	  GeneChip	  Mouse	  Genome	  430	  2.0	  Arrays	   (Affymetrix,	   Santa	  Clara,	  CA)	  
covering	   39,000	   gene	   transcripts	   using	   45,000	   probe	   sets	  were	   used	   for	   gene	   expression	  
analysis.	   Sequence	   clusters	  used	   in	   the	  design	  of	   the	  GeneChip	  were	   created	  using	  Mouse	  
Build	  107.	  Data	  were	  normalized	  using	  Linear	  Models	  for	  Microarray	  Data	  (LIMMA)	  (Smyth,	  
2003).	   Genes	   for	   which	   any	   change	   with	   a	   genome-­‐adjusted	   P	   <	   0.05	   were	   considered	  
significant.	   GSEA	   (Subramanian,	   Tamayo	   et	   al.,	   2005)	  
(http://www.broadinstitute.org/gsea/)	  was	   used	   to	   identify	   Kyoto	   Encyclopedia	   of	   Genes	  
and	  Genomes	  (KEGG)	  biological	  pathways	  that	  showed	  differential	  regulation	  between	  the	  
strains.	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Confirmation	  of	  changes	  in	  gene	  expression	  using	  rt-­‐PCR	  
	   Genes	  of	  interest	  were	  studied	  using	  rt-­‐PCR	  expression	  analysis	  to	  confirm	  changes	  
in	  expression.	  Retinal	  RNA	  samples	  from	  different	  mice	  in	  the	  same	  litters	  as	  those	  tested	  in	  
the	  microarray	   analysis	   were	   extracted	   using	   an	   RNEasy	  Mini	   Kit	   (Qiagen).	   Both	   retinae	  
from	  the	  same	  mouse	  were	  pooled	  to	  create	  one	  sample;	  3	  samples	  from	  3	  different	  litters	  
were	   created	   for	  each	   strain/treatment	   condition	   for	  a	   total	  of	  12	   samples.	  The	  extracted	  
RNA	  was	   then	   reverse-­‐transcribed	   in	   20	  µL	   reactions	   using	   an	   iScript	   cDNA	   synthesis	   kit	  
(Bio-­‐Rad,	   Hercules,	   CA),	   using	   nuclease-­‐free	   H2O	   in	   place	   of	   reverse	   transcriptase	   for	   a	  
negative	  control.	  Primers	  were	  designed	  to	  flank	  an	  intron	  using	  Primer3	  software	  (Rozen	  
and	   Skaletsky,	   2000)	   and	   tested	   for	   specificity	   against	   sequences	   for	  Mus	  musculus	   using	  
BLAST	  software	   (NCBI,	  Bethesda,	  MD).	  Primers	  were	   then	   commercially	   synthesized	   (IDT	  
Technology,	   Skokie,	   IL)	   (Table	   5.1).	   S16	  was	   used	   as	   an	   endogenous	   control	   from	  which	  
relative	  level	  of	  mRNA	  expression	  was	  estimated.	  	  
	   Each	   20µL	   reaction	  mixture	   contained	   10	   µL	   2x	   SYBR	   Green	  master-­‐mix	   (Applied	  
Biosystems,	   Foster	   City,	   CA),	   1	   µL	   each	   of	   forward	   and	   reverse	   primers	   (0.5	   µM	   final	  
concentration),	  and	  2	  µL	  cDNA	  sample	  diluted	  1:2	  with	  nuclease-­‐free	  H2O.	  Reactions	  were	  
run	   on	   an	   HT	   7900	   Real-­‐Time	   PCR	   System	   (Applied	   Biosystems).	   Cycling	   conditions	  
included	  an	   initial	  denaturation	   (95oC,	  10	  minutes)	   followed	  by	  40	   cycles	  of	  denaturation	  
(95oC,	   15	   seconds),	   annealing	   (60oC,	   10	   minutes),	   and	   extension	   (72oC,	   35	   seconds).	  
Samples	  were	  tested	  in	  duplicate	  for	  each	  candidate	  gene,	  as	  were	  standard	  cDNA	  pool	  and	  
water	  samples	  to	  provide	  positive	  and	  negative	  controls,	  respectively.	  Melting	  curves	  were	  
analyzed	   to	   confirm	   amplicon	   specificity.	   PCR	   products	   were	   run	   a	   2%	   agarose	   gel	   to	  
identify	  bands	  and	  compare	  to	  the	  predicted	  amplicon	  size	  to	  confirm	  identity.	  A	  threshold	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Gene	  Name	   Forward	  Primer	   Reverse	  Primer	  
Ltbp2	   CATCAAACAGCACCAACCAC	   GACTTCCTCTGGCCTCACTG	  
Il1b	   GCCCATCCTCTGTGACTCAT	   AGGCCACAGGTATTTTGTCG	  
Col18a1	   ACAGTTGCTGCCTCAGACCT	   CAGTCAGGAGAGCTGGTTCC	  
Sfrp1	   CCTGGCTCTGTTCCTACAGC	   CGGCCAACATTTTCTGTTTT	  
Fzd5	   AGCCAAATGAGGCACATACC	   TCTCCTTTTGCGAGCGTTAT	  




















Table	  5.1	  Sequence	  of	  primers	  used	  in	  rt-­‐PCR	  gene	  expression	  analysis	  experiment.	  
Primers	  were	  designed	  using	  Primer3	  software	  and	  tested	  for	  specificity	  using	  BLAST	  
software.	  Sequences	  expressed	  as	  5’	  to	  3’.	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was	  established	  for	  each	  plate	  of	  reactions,	  and	  the	  cycle	  number	  where	  the	  fluorescence	  
curve	  intersected	  with	  the	  threshold	  was	  calculated	  (Ct).	  The	  Ct	  values	  for	  the	  genes	  of	  
interest	  were	  compared	  with	  the	  Ct	  for	  the	  transcripts	  of	  the	  ribosomal	  S16	  protein	  (ΔCt).	  
The	  relative	  gene	  expression	  levels	  were	  calculated	  by	  using	  the	  comparative	  Ct	  (ΔΔCt).	  	  
	  
RESULTS	  
Changes	  in	  gene	  expression	  
We	  report	  the	  results	  of	  our	  microarray	  data	  as	  4	  two-­‐way	  comparisons:	  1)	  response	  
to	  OIR	   (compared	  with	  normoxia)	   in	  C57BL/6ByJ	  mice,	   2)	   response	   to	  OIR	   in	  BALB/cByJ	  
mice,	   3)	   C57BL/6ByJ	   mice	   vs.	   BALB/cByJ	   mice	   in	   normoxia,	   4)	   C57BL/6ByJ	   mice	   vs.	  
BALB/cByJ	  mice	  in	  response	  to	  OIR.	  Genes	  were	  broadly	  classified	  into	  groups	  according	  to	  
their	   Gene	   Ontology	   classifications.	   In	   all	   4	   comparisons,	   both	   up-­‐regulated	   and	   down-­‐
regulated	  groups	  contained	  genes	  classified	  as	  being	  related	  to	  Angiogenesis,	  Metabolism	  
and	  Transport.	  However,	  different	  genes	   in	   these	  groups	  were	  differentially	  expressed	   in	  
different	   comparisons.	   Additionally,	   in	   most	   groups,	   some	   of	   the	   differentially	   expressed	  
genes	  are	  still	  of	  unknown	  function.	  
	  
Response	  to	  hyperoxia	  
In	  both	  C57BL/6ByJ	  and	  BALB/cByJ,	  genes	  related	  to	  Apoptosis,	  Cellular	  Adhesion,	  
Cell	   Cycle,	   Development,	   Inflammation,	  Mitochondria	   and	  Stress	   Response	  were	  up-­‐
regulated	   (Table	   5.2).	   In	   C57BL/6ByJ,	   but	   not	   in	   BALB/cByJ,	   genes	   classified	   as	   being	  
related	  to	  Cellular	  Component,	  Chemotaxis	  and	  Coagulation	  were	  up-­‐regulated	  in	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Table	  5.2	  Differential	  gene	  expression	  of	  C57BL/6ByJ	  mice	  in	  response	  to	  hyperoxia.	  	  
Genes	   are	   organized	   by	   functional	   category.	   Down-­‐regulated	   genes	   are	   listed	   in	   the	   left-­‐
hand	  table;	  up-­‐regulated	  genes	  are	  listed	  on	  the	  right.	  Data	  are	  expressed	  as	  ΔΔCt	  values.	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hyperoxia.	  Categories	  containing	  genes	  up-­‐regulated	  in	  hyperoxia	   in	  BALB/cByJ	  but	  not	   in	  
C57BL/6ByJ	  were	  Signal	  Transduction,	  Transcription,	  and	  Vision	  (Table	  5.3).	  
	   Some	  of	  the	  genes	  that	  were	  down-­‐regulated	  in	  hyperoxia	  fell	  into	  the	  classifications	  
of	   Cellular	   Adhesion,	   Cellular	   Component,	   Development,	   Mitochondrial,	   Stress	  
Response	   and	  Vision	   in	   both	   C57BL/6ByJ	   and	   BALB/cByJ.	   Additionally,	   BALB/cByJ	   had	  
genes	  that	  were	  down-­‐regulated	  that	  fell	  into	  the	  category	  of	  Signal	  Transduction.	  	  
	  
Differential	  gene	  expression	  between	  C57BL/6ByJ	  and	  BALB/cByJ	  Mice.	  
	   In	  both	  normoxia	  and	  hyperoxia	  (Tables	  5.4	  and	  5.5,	  respectively),	  the	  classifications	  
Cellular	  Adhesion	  and	  Cellular	  Component	  described	  some	  of	  the	  genes	  that	  were	  more	  
highly	  expressed	  in	  C57BL/6ByJ	  and	  some	  of	  the	  genes	  that	  were	  more	  highly	  expressed	  in	  
BALB/cByJ.	  The	  classifiers	  Cell	  Cycle,	  Development,	  Inflammation,	  Signal	  Transduction,	  
and	   Vision	  were	  used	   to	  describe	   some	  of	   the	   genes	   that	  were	  more	  highly	   expressed	   in	  
C57BL/6ByJ	  in	  both	  normoxia	  and	  hyperoxia.	  Inflammation,	  Signal	  Transduction,	  Stress	  
Response	  and	  Transcription	  classifiers	  were	  used	  to	  describe	  some	  of	  the	  genes	  that	  were	  
more	   highly	   expressed	   in	   BALB/cByJ	   in	   both	   normoxia	   and	   hyperoxia.	   Some	   genes	   that	  
were	   more	   highly	   expressed	   in	   BALB/cByJ	   in	   normoxia	   fell	   into	   the	   Development	   and	  
Mitochondria	  classifications.	  The	  Apoptosis	  classification	  applied	  to	  some	  genes	  that	  were	  
more	   highly	   regulated	   in	   C57BL/6ByJ	   and	   some	   that	   were	   more	   highly	   regulated	   in	  
BALB/cByJ	  in	  hyperoxia.	  Some	  of	  the	  genes	  that	  were	  more	  highly	  expressed	  in	  C57BL/6ByJ	  
in	  hyperoxia	  fell	  into	  the	  Chemotaxis,	  Coagulation	  and	  Mitochondrial	  groups.	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Table	  5.3	  Differential	  gene	  expression	  of	  BALB/6ByJ	  mice	  in	  response	  to	  hyperoxia.	  
Genes	   are	   organized	   by	   functional	   category.	   Down-­‐regulated	   genes	   are	   listed	   in	   the	   left-­‐
hand	  table;	  up-­‐regulated	  genes	  are	  listed	  on	  the	  right.	  Data	  are	  expressed	  as	  ΔΔCt	  values	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Table	  5.4	  Differential	  gene	  expression	  between	  strains	  of	  mice	  raised	  in	  normoxia.	  	  
Genes	   are	   organized	   by	   functional	   category.	   Down-­‐regulated	   genes	   are	   listed	   in	   the	   left-­‐
hand	  table;	  up-­‐regulated	  genes	  are	  listed	  on	  the	  right.	  Data	  are	  expressed	  as	  ΔΔ	  Ct	  values.	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Table	  5.5	  Differential	  gene	  expression	  between	  strains	  of	  mice	  exposed	  to	  OIR.	  	  
Genes	  are	  organized	  by	  functional	  category.	  Down-­‐regulated	  genes	  are	  listed	  in	  the	  ΔΔ	  Ct	  
values.	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Gene	  set	  enrichment	  analysis	  results	  
	  
Using	   the	   expression	   profiles	   of	   both	   experimental	   and	   control	   C57BL/6ByJ	   and	  
BALB/cByJ	  mice,	   GSEA	  was	   performed	   to	   reveal	   functional	   gene	   sets	   associated	  with	   our	  
data	  using	  a	  false	  discovery	  rate	  of	  <	  0.25	  as	  our	  cut-­‐off.	  Seventeen	  KEGG-­‐defined	  gene	  sets	  
were	  found	  to	  be	  up-­‐regulated	  in	  the	  retina	  of	  C57BL/6ByJ	  mice	  exposed	  to	  OIR	  compared	  
to	  normoxic	  controls;	  only	  one	  gene	  set	  was	  down-­‐regulated	  (Table	  5.6).	  
	   Only	  2	  KEGG-­‐curated	  pathways	  were	  found	  to	  be	  differentially	  regulated	  between	  
BALB/cByJ	  mice	  exposed	  to	  OIR	  and	  controls.	  Both	  were	  down-­‐regulated	  in	  experimental	  
OIR	  mice	  compared	  to	  control	  (Table	  5.7).	  	  
Six	  KEGG-­‐defined	  biological	  pathways	  were	  found	  to	  be	  up-­‐regulated	  in	  C57BL/6ByJ	  
mice	  exposed	  to	  OIR	  compared	  to	  OIR	  BALB/cByJ	  animals;	  4	  pathways	  were	  up-­‐regulated	  in	  
BALB/cByJ	  mice	  (Table	  5.8).	  	  
	  
Validation	  of	  microarray	  data	  by	  real-­‐time	  PCR	  
To	  validate	   the	  outcome	  of	  our	  microarray	  analyses,	  we	  performed	  quantitative	  rt-­‐
PCR	  assays.	  Relative	  quantifications	  of	  the	  mRNA	  expression	  by	  rt-­‐PCR	  were	  calculated	  for	  5	  
genes	   significantly	   altered	   between	   strains	   (Table	   5.9).	   We	   found	   excellent	   agreement	  
between	  microarray	  and	  rt-­‐PCR,	  and	  expression	  changes	  of	  each	  gene	  examined	  were	  in	  the	  
same	  direction	   of	   regulation.	   These	   findings	   demonstrate	   the	   high	   reliability	   of	   our	   array	  
results.	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Table	  5.6	  GSEA	  results	  identifying	  KEGG-­‐defined	  gene	  sets	  differentially	  expressed	  in	  
C57BL/6ByJ	  mice	  exposed	  to	  OIR.	  	  
(A)	   GSEA	  was	   performed	   to	   reveal	   functional	   gene	   sets	   associated	  with	   our	   data	   using	   a	  
false	  discovery	  rate	  of	  <	  0.25	  as	  our	  cut-­‐off.	  Seventeen	  gene	  sets	  were	  up-­‐regulated	   in	   the	  
retina	  of	  C57BL/6ByJ	  mice	  exposed	  to	  OIR	  compared	  to	  normoxic	  controls;	  only	  one	  gene	  
set	  was	  down-­‐regulated.	  (B)	  Example	  enrichment	  plot	  with	  enrichment	  score	  profile	  for	  the	  
KEGG-­‐defined	  Cell	  Cycle	  gene	  set.	  
	   	  
	   146	  
	   	  
	   147	  










Table	  5.7	  GSEA	  results	  identifying	  KEGG-­‐defined	  gene	  sets	  differentially	  expressed	  in	  
BALB/cByJ	  mice	  exposed	  to	  OIR.	  	  
(A)	   GSEA	  was	   performed	   to	   reveal	   functional	   gene	   sets	   associated	  with	   our	   data	   using	   a	  
false	  discovery	  rate	  of	  <	  0.25	  as	  our	  cut-­‐off.	  Two	  gene	  sets	  were	  up-­‐regulated	  in	  the	  retina	  of	  
BALB/cByJ	   mice	   exposed	   to	   OIR	   compared	   to	   normoxic	   controls;	   none	   were	   down-­‐
regulated.	  (B)	  Example	  enrichment	  plot	  with	  enrichment	  score	  profile	  for	  the	  KEGG-­‐defined	  
PPAR	  Signaling	  Pathway	  gene	  set.	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Table	  5.8	  GSEA	  results	  identifying	  KEGG-­‐defined	  gene	  sets	  differentially	  expressed	  
between	  strains	  of	  mice	  exposed	  to	  OIR.	  	  
(A)	   GSEA	  was	   performed	   to	   reveal	   functional	   gene	   sets	   associated	  with	   our	   data	   using	   a	  
false	  discovery	  rate	  of	  <	  0.25	  as	  our	  cut-­‐off.	  Six	  gene	  sets	  were	  up-­‐regulated	  in	  the	  retina	  of	  
C57BL/6ByJ	  mice	  exposed	  to	  OIR	  compared	  to	  BALB/cByJ;	  four	  gene	  set	  were	  up-­‐regulated	  
in	   BALB/cByJ	   (B)	   Example	   enrichment	   plot	   with	   enrichment	   score	   profile	   for	   the	   KEGG-­‐
defined	  ECM	  Receptor	  Interaction	  pathway.	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DISCUSSION	  
	   The	   purpose	   of	   this	   study	  was	   to	   identify	   specific	   genes	   and	   pathways	   associated	  
with	  more	  or	   less	  successful	   retinal	   revascularization	  responses	   to	   the	  OIR	  model	  of	  ROP.	  
The	   BALB/cByJ	  murine	   strain	   has	   been	   shown	   in	  multiple	   studies	   to	   revascularize	  more	  
rapidly	   and	   in	   a	  more	   physiologically	   normal	  manner	   in	   the	   OIR	  model	   compared	   to	   the	  
C57BL/6	  strain	  (Ritter,	  Banin	  et	  al.,	  2006;	  Dorrell,	  Aguilar	  et	  al.,	  2010;	  O'Bryhim,	  Radel	  et	  al.,	  
2012).	  
	   While	  several	  published	  microarray	  studies	  have	  elucidated	  gene	  expression	  changes	  
that	  occur	  in	  murine	  OIR	  (Sato,	  Kusaka	  et	  al.,	  2009;	  Ishikawa,	  Yoshida	  et	  al.,	  2010;	  Recchia,	  
Xu	  et	  al.,	  2010),	  all	  used	  the	  C57BL/6	  strain	  that	  is	  highly	  susceptible	  to	  the	  development	  of	  
proliferative	   OIR.	   In	   contrast,	   BALB/cByJ	   exhibits	   faster	   regeneration	   of	   the	   obliterated	  
retinal	  vasculature	  and	  is	  less	  susceptible	  to	  proliferative	  OIR	  (Dorrell,	  Aguilar	  et	  al.,	  2010;	  
O'Bryhim,	  Radel	  et	  al.,	  2012).	  By	  comparing	  differences	   in	  gene	  expression	  between	  these	  
strains	  we	  sought	  to	  identify	  mechanisms	  associated	  with	  more	  or	  less	  adaptive	  responses	  
to	  OIR.	  	  
	  
Comparison	  of	  C57	  Data	  with	  Previously	  Published	  Reports	  
The	   genes	   we	   determined	   to	   be	   differentially	   expressed	   in	   C57BL/6ByJ	   retinas	   in	  
response	   to	   hypoxia	   in	   the	   OIR	   model	   largely	   agree	   with	   those	   of	   Ishikawa	   (Ishikawa,	  
Yoshida	  et	  al.,	  2010)	  and	  Sato	  (Sato,	  Kusaka	  et	  al.,	  2009),	  although	  the	  other	   investigators	  
used	   different	   time	   points.	   In	   all	   cases	   where	   genes	   were	   differentially	   expressed	   in	   our	  
experiment	   as	   well	   as	   in	   the	   work	   of	   Ishikawa	   or	   Sato,	   then	   the	   direction	   of	   differential	  
expression	  was	  concordant	  between	  the	  experiments.	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Connective	   tissue	   growth	   factor	   (Ctgf)	   and	   Tumor	   necrosis	   factor	   receptor	  
superfamily	  member	  12A	  (Tnfrsf12a)	  were	  the	  only	  2	  genes	  up-­‐regulated	  in	  our	  experiment	  
as	  well	  as	  in	  those	  of	  Ishikawa	  and	  Sato.	  Inhibition	  of	  Ctgf	  has	  been	  demonstrated	  to	  hasten	  
retinal	  revascularization	  and	  to	  inhibit	  NV	  in	  OIR	  (Pi,	  Shenoy	  et	  al.,	  2012).	  Tnfrsf12a	  is	  also	  
known	  as	  Fn14	  and	  as	  the	  TWEAK	  receptor.	  Fn14	   is	  up-­‐regulated	   in	  renal	   ischemia.	  Renal	  
blockade	   of	  Fn14	   reduced	   proinflammatory	   cytokine	   production,	   decreased	   inflammatory	  
infiltrate,	  inhibited	  tubular	  cell	  apoptosis,	  and	  prolonged	  survival	  of	  mice	  in	  a	  model	  of	  renal	  
ischemia	   reperfusion	   injury	   (Hotta,	   Sho	   et	   al.,	   2011).	   Similarly,	   Fn14	   deficiency	   has	   been	  
found	  to	  be	  neuroprotective	  (Frauenknecht,	  Bargiotas	  et	  al.,	  2010),	  and	  to	  reduce	  neuronal	  
apoptosis	  (Haile,	  Echeverry	  et	  al.,	  2010)	  in	  an	  experimental	  model	  of	  stroke	  (Echeverry,	  Wu	  
et	   al.,	   2012).	   Interestingly,	   Fn14	   is	   not	   up-­‐regulated	   in	   response	   to	   the	   OIR	   model	   in	  
BALB/cByJ	  retinas.	  It	  is	  possible	  that	  Fn14	  up-­‐regulation	  in	  C57BL/6ByJ	  mice	  contributes	  to	  
increased	  apoptosis	  of	  microglial	  cells	  and	  astrocytes	  reported	  previously	  (Dorrell,	  Aguilar	  
et	  al.,	  2010),	  which	  may	  explain	  in	  part	  why	  C57BL/6ByJ	  mice	  revascularize	  more	  slowly	  in	  
the	  OIR	  model.	  	  
	  
Comparison	  of	  Retinal	  Response	  to	  Hypoxia	  between	  Strains	  
	   At	   P13,	   24	   hours	   after	   return	   to	   normoxia	   in	   the	   OIR	   model,	   retinae	   from	   both	  
C57BL/6	  and	  BALB/c	  mice	  exhibit	  up-­‐regulation	  of	  genes	  related	  to	  inflammation	  compared	  
to	   normoxic	   controls.	   This	   finding	   is	   consistent	   with	   previously	   published	   microarray	  
studies	  (Sato,	  Kusaka	  et	  al.,	  2009;	  Ishikawa,	  Yoshida	  et	  al.,	  2010)	  and	  other	  data	  suggesting	  
that	   hypoxic	   retinas	   are	   in	   an	   elevated	   state	   of	   immune	   responsiveness	   (Matsuoka,	  
Kitamura	  et	  al.,	  1998;	  Lin,	  Chen	  et	  al.,	  2011;	  Sivakumar,	  Foulds	  et	  al.,	  2011).	  For	  example,	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retinal	  microglia	   have	  been	   shown	   to	   increase	  production	  of	   tumor	  necrosis	   factor	  α	   and	  
interleukin	  1β	  in	  rat	  OIR	  models	  (Sivakumar,	  Foulds	  et	  al.,	  2011).	  	  
	   The	   inflammation-­‐associated	   genes	   showing	   the	   greatest	   degree	   of	   differential	  
expression	   are	   the	  major	   histocompatibility	   complex	   (MHC)	   class	   Ib	   gene	  H2-­‐Q7	   and	   the	  
MHC	  class	   II	   gene	  H2-­‐Ab1.	  H2-­‐Q7,	   also	  known	  as	  H2-­‐Qa2	  and	  Preimplantation	  embryonic	  
development	  (Ped)	  gene,	  is	  a	  non-­‐classical	  class	  1b	  MHC	  molecule	  that	  is	  widely	  expressed	  
(Niederkorn,	   Chiang	   et	   al.,	   1999;	   Comiskey,	   Goldstein	   et	   al.,	   2003;	   Ohtsuka,	   Inoko	   et	   al.,	  
2008).	   While	   its	   role	   in	   blastocyst	   implantation	   and	   embryonic	   survival	   are	   better	  
described,	  there	  is	  evidence	  that	  H2-­‐Q7	  along	  with	  other	  class	  1b	  MHC	  genes	  inhibit	  Natural	  
Killer	   cells	   and	   thus	   cell-­‐mediated	   cytotoxicity	   (Niederkorn,	   Chiang	   et	   al.,	   1999;	   Chiang,	  
Henson	  et	  al.,	  2003).	  H2-­‐Q7	  is	  more	  highly	  expressed	  in	  the	  hypoxic	  retina	  of	  C57BL/6ByJ	  
than	  of	  BALB/cByJ.	  	  
	   In	   contrast,	  H2-­‐Ab1	   is	  more	   highly	   expressed	   in	   the	   hypoxic	   retinae	   of	   BALB/cByJ	  
than	  of	  C57BL/6ByJ	  mice.	  H2-­‐Ab1,	  is	  class	  II	  molecule	  expressed	  on	  antigen	  presenting	  cells	  
and	   recognized	  by	  CD4+	  T	   cells.	  This	   serves	   to	   activate	  CD4+	  T	   cells,	  which	   subsequently	  
regulate	  activation	  and	  apoptosis	  of	  T	  cells	  (Tsang,	  Chai	  et	  al.,	  2003;	  Zhou,	  Ding	  et	  al.,	  2011).	  
The	  substantial	  strain	  specific	  differences	  of	  expression	  of	  these	  MHC	  genes	  may	  point	  to	  a	  
difference	  in	  polarization	  of	  the	  immune	  response	  in	  hypoxia	  between	  these	  strains.	  	  
Chemokine	  (C-­‐C	  motif)	  ligand	  3	  (Ccl3),	  also	  known	  as	  Macrophage	  inhibitory	  protein-­‐
1	  α	  (MIP-­‐1α),	  is	  more	  highly	  expressed	  in	  C57BL/6ByJ	  than	  BALB/cByJ	  retinas.	  MIP-­‐1α	  is	  a	  
cytokine	  functions	  to	  recruit	  monocytes,	  and	  is	  produced	  in	  response	  to	  tissue	  ischemia.	  	  In	  
the	   OIR	  model,	   MIP-­‐1α	  mRNA	   expression	   was	   increased	  within	   12	   hours	   after	   return	   to	  
normoxia.	  Antibody	  blockade	  delivered	  at	  P12	  and	  P14	  successfully	  inhibited	  retinal	  NV	  by	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P17	   (Yoshida,	   Yoshida	   et	   al.,	   2003).	   	   Up-­‐regulation	   of	   this	   gene	   in	   C57BL/6ByJ	   retinae	  
compared	  to	  BALB/cByJ	  could	  therefore	  contribute	  to	  the	  increased	  NV	  seen	  in	  this	  strain.	  	  
Complement	  components	  C3	  and	  C4b	  were	  up-­‐regulated	  in	  response	  to	  hypoxia.	  C3	  
was	   up-­‐regulated	   in	   both	   strains,	   and	   C4b	   was	   up-­‐regulated	   in	   BALB/cByJ	   retinae.	   C3-­‐
deficienct	  mice	  had	  worsened	  NV	  after	  exposure	   to	  OIR	  compared	   to	  wild-­‐type	   littermate	  
controls	   via	   polarization	   of	   macrophages	   toward	   an	   anti-­‐angiogenic	   phenotype	   (Langer,	  
Chung	   et	   al.,	   2010).	   Although	   several	   patents	   have	   been	   filed	   for	   complement	   inhibitors	  
designed	  to	  treat	  other	  retinal	  vasculopathies	  (Epstein	  and	  Kurz,	  2009;	  Fung	  and	  Yao,	  2009;	  
Hass,	   Jianping	   et	   al.,	   2011),	   to	   date	   no	   other	   data	   has	   been	   published	   on	   the	   role	   of	  
complement	  activation	  in	  OIR	  or	  ROP.	  
	   Hypoxic	   C57BL/6ByJ	   retinae	   showed	   greater	   differential	   expression	   of	   angiogenic	  
genes	  than	  did	  BALB/cByJ	  retinae.	  Genes	  related	  to	  angiogenesis	  that	  were	  up-­‐regulated	  in	  
response	  to	  hypoxia	  in	  C57BL/6ByJ	  OIR	  retinae	  included	  genes	  known	  to	  play	  an	  important	  
role	   in	   retinal	   vascularization	   such	  as	  Vegfa	  (Chen	  and	  Smith,	  2007)	   and	   Igfbp3	  (Lofqvist,	  
Chen	   et	   al.,	   2007).	   The	   only	   2	   down-­‐regulated	   angiogenic	   genes	   in	   this	   comparison	  were	  
Chemokine	   (C-­‐X-­‐C	   motif)	   receptor	   4	   (Cxcr4)	   and	   Tek.	   Cxcr4	   is	   the	   SDF-­‐1	   receptor	   that	  
mediates	  EPC	  recruitment	  (Ceradini,	  Kulkarni	  et	  al.,	  2004;	  Urbich	  and	  Dimmeler,	  2004;	  Lima	  
e	  Silva,	  Shen	  et	  al.,	  2007).	  EPC	  contribute	  to	  angiogenesis	  in	  the	  retina(Nakagawa,	  Masuda	  et	  
al.,	   2011),	   and	   reduced	   recruitment	   of	   progenitor	   cells	   could	   potentially	   lead	   to	   either	  
reduced	  revascularization	  or	  reduced	  development	  of	  pathological	  NV.	  	  
	   Tek,	  or	  Tie-­‐2,	  is	  the	  angiopoietin	  1	  receptor.	  Angiopoietin	  1	  has	  been	  shown	  to	  inhibit	  
EC	  apoptosis,	  and	  to	  promote	  angiogenesis,	  vascular	  perfusion	  and	  EPC	  recruitment	  (Koh,	  
2012).	  The	  most	  up-­‐regulated	  angiogenesis-­‐related	  gene	  in	  the	  hypoxic	  BALB/cByJ	  retina	  is	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Igfbp3,	   which	   is	   associated	   with	   successful	   retinal	   revascularization	   and	   increased	   EPC	  
recruitment	  in	  OIR	  (Lofqvist,	  Chen	  et	  al.,	  2007).	  
	   BALB/cByJ	   retinae	  were	   shown	   to	   increase	   expression	   of	   several	  metabolic	   genes	  
after	   exposure	   to	   OIR.	   Several	   of	   these	   genes	   (Gpi1,	   Hk2,	   Pfkfb3,	   Pfkp)	   are	   involved	   in	  
glycolysis.	  The	  HIF-­‐1α	  mediated	   increase	   in	  glycolysis	   in	  hypoxia	  (Semenza,	  2000;	  Marsin,	  
Bouzin	   et	   al.,	   2002)	   is	   thought	   to	   increase	   cell	   survival	   in	   hypoxic	   environments	   by	  
maintaining	  sufficient	  levels	  of	  ATP	  (Warburg,	  1956;	  Semenza,	  2009;	  Shi,	  Xie	  et	  al.,	  2009).	  It	  
is	  possible	  that	  the	  failure	  of	  C57BL/6	  to	  significantly	  up-­‐regulate	  these	  glycolytic	  enzymes	  
may	   be	  maladaptive,	   but	   we	   have	   no	   data	   regarding	   the	   consequences	   on	   differences	   in	  
energy	  metabolism	  or	  reactive	  oxygen	  species	  production	  between	  the	  strains.	  	  
	   Although	   a	   number	   of	   genes	   demonstrate	   particularly	   pronounced	   differential	  
expression	   between	   the	   strains	   in	   hypoxia,	   in	   most	   cases	   the	   function	   of	   these	   is	  
insufficiently	  understood	  to	  allow	  any	  useful	  speculation	  linking	  this	  differential	  regulation	  
with	  disease	  outcome.	  
	  
Gene	  Set	  Enrichment	  Analysis	  	  
	   The	  goal	  of	  our	  gene	  set-­‐based	  approach	  was	  to	  detect	  coordinated	  changes	  in	  pre-­‐
specified	  sets	  of	  related	  genes,	  especially	  those	  where	  the	  individual	  transcripts	  fail	  to	  meet	  
significance	  criteria.	  The	  use	  of	  GSEA	  to	  identify	  differentially	  expressed	  KEGG	  curated	  gene	  
sets,	  several	  expression	  patterns	  emerged	  in	  each	  comparison.	  	  
	   Comparison	  of	  hyperoxia	  exposed	  C57BL/6ByJ	  retinas	  with	  the	  retinas	  of	  normoxic	  
control	   mice	   demonstrated	   up-­‐regulation	   of	   KEGG	   pathways	   related	   to	   Cell	   Cycle,	   P53	  
Signaling	  Pathway,	  Extracellular	  Matrix	   Interaction,	  Cell	  Communication,	  Complement	  and	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Coagulation	  Cascades,	  as	  well	  as	  differential	  expression	  observed	  in	  several	  neoplasia.	  The	  
neoplasia-­‐related	   gene	   sets	   encompass	   families	   of	   genes	   related	   to	   angiogenesis	   and	  Wnt	  
signaling	  pathways,	  which	  have	  been	  shown	  to	  play	  an	  important	  role	  in	  ROP	  development	  
(Hiraoka,	  Takahashi	  et	  al.,	  2010;	  Shastry,	  2010)	  and	  other	  related	  retinal	  vascular	  diseases	  
(Gong,	  Slee	  et	  al.,	  2001;	  Robitaille,	  MacDonald	  et	  al.,	  2002;	  Xu,	  Wang	  et	  al.,	  2004;	  Ye,	  Wang	  et	  
al.,	  2009).	  	  
	   In	   BALB/cByJ	   mice,	   no	   gene	   sets	   were	   up-­‐regulated	   in	   OIR	   retinae	   compared	   to	  
normoxic.	  Control	  retinae	  were	  found	  to	  have	  relatively	  greater	  expression	  of	  genes	  related	  
to	   the	  Biosynthesis	  of	  Steroids	  and	  PPAR	  signaling.	  Data	  regarding	  the	  role	  of	  peroxisome	  
proliferator-­‐activated	  receptors	  (PPAR)	  in	  angiogenesis	  are	  conflicting	  (Biscetti,	  Straface	  et	  
al.).	  Some	  reports	  suggest	  that	  PPARγ	  agonists	  increase	  the	  number	  and	  functional	  activity	  
of	  EPCs	  (Pistrosch,	  Herbrig	  et	  al.,	  2005;	  Chu,	  Lee	  et	  al.,	  2006;	  Besler,	  Doerries	  et	  al.,	  2008).	  
Others	   have	   found	   that	   PPARα	   is	   required	   for	   EPC	   differentiation	   and	   stimulates	  
angiogenesis	   (Benameur,	  Tual-­‐Chalot	   et	   al.,	   2010).	  However,	   several	   groups	   reported	   that	  
both	  PPARα	  and	  γ	   activation	   result	   in	   inhibition	  of	   angiogenesis	   (Murata,	  He	   et	   al.,	   2000;	  
Panigrahy,	  Singer	  et	  al.,	  2002;	  Peeters,	  Vigne	  et	  al.,	  2005;	  Bishop-­‐Bailey,	  2011).	  Given	  that	  
OIR-­‐exposed	  retinae	  are	  revascularizing	  at	  P13,	  our	  data	   is	   in	   line	  with	   this	   latter	  body	  of	  
evidence,	  but	  more	  work	  is	  needed	  to	  explore	  the	  role	  of	  these	  genes	  in	  OIR	  development.	   	  
	   Comparing	   gene	   set	   changes	   between	   strains	   exposed	   to	   OIR,	   C57BL/6ByJ	   retinae	  
have	  greater	  expression	  of	  genes	  related	   to	  Extracellular	  Matrix	  Receptor	   Interaction,	  Cell	  
Communication,	   and	   Cell	   Adhesion	   Molecules.	   These	   3	   pathways	   share	   many	   genes.	   The	  
Extracellular	   Matrix	   Receptor	   Interaction	   and	   Cell	   Communication	   pathways	   were	  
particularly	  driven	  by	  various	  collagens,	   integrins,	   fibronectins,	  and	  laminins.	  Additionally,	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the	   Bladder	   Cancer	   Pathway,	   which	   includes	   growth	   factors,	   transcription	   factors,	   and	  
matrix	  metalloprotease	  expression,	  was	  up-­‐regulated	  in	  C57BL/6ByJ	  OIR	  retinae.	  	  	  
	   BALB/cByJ	   retinae	   again	   showed	   higher	   expression	   of	   metabolic	   pathways.	  
Specifically,	  GSEA	  analysis	  indicated	  increase	  in	  expression	  of	  genes	  involved	  in	  metabolism	  
of	   methionine,	   glycine/serine/threonine,	   and	   glutathione.	   Methionine	   and	  
glycine/serine/threonine	   pathways	   have	   some	   overlap	   of	   genes	   with	   the	   highest	  
enrichment	   scores.	   Up-­‐regulation	   of	   the	   glutathione	   pathway	   is	   driven	   primarily	   by	  
expression	   of	   glutathione	   S-­‐transferase	   genes,	   which	   are	   involved	   in	   protection	   against	  
chemical	  toxicity	  and	  oxidative	  stress	  (Raza,	  2011).	  As	  glutathione	  is	  a	  potent	  anti-­‐oxidant	  
(Lubos,	  Loscalzo	  et	  al.,	  2011),	  up-­‐regulation	  of	  this	  pathway	  may	  prevent	  oxidative	  damage	  
to	  the	  retina	  during	  exposure	  to	  hyperoxia	  and	  thus	  minimize	  OIR-­‐induced	  vascular	  damage	  
in	  BALB/cByJ	  mice.	  This	  may	  explain	  differences	  in	  avascular	  area	  at	  P12.	  To	  date,	  neither	  
the	  role	  of	  glutathione	  transferases	  specifically	  nor	  glutathione	  metabolism	  generally	  have	  
been	   studied	   in	   ROP	   or	   OIR,	   but	   may	   be	   an	   intriguing	   avenue	   to	   explore.	   The	   higher	  
expression	   of	   genes	   involved	   in	   metabolic	   pathways	   in	   BALB/cByJ	   may	   indicate	   a	   more	  
adaptive	  response	  to	  the	  stress	  of	  the	  OIR	  model.	  	  
	   It	  is	  unclear	  from	  this	  study	  whether	  the	  more	  adaptive	  response	  in	  BALB/cByJ	  is	  in	  
any	  way	  responsible	  for	  the	  faster	  vascular	  regeneration	  seen	  in	  this	  strain,	  or	  whether	  it	  is	  
a	  consequence	  of	  the	  smaller	  area	  of	  avascular	  retina	  seen	  in	  BALB/cByJ	  mice	  at	  this	  time	  
point.	   Similarly,	   the	   higher	   expression	   of	   extracellular	  matrix	   components	   and	   of	   cellular	  
communications	   pathways	   in	   C57BL/6ByJ	   may	   simply	   be	   a	   consequence	   of	   the	   greater	  
ischemic	   area	   in	   this	   strain	   rather	   than	   a	   sign	   of	   maladaptive	   angiogenic	   efforts.	  
Nevertheless,	  this	  result	  raises	  the	  question	  of	  why	  retinal	  vascular	  regeneration	  proceeds	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more	  slowly	  in	  C57BL/6ByJ	  than	  BALB/cByJ	  despite	  the	  higher	  levels	  of	  expression	  of	  genes	  
that	  would	  normally	  promote	  revascularization.	  
	  
CONCLUSIONS	  
	   Our	  comparative	  microarray	  studies	  in	  murine	  OIR	  development	  provide	  molecular	  
insights	  on	  disease	  susceptibility	  and	  resistance	  using	  C57BL/6ByJ	  and	  BALB/cByJ	  strains,	  
respectively.	   Initial	   experiments	   confirmed	   that	   BALB/cByJ	   mice	   are	   more	   resistant	   to	  
initial	  vaso-­‐obliteration	  during	  the	  hyperoxic	  phase	  of	  OIR,	  and	  that	  they	  revascularize	  more	  
rapidly	   than	   C57BL/6ByJ	   mice	   following	   return	   to	   normoxia.	   Our	   microarray	   analysis,	  
confirmatory	  rt-­‐PCR	  data,	  and	  GSEA	  results	  suggest	  that	  up-­‐regulation	  of	  angiogenic	  genes	  
is	   associated	   with	   slower	   vascular	   regeneration	   and	   a	   greater	   degree	   of	   pathological	  
revascularization.	  	  
	   Increased	  expression	  of	  metabolic	  genes	  was	  associated	  with	  improved	  OIR	  outcome	  
in	  the	  BALB/cByJ	  strain.	  This	  finding	  may	  be	  a	  direct	  result	  of	  HIF-­‐1α	  signaling	  in	  hypoxia.	  
However,	  GSEA	  results	  alternatively	  suggest	  changes	   in	  expression	  of	  metabolic	  pathways	  
may	  be	  related	  to	  an	  up-­‐regulation	  of	  the	  glutathione	  pathway,	  which	  would	  likely	  decrease	  
damaged	  related	  to	  oxidative	  stress.	  The	  latter	  mechanism	  may	  also	  explain	  why	  BALB/cByJ	  
mice	  are	  more	  resistant	  to	  vaso-­‐obliterative	  damage	  seen	  in	  the	  retina	  at	  P12.	  
	   Identifying	   expression	   patterns	   associated	   with	   varying	   outcomes	   can	   potentially	  
identify	   gene	   targets	   that	  would	   allow	   for	   earlier	   and	   less	   invasive	   treatments	   for	  ROP,	   a	  
leading	  cause	  of	  blindness	  in	  the	  pediatric	  population	  in	  the	  US.	  Future	  work	  expanding	  on	  
these	   results	   may	   uncover	   additional	   pharmacological	   targets	   to	   improve	   the	   visual	  
outcomes	  of	  premature	  infants	  affected	  by	  ROP.	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LIST	  OF	  ABBREVIATIONS	  
BM	  –	  bone	  marrow	  
c-­‐2J	  –	  B6(Cg)-­‐Tyrc-­‐2J/J	  mouse	  strain	  
DA	  –	  dopamine	  
D1	  –	  dopamine	  receptor	  1	  
EPC	  –	  endothelial	  progenitor	  cell	  
F2	  –	  familial	  (intercross)	  2nd	  generation	  
FEVR	  –	  familial	  exudative	  vitreoretinopathy	  
HIF-­‐1α	  –	  hypoxia-­‐inducible	  factor	  1	  α	  	  
HPLC-­‐ED	  –	  high	  performance	  liquid	  chromatography	  with	  electrochemical	  detection	  
IGF-­‐1–	  insulin-­‐like	  growth	  factor1	  
IGFBP3	  –	  insulin-­‐like	  growth	  factor	  binding	  protein	  3	  
OIR	  –	  oxygen-­‐induced	  retinopathy	  
P	  –	  post-­‐natal	  day	  
QTL	  –	  quantitative	  trait	  loci	  
ROP	  –	  Retinopathy	  of	  Prematurity	  
rt-­‐PCR	  –	  real	  time	  polymerase	  chain	  reaction	  	  
Tyr	  –	  Tyrosinase	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   ROP	   is	   a	   major	   cause	   of	   vision	   loss	   in	   infants,	   and	   incidence	   of	   this	   disease	   is	  
increasing	   worldwide.	   The	   pathogenesis	   of	   ROP	   is	   multifactorial,	   and	   several	   well-­‐
characterized	   risk	   factors	   have	   been	   identified.	   These	   include	   the	   use	   of	   oxygen	   therapy	  
(Wheatley,	   Dickinson	   et	   al.,	   2002);	   decreased	   gestational	   age	   (Wheatley,	   Dickinson	   et	   al.,	  
2002;	   Kim,	   Sohn	   et	   al.,	   2004;	   Good,	   Hardy	   et	   al.,	   2005;	   Bizzarro,	   Hussain	   et	   al.,	   2006);	  
reduced	  gestational	  weight	  (Wheatley,	  Dickinson	  et	  al.,	  2002;	  Kim,	  Sohn	  et	  al.,	  2004;	  Good,	  
Hardy	   et	   al.,	   2005;	   Bizzarro,	   Hussain	   et	   al.,	   2006)	   and	   associated	   reduced	   levels	   of	   IGF-­‐1	  
(Hellstrom,	  Perruzzi	  et	  al.,	  2001);	  and	  reduced	  levels	  of	  IGFBP3	  (Lofqvist,	  Chen	  et	  al.,	  2007;	  
Fleck	  and	  McIntosh,	  2008).	  	  
	   A	  growing	  body	  of	  evidence	  suggests	  that	  genetic	  component	  may	  also	  modulate	  risk	  
of	  ROP	  development.	  Several	  epidemiological	  studies	  have	  identified	  differences	  in	  risk	  and	  
severity	  of	  ROP	  between	  varieties	  of	  different	  ethnic	  groups	  both	  in	  the	  US	  and	  worldwide	  
(Munoz	   and	  West,	   2002;	   Tadesse,	   Dhanireddy	   et	   al.,	   2002;	   Lang,	   Blackledge	   et	   al.,	   2005;	  
Yang,	  Donovan	  et	  al.,	  2006;	  Lad,	  Nguyen	  et	  al.,	  2008).	  Two	  inherited	  diseases	  of	  the	  retinal	  
vasculature,	   FEVR	   and	   Norrie	   disease,	   share	   similar	   phenotypes	   with	   ROP;	   mutations	   in	  
causative	   genes	   have	   been	   identified	   in	   a	   small	   number	   of	   severe	   cases	   of	   ROP	   (Shastry,	  
Pendergast	  et	  al.,	  1997;	  Hiraoka,	  Berinstein	  et	  al.,	  2001;	  Talks,	  Ebenezer	  et	  al.,	  2001;	  Haider,	  
Devarajan	   et	   al.,	   2002;	   Hutcheson,	   Paluru	   et	   al.,	   2005;	  MacDonald,	   Goldberg	   et	   al.,	   2005;	  
Dickinson,	   Sale	   et	   al.,	   2006;	   Ells,	   Guernsey	   et	   al.,	   2010;	   Hiraoka,	   Takahashi	   et	   al.,	   2010).	  
Additionally,	  a	  retrospective	  twin	  study	  suggested	  that	  as	  much	  as	  70%	  of	   the	  variance	   in	  
susceptibility	   to	   ROP	   is	   due	   to	   a	   heritable	   component	   (Bizzarro,	   Hussain	   et	   al.,	   2006).	  
Despite	  this	  evidence,	  no	  genes	  associated	  with	  increased	  risk	  of	  developing	  ROP	  have	  been	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identified	  to	  date.	  Therefore,	  the	  central	  purpose	  of	  the	  described	  studies	  is	  to	  identify	  genes	  
related	  to	  susceptibility	  to	  ROP.	  	  
	   Using	   classical	   forward	   genetic	   techniques,	   we	   identified	   regions	   of	   the	   genome	  
associated	   with	   retinal	   revascularization	   in	   the	   murine	   OIR	   model	   of	   ROP.	   Subsequent	  
experiments	   confirmed	   the	   role	   of	   a	   specific	   candidate	   gene,	   Tyr,	   and	   elucidated	   a	  
mechanism	   by	   which	  Tyr	   function	   alters	   susceptibility	   to	   OIR.	   These	   studies	   additionally	  
characterize	  the	  role	  of	  EPCs	  in	  OIR	  development,	  and	  compare	  EPC	  response	  between	  Tyr-­‐
sufficient	   susceptible	   and	  Tyr-­‐null	   resistant	   strains	   of	  mice.	   Finally,	   a	  microarray	   analysis	  
adds	   insight	   into	   general	   transcriptional	   patterns	   associated	  with	  more	   or	   less	   successful	  
responses	   to	   OIR	   and	   identified	   alternative	  mechanisms	   that	  may	   also	   play	   a	   role	   in	   OIR	  
susceptibility.	  
	  
Chapter	  II:	  Identification	  of	  QTL	  related	  to	  OIR	   	  
Using	  murine	  strains	  with	  known	  differences	   in	  susceptibility	   to	  ROP,	  we	  created	  a	  
mapping	   cross	   to	   identify	   QTL	   associated	   with	   susceptibility	   to	   OIR.	   C57BL/6ByJ	   and	  
BALB/cByJ	   animals	   were	   inbred	   and	   the	   resulting	   F2	   generation	   was	   phenotyped	   and	  
selectively	  genotyped.	  Linkage	  analysis	  identified	  QTL	  associated	  with	  avascular	  area	  at	  P16	  
on	   chromosome	   7	   and	   chromosome	   9.	   Positional	  Medline	   identified	   185	   candidate	   genes	  
located	  within	  the	  support	  intervals	  of	  these	  2	  QTL	  and	  related	  to	  retinal	  angiogenesis.	  	  
Data	   from	   the	  F2	   generation	   also	   revealed	   significantly	  different	   areas	  of	   avascular	  
retina	   between	   albino	   and	   non-­‐albino	   mice.	   This	   result	   supports	   findings	   from	   a	   rat	  
backcross	  (van	  Wijngaarden,	  Brereton	  et	  al.,	  2007)	  as	  well	  as	  across	  different	  strains	  of	  rats	  
(van	   Wijngaarden,	   Coster	   et	   al.,	   2005).	   As	   albinism	   in	   the	   parental	   BALB/cByJ	   strain	   is	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caused	  by	  homozygous	  loss	  of	  function	  of	  Tyr,	  these	  data	  suggest	  that	  Tyr	  or	  a	  linked	  gene	  
may	  play	  a	  role	  in	  disease	  susceptibility.	  The	  QTL	  identified	  on	  chromosome	  7	  by	  mapping	  
analysis	  includes	  Tyr	  (located	  94.58-­‐94.64	  Mbp)	  within	  the	  support	  interval.	  	  
	  
Chapter	  III:	  Exploration	  of	  the	  role	  of	  Tyr	  in	  OIR	  
	   The	   putative	   role	   of	   Tyr	   in	   OIR	   susceptibility	   was	   further	   explored	   in	   studies	  
described	   in	   chapter	   3.	   These	   experiments	   employed	   the	   c-­‐2J	   strain	   of	  mice,	  which	  were	  
derived	   from	   the	  C57BL/6J	   strain	  but	  had	  a	   spontaneous	   loss	  of	   function	  mutation	   in	  Tyr	  
that	   was	   subsequently	   bred	   to	   homozygosity.	   Thus,	   c-­‐2J	   mice	   share	   the	   same	   genetic	  
background	  as	  C57BL/6J	  but	  are	  Tyr	  deficient.	  Exposure	  of	  both	   strains	   to	   the	  OIR	  model	  
revealed	  that	  c-­‐2J	  mice	  revascularize	  the	  retina	  more	  rapidly	  after	  hyperoxia-­‐induced	  vaso-­‐
obliteration.	  This	  finding	  is	  associated	  with	  increased	  numbers	  of	  CD34+/CD133+	  putative	  
EPCs	   in	   the	   retina	   and	   more	   numerous	   CD45-­‐/CD34+/CD133+	   cells	   in	   both	   the	   bone	  
marrow	  and	  in	  circulation.	  Together,	  these	  data	  suggest	  that	  Tyr	   function	  inhibits	  putative	  
EPC	  proliferation,	  mobilization,	  and	  retinal	  recruitment	  in	  vivo.	  
	   We	   next	   began	   to	   explore	   a	   possible	  mechanism	   by	  which	  Tyr	  may	  modify	   retinal	  
revascularization	   in	  OIR.	  HPLC-­‐ED	  analysis	  of	  serum	  samples	   found	  higher	  concentrations	  
of	   DA	   in	   serum	   of	   Tyr-­‐functional	   C57BL/6J	   mice.	   This	   finding	   is	   in	   concordance	   with	  
previously	  published	  work	  demonstrating	  that	  Tyr	  can	  contribute	  to	  peripheral	  production	  
of	   DA	   early	   in	   murine	   life,	   prior	   to	   a	   developmental	   switch	   to	   melanin	   production	  
(Eisenhofer,	  Tian	  et	  al.,	  2003).	  Intraperitoneal	  administration	  of	  DA	  in	  both	  C57BL/6J	  and	  c-­‐
2J	   mice	   results	   in	   inhibition	   of	   revascularization	   compared	   to	   saline-­‐treated	   controls.	  
Additionally,	  this	  treatment	  is	  associated	  with	  reduced	  recruitment	  of	  EPCs	  to	  the	  retina.	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   Use	  dopaminergic	  agonists	  indicate	  that	  the	  D1-­‐like	  family	  of	  receptors	  mediates	  this	  
response	  to	  DA	  signaling.	  These	  data	  support	  rt-­‐PCR	  results	  that	  demonstrate	  expression	  of	  
both	   D1	   and	   D5	   by	   BM	   and	   cultured	   EPCs.	   While	   our	   data	   conflict	   with	   prior	   work	  
identifying	  D2	  as	  the	  primary	  receptor	  responsible	  for	  inhibition	  of	  EPC	  mobilization	  by	  DA,	  
other	  studies	  have	  demonstrated	  that	  DA	  receptor	  expression	  in	  EPCs	  is	  highly	  dynamic	  and	  
responsive	  to	  the	  cytokine	  milieu	  present.	  As	  the	  aforementioned	  work	  examined	  the	  role	  of	  
DA	   in	   tumor-­‐laden	   adult	   mice,	   it	   is	   likely	   that	   differences	   in	   cytokine	   expression	   in	   our	  
neonatal,	  hyperoxia-­‐exposed	  mice	  explain	  these	  differences.	  
	  
Chapter	  IV:	  Dynamic	  role	  of	  EPCs	  in	  OIR	  
	   Given	  the	  important	  role	  EPCs	  play	  in	  retinal	  revascularization	  in	  ROP	  and	  OIR,	  our	  
next	   experiments	   were	   designed	   to	   better	   characterize	   changes	   in	   CD34+/CD133+	   EPC	  
populations	  that	  occur	  throughout	  the	  OIR	  protocol.	  Using	  the	  C57BL/6J	  and	  c-­‐2J	  strains,	  we	  
quantified	  EPC	  numbers	  in	  bone	  marrow,	  blood,	  and	  retina	  and	  quantified	  avascular	  area	  at	  
every	  day	   from	  P7	   through	  P13,	   and	  additionally	   at	  P7.5	  and	  P9.5,	  12	  and	  60	  hours	  after	  
exposure	  to	  hyperoxia.	  	  	  
	   Our	  data	   show	   that	  EPCs	   are	  highly	  dynamic	   and	   responsive	   to	   the	   stresses	  of	   the	  
OIR	  model.	  EPCs	  followed	  different	  patterns	  in	  each	  tissue	  tested.	  Circulating	  EPCs	  were	  an	  
especially	   variable	   population,	   which	   may	   explain	   some	   discrepancies	   in	   the	   literature	  
amongst	  reports	  that	  suggest	  conflicting	  effects	  of	  dopaminergic	  regulation	  of	  this	  process.	  
	   Importantly,	   our	   data	   suggest	   that	   the	   customary	   time	  points	   used	   to	   describe	   the	  
OIR	  model	  may	  not	  accurately	  describe	  the	  physiological	  changes.	  Traditionally,	  P7	  through	  
P12	   are	   the	   time	   points	   used	   to	   describe	   the	   vaso-­‐obliterative	   phase	   of	   OIR,	   and	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revascularization	  and	  NV	  are	  thought	  to	  occur	  after	  P12.	  However,	  our	  data	  suggest	  that	  OIR	  
can	  no	  longer	  be	  considered	  a	  2-­‐stage	  process.	  Rather,	  there	  are	  several	  stages:	  early	  vaso-­‐
obliteration,	   late	   vaso-­‐obliteration,	   EPC	   response	   in	   the	   presence	   of	   hyperoxia,	   EPC	  
response	  in	  the	  presence	  of	  normoxia,	  and	  pathological	  vascularization.	  Thus,	  the	  timing	  of	  
interventions	  targeting	  these	  processes	  should	  be	  designed	  with	  this	  sequence	  in	  mind.	  	  	  	  
	  
Chapter	  V:	  Microarray	  analysis	  
Our	   microarray	   analysis,	   confirmatory	   rt-­‐PCR	   data,	   and	   GSEA	   results	   identified	  
several	   interesting	   pathways	   that	   may	   contribute	   to	   differential	   susceptibility	   to	   OIR.	  
Exposure	   to	   the	  OIR	  model	   led	   to	   increased	   expression	   in	   inflammatory	   genes	   in	  mice	   of	  
both	  strains.	   	   In	  the	  C57BL/6ByJ	  strain,	  up-­‐regulation	  of	  angiogenic	  genes	   is	  paradoxically	  
associated	  with	  slower	  vascular	  regeneration	  and	  a	  greater	  degree	  of	  pathological	  NV.	  These	  
genes	  may	  be	  up-­‐regulated	  compared	   to	  BALB/cByJ	  mice	  due	   to	   the	   increased	  hypoxia	  of	  
their	  larger	  avascular	  area,	  although	  more	  studies	  are	  need	  to	  clarify	  the	  regulation	  of	  these	  
genes	  changes.	  Our	  microarray	  data	  are	   in	   line	  with	  other	  studies	  published	  using	  various	  
C57BL	  sub-­‐strains	  of	  mice.	  
	   Increased	  expression	  of	  metabolic	  genes	  was	  associated	  with	  improved	  OIR	  outcome	  
in	  the	  BALB/cByJ	  strain.	  This	  finding	  may	  be	  a	  direct	  result	  of	  HIF-­‐1α	  signaling	  in	  hypoxia.	  
However,	  GSEA	  results	  alternatively	  suggest	  changes	   in	  expression	  of	  metabolic	  pathways	  
may	  be	  related	  to	  an	  up-­‐regulation	  of	  the	  glutathione	  pathway,	  which	  would	  likely	  decrease	  
oxidative	  stress.	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   Identifying	   expression	   patterns	   associated	   with	   varying	   outcomes	   can	   potentially	  
identify	   gene	   targets	   that	   would	   allow	   for	   earlier	   and	   less	   invasive	   treatments	   for	   ROP.	  
Follow-­‐up	  studies	  will	  explore	  gene	  candidates	  identified	  in	  this	  study.	  
	  
Perspective	  
	   This	   study	   represents	   the	   first	   genome-­‐wide	   approach	   to	   determining	   novel	  
mechanisms	  underlying	  retinal	  revascularization	  in	  OIR.	  Additionally,	  we	  have	  identified	  a	  
novel	  mechanism	  of	   dopaminergic	   control	   of	   angiogenesis	   in	   the	   retina.	  This	   finding	   is	   of	  
particular	  importance	  clinically	  as	  DA	  is	  used	  therapeutically	  in	  the	  neonatal	  intensive	  care	  
unit.	  Our	  work	  revives	  the	  earlier	  hypothesis	  that	  use	  of	  DA	  is	  associated	  with	  increased	  risk	  
of	  severe	  ROP.	  
	   	  This	  pathway	  may	  offer	  a	  pharmacological	   target	   for	   improving	  ROP	  outcome.	   It	   is	  
possible	   that	   improvement	   of	   EPC	   function	   and	   recruitment	   to	   the	   retina	   may	   mitigate	  
retinal	   vascular	   arrest	   in	   the	   first	   phase	   of	   ROP,	   thus	   preventing	   the	   vision-­‐threatening	  
complications	  of	  the	  second	  stage.	  Additionally,	  these	  findings	  likely	  apply	  to	  other	  vascular	  
retinopathies	   such	  as	  diabetic	   retinopathy	  and	  vein	  occlusion	  retinopathy,	  and	  potentially	  
other	  diseases	  of	  angiogenesis,	  such	  as	  cardiovascular	  repair	  after	  myocardial	  infarction	  and	  
tumor	  metastasis.	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